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GENERAL SUMMARY 
 Infections due to Escherichia coli and Salmonella spp. are known to 
account for a substantial degree of morbidity and mortality in different age 
groups and populations worldwide. These infections may be self-limiting but in 
some cases antimicrobial therapy are indicated. With vaccine development still in 
its infancy in most cases and the increasing trend of drug resistance, the 
continued monitoring and assessment of antibiotics used in the treatment of 
these infections are paramount. In addition, there is a need to complement 
orthodox medicine with ethnomedicine for a lead to new drug discovery and for 
total primary health care coverage of the underserved populations.  In this 
regard, medicinal plants offer great promise and studies to uncover the 
antimicrobial activities of medicinal plants, including structural elucidation of the 
active compounds and cytotoxicities of such plants are usually warranted. 
Furthermore, studies on the molecular landscape of the organisms, especially the 
various genes coding for virulence and antimicrobial resistance and the 
phylogenetic relatedness will illuminate knowledge on the pathogenesis and 
epidemiology of the pathogens. 
The thesis, consisting of eight chapters, chronicles the findings on 
antibiogram profiles of the designated pathogens, inhibitory activities of selected 
medicinal plants, including their active compounds and cytotoxicity profiles as 
well as the molecular epidemiology of the pathogens. The first chapter gives a 
vivid account of the background to the study and the review of the literature.    
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 Chapter 2 is an account of the antimicrobial resistance patterns as well as   
the molecular basis of resistance in E. coli and Salmonella isolates from clinical 
specimens. Isolates were antibiotyped while PCR and sequencing were carried 
out to identify genes modulating antibiotic resistance. The study showed an 
increase in multiple-drug resistance and an emerging resistance to penem drugs, 
an indication of limited choice of drugs in the chemotherapy of enteric disease. 
An alarmingly high percentage of isolates produced extended-spectrum beta-
lactamases (ESBL), with prevalent genotypes being blaCMY-2, blaSHV-1, blaTEM-20 and 
blaTEM-1. In addition, Class I integron was significantly involved in the resistance 
mechanism among the isolates. 
 Chapter 3 was designed to investigate the pathotypes and the various 
virulence factors among E. coli and Salmonella isolates. Using standard 
diagnostic methods and molecular analysis, of the 119 Salmonella isolates, the 
results of the serovars were S. enterica serovar Choleraesuis (6%), S. enterica 
serovar Enteritidis (4%), S. enterica serovar Eppendorf (1%), S. enterica serovar 
Hadar (1%), S. enterica serovar Isangi (8%), S. enterica serovar Panama (1%), 
S. enterica serovar Typhi (52%), S. enterica serovar Typhimurium (25%) and 
untyped Salmonella spp. (2%). The greatest proportion of the 90 diarrhoegenic 
E. coli were enteroaggregative E. coli (EAEC) 37 (41.1%), enteropathogenic E. 
coli (EPEC) 21 (23.3%) and enterohemorrhagic E. coli (EHEC) 21 (23.3%). 
Various virulence factors identified amongst the Salmonella strains were flic-
flagellin H1 (12.6%), invA-invasion (88.2%), sefA- fimbrial antigen (1.7%) while 
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aggR- transcriptional activator for EAEC aggregative adherence fimbria I 
expression, eaeA-E. coli attaching and effacing and LT- heat-labile enterotoxin 
were found among the E. coli isolates. 
 In chapter 4, an ethnobotanical survey of medicinal plants used in the 
treatment of diarrhoea and related diseases in the ORTDM in the Eastern Cape of 
South Africa was embarked upon. This assisted in documentation of herbal 
plants and the extent of usage of ethnomedicine in the district municipality with 
the eventual aim of assessing the efficacies of some of the plants. A total of 32 
plant species belonging to 26 families were reportedly used as diarrhoea remedy 
in the study area. The most predominant families of medicinal plants employed 
and most frequently recommended were Fabaceae (16.67%), followed by 
Hyacinthaceae and Hydnoraceae , each accounting for 8.33%. The majority of 
the rural dwellers depended on ethnomedicine due to the inaccessibility to 
orthodox medicine. This was due to several factors such as the distance between 
the communities and the nearest health care centres and financial constraints.  
 The ethnobotanical survey led to the antibacterial screening of 12 
medicinal plants: Acacia mearnsii, Aloe arborescens, Aloe striata, Cyathula 
uncinulata, Eucomis autumnalis (Mill.) Chitt., E. comosa (Houtt.) Wehrh. 
Hermbstaedtia odorata, Hydnora africana, Hypoxis latifolia, Pelargonium 
sidoides, Psidium guajava and, Scilla natalensis frequently recommended by the 
traditional healers. A qualitative phytochemical screening and bioassays of the 
plants’ extracts was carried out. Antimicrobial screening was by broth 
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microdilution and bioautography. The presence of terpenoid and flavonoids in 
some herbs were inferred from the TLC fingerprints. Most of the tested 
organisms were sensitive to the crude acetone extracts with MIC values ranging 
from 0.078–2.5 mg/mℓ. Acetone and methanolic extracts of Aloe striata, Cyathula 
uncinulata, E. autumnalis and P. guajava were more active against 
enteropathogens This preliminary study revealed the promising antibacterial 
activities of some of the selected herbs used in the treatment of diarrhoea and 
related diseases and corroborated assertions on their efficacies by traditional 
healers, as reflected in Chapter 5. 
 Chapter 6 described the separation of compounds from the bioactive ethyl 
acetate fractions of C. uncinulata by solvent-solvent fractionation. This plant was 
selected based on its antibacterial activity. The structure of the isolated 
compound was elucidated by nuclear magnetic resonance spectroscopy and 
mass spectroscopy methods. The NMR spectra of the isolated compound showed 
that the compound, with formula C22H38O7 and molecular weight 414.5329 had a 
long aliphatic chain. The isolated compound was described as Glycosylated 
oleanolic acid, made up of sugar with fatty acyl moiety. The MIC of fractions of 
extracts ranged from 0.39 to 2.5 mg/mL. The lowest MIC was observed in ethyl-
acetate fraction and for the selected sub-fraction of the ethyl acetate (SSC 1) 
fractionation MIC was 0.63 mg/mL. The MIC of the final purified compound was 
0.34 mg/mL, indicating considerable bioactivity; hence, this may serve as 
template for new antimicrobial formulations. 
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 The study in chapter 7 was carried out to assess the therapeutic safety of 
some selected medicinal plants. The cytotoxicity of methanol extracts and 
fractions of six selected plants was determined using a modified tetrazolium-
based colorimetric assay [3-(4, 5-dimethylthiazol)-2, 5-diphenyl tetrazolium 
bromide (MTT) assay]. The in vitro cytotoxicity assay on human 
hepatocarcinoma cell line (Huh-7) revealed that the methanol extract of E. 
autumnalis had the strongest cytotoxicity with IC50 of 7.8 µg/mL. Ethyl acetate 
and butanol fractions of C. uncinulata, H. latifolia, E. autumnalis and Lantana 
camara had lower cytotoxic effects on the cancer cell lines tested with IC50 
values ranging from 24.8 µg/mL to 44.1 µg/mL while all the fractions of A. 
arborescens and A. striata had insignificant or no cytotoxic effects after 72 h of 
treatment. The results showed that E. autumnalis may serve as anticancer agent 
while the Aloe species were apparently safe within the range studied. 
The general conclusions and recommendations of the various parts of the 
findings were captured in Chapter 8. There was increasing multi-drug resistant 
and emerging resistance to penem drugs among isolates particularly Salmonella 
strains. Molecular analysis showed that beta-lactamase enzymes and class 1 
integron (Int1) genes played significant roles in antibiotic resistance among 
Salmonella spp. with diverse virulence genes identified among the Salmonella 
and E. coli isolates. In addition, E. coli strains from apparently asymptomatic 
subjects harboured considerable virulence genes making them potential 
reservoirs of factors important in the spread and acquisition of virulence and 
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drug resistance genes. Among the plants used in ethnomedicine in ORTDM, A. 
arborescens, A. striata, C. uncinulata, E. autumnalis and P. guajava were noted 
as potential plants for antibacterial agents. Further fractionation and purification 
of bioactive components of the ethyl acetate fraction of C. uncinulata yielded an 
isolated compound - glycosylated oleanolic acid, a sugar with fatty acyl moiety 
which had considerable antibacterial activities. The evaluation assay for 
therapeutic safety of selected medicinal plants indicated extensive cytotoxicity 
and selective anticancer activity of E. autumnalis, even though it had strong 
antibacterial activities.  
 It was recommended that measures be put in place to curtail the 
spread of drug resistance, particularly the ESBL-type resistance through 
improved and standardized laboratory practice. Proper and regular surveillance 
should be maintained to help guide the rational use of antibiotics in empirical 
treatment and measures should be in place to discourage the use of broad-
spectrum antibiotics. The recognition but cautious use of medicinal plants as an 
alternative therapy and a probable means to mitigate the emerging resistance 
problem was recommended. 
 Overall, improved standard of hygiene both in the hospital settings and 
the communities is paramount to prevention of infections as ‘prevention is better 
than cure’. 
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CHAPTER 1 
 
1. GENERAL INTRODUCTION AND LITERATURE REVIEW 
1.1. Introduction 
Diarrhoeal diseases remain one of the greatest health problems in many 
parts of the world. In some cases, the disease is mild and self-limiting; however, 
the symptoms may be very severe in the elderly and young children (Smith and 
Cheasty, 1998), as well as in immunocompromised patients such as HIV/AIDS 
patients. The disease is one of the hallmarks of HIV/AIDS in developing countries 
and is also a cardinal clinical manifestation of water borne infections (Obi et al., 
2007). According to a World Health Organization report (WHO, 2004), diarrhoea 
was rated second, after respiratory infections out of the eight deadliest diseases 
worldwide and was responsible for 1.8 million deaths per year. This infectious 
disease which can cause dehydration is primarily a symptom of gastrointestinal 
infection but chemical irritation of the gut or non-infectious bowel disease can 
also result in diarrhoea.  
Studies have shown that the predominant causative agents of acute and 
persistent diarrhoea are Gram-negative rods such as Escherichia coli, Vibrio 
cholerae, Aeromonas, Campylobacter, Salmonella species, Shigella species, 
Plesiomonas shigelloides and Yersinia enterocolitica (Obi et al., 1995, 1998, 
2003; Lainson and Silva, 1999; Coker et al., 2002; Oyofo et al., 2002). Aside 
from bacterial agents of diarrhoea, other causative pathogens include protozoa 
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such as Giardia lamblia and Cryptosporidium parvum; viruses such as 
norwalkvirus and rotavirus. Although fungal agents such as Candida have been 
shown to be prevalent in children with diarrhoea (Enweani et al. 1994), a more 
recent study (Forbes et al., 2001), associated higher Candida counts with recent 
antibiotic use. Faecal concentrations of Candida were higher in patients with 
diarrhoea but the study confirmed no association between faecal candida or 
other yeasts and diarrhoea. Norwalk viruses, calci-like viruses and rotaviruses are 
the major viral agents of diarrhoea. According to Parashar et al., (2006), 
rotavirus is the leading cause of diarrhoeal hospitalization among children 
worldwide, causing 440,000 annual deaths in children under 5 years of age.  
Production of disease by enteropathogens often involves specific 
serotypes of the organisms and special virulence factors. Some arsenals for 
pathogenicity include ability to adhere to host surfaces, production of special 
proteins for invasion and colonization. In addition, some pathogens are able to 
produce virulent factors which incapacitate the host's immune system defenses 
or those that poison host cells and cause tissue damage. Studies have shown 
that some of the pathogenic factors of enterobacteria are genetically modulated. 
The mechanisms of diarrhoea induction and role in the development of 
diarrhoeal syndrome of several genes associated with pathogenicity islands 
(PAIS): adhesins, hlyA, hlyB (hemolysin), sfaG (fimbria antigen type S), cnf1 
(cytotoxic necrotizing factor 1), estB (heat-stable enterotoxin B), bacterial 
modulins, cytotonic and cytotoxic enterotoxins, including LT, ST, Shiga-like and 
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cytolethal toxins have been described (Mavzutov et al., 2007; Zherebtsova et al., 
2007). Virulence factors of Salmonella and Shigella species are complex and 
encoded both on the organism's chromosome and on large (34-120 kd) plasmids. 
Several Salmonella pathogenicity islands have been identified that mediate 
uptake of the bacteria into epithelial cells (type III secretion system), non-
phagocytic cell invasion (Salmonella pathogenicity-island 1), and survival and 
replication within macrophages (Salmonella pathogenicity-island 2, phoP/phoQ) 
(Finlay, 1994; Darwin and Miller, 1999, Kato et al., 2008; Charles et al., 2009). 
Shigella species cause damage by two mechanisms, invasion of the colonic 
epithelium, which is dependent on a plasmid-mediated virulence factor (ipa 
protein, invasin), and production of enterotoxin (ShET 1 and ShET 2), secreted 
by the organism. These have been shown to cause small bowel secretion and 
watery diarrhoea, which is not essential for colitis but enhances virulence (Wolf 
and Gianella, 1996; Bernasconi et al., 2004). Verotoxin, which 
enterohemorrhagic E coli and Shigella species produce, causes systemic 
disorders such as seizures and hemolytic-uremic syndrome (HUS) (Trachtman 
and Christen, 1999).  
Increasing resistance to the fluoroquinolones and the third-generation 
cephalosporins is of major concern among members of the Enterobacteriaceae.  
The susceptibility patterns of enteric bacteria to various antibiotics as reported in 
sub-Saharan Africa, (Sinha et al., 2004; Maraki et al., 2005; Yismaw et al., 2006; 
Obi et al., 2007),  showed a slow decline in fluoroquinolone susceptibility. Over 
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90% of all the organisms isolated from a cohort study in Limpopo (Obi et al., 
2007), showed resistance to penicillin, cloxacillin and amoxicillin but conversely, 
almost all the organisms were sensitive to ciprofloxacin, gentamycin, meropenem 
and imipenem. On the contrary, decrease in fluoroquinolone susceptibility has 
been more dramatic in other areas of the world such as Latin America and 
Southern Europe (Jones et al., 1997). Several mechanisms are involved in the 
antibiotic resistance of members of the Enterobacteriaceae; these include 
mutations involved in enzyme productions (Jones et al., 1997; Jones, 2003). 
Enterobacteriaceae commonly express plasmid-encoded β-lactamases (mostly 
TEM-1, TEM-2, and SHV-1) that confer resistance to penicillins (Maurine et al., 
2002). Another type of resistance affecting third-generation cephalosporins and 
aztreonam (a monobactam) has been the hyperproduction of an Amp C 
cephalosporinase by some of the enteric strains (Jones et al., 1997). The 
resistance to extended-spectrum cephalosporin among the Enterobacteriaceae 
has become a growing problem (Bradford et al., 2001). 
Another factor which confers antibiotic resistance to clinical isolates is 
class 1 integron (Leverstein-van Hall et al., 2003; Segal et al. 2003). Most 
resistance integrons belong to class 1. Integrons are genetic elements composed 
of a gene encoding an integrase, gene cassettes and an integration site for the 
gene cassettes (Fluit and Schmitz, 2004). These DNA elements play important 
role in the spread of antibiotic-resistance genes. Recently, the discovery of larger 
integron structures, termed super-integrons has broadened bacterial genome 
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(Mazel, 2006). Integrons can be broadly divided into two: the resistance 
integrons and super-integrons. Several reports have linked Class 1 integrons to 
resistance in various Gram negative genera. This genetic element was detected 
and characterized in various serotypes of Salmonella enterica (Brown et al., 
2000; Guerra et al., 2001); Shigella (Navia et al., 1999; McIver et al., 2002), 
Escherichia (Mazel et al., 2000; Zhao et al., 2001). An integron-like drug 
resistance region and a plasmid-borne class 1 integron was found on the 
transferable R-plasmid pJA8102-1 from Aeromonas salmonicida and an atypical 
A. salmonicida respectively (Inglis et al., 1993; Barnes et al., 1994). Class 2 
integrons are embedded in the Tn7 family of transposons and consist of an 
integrase gene followed by gene cassettes (Radstrom et al., 1994). Integrons 
belonging to class 2 have also been reported in Salmonella (Orman et al., 2000) 
and Shigella (Gonzalez et al., 1998). Class 3 integrons have been described in 
Pseudomonas aeruginosa, Serratia marcescens, Alcaligenes xylosoxidans, P. 
putida and Klebsiella pneumoniae isolates from Japan (Izumiya et al., 2000).  
With the emerging multiple antibiotic resistance saga, there has been a 
paradigm shift to natural products particularly medicinal plants for succor. A 
large proportion of the populace of developing countries employ the use of 
traditional medicine, alone, or in combination with Western drugs to treat a wide 
variety of ailments including diarrhoea (Taylor et al., 2001). In South Africa, 
traditional medicine is well recognized and different communities use a wide 
variety of plants to treat gastrointestinal disorders such as diarrhea and infection 
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by intestinal parasites, which are particularly prevalent in rural areas (McGaw et 
al., 2000). Many studies have documented the anti-enteric bacterial activities of 
some medicinal plants, Herba pogostemonis extracts (Liu et al., 1999), 
Roureopsis obliquifoliolata and Epinetrum villosum (Longaga et al., 2001), Aegle 
Marmelos (Correa) Linn. root extract (Mazumder et al., 2006), Zornia milneana 
(Papilionoideae) (Samie et al., 2007).   
The importance of enteric bacteria such as Salmonella, Shigella and E. coli 
as agents of diarrhoeal disease is of great significance but, their involvements in 
diarrhoea cases in this local setting of Eastern Cape Province, South Africa, 
including associated virulence factors and genes coding for antibiotic resistance 
in these enteric bacterial species particularly at the molecular level have not been 
extensively investigated.   
 
1.2. Literature survey 
1.2.1. Diarrhoea as a Disease 
Of major public health concern are diarrhoeal diseases, particularly with 
regards to the developing countries where they are the leading cause of 
childhood morbidity and mortality. Diarrhoea, most commonly caused by 
gastrointestinal infections occurs world-wide and causes 4% of all deaths and 
5% of health loss to disability (WHO, 2000). Annually, there are approximately 4 
billion cases of diarrhoea worldwide which kill around 2.2 million people, mostly 
children in developing countries (WHO and UNICEF, 2000). Diarrhoea goes hand 
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in hand with hygiene, food and water quality. It has been reported that 88% of 
diarrhoeal diseases are attributed to unsafe water supply, inadequate sanitation 
and hygiene (WHO, 2004). In the developing world, sporadic outbreaks of 
diarrhoea are still a common feature despite advances in health interventions. 
Diarrhoea has been defined as the passage of loose, watery stools 
occurring more than three times in one day or the passage of loose or liquid 
stools more frequently than is normal for the individual (WHO, 2000). The 
disease may be mild and lasting a day or two and self-resolves without any 
special treatment. However, prolonged diarrhoea can be a sign of other 
problems. Diarrhoea can cause dehydration, which means the body lacks enough 
fluid to function properly. Dehydration is particularly dangerous in children and 
the elderly, and it must be treated promptly to avoid serious health problems. 
Likewise, diarrhoea has been associated with other infections such as malaria, 
measles, HIV/AIDS, pneumonia, systemic infections and meningitis (Reisinger et 
al., 2005). 
1.2.2. Forms of Diarrhoea 
Diarrhoea comes in different forms depending on the type of infection; it may 
be mucoid, watery or passed with blood. 
1.2.2.1. Acute Watery Diarrhoea 
Acute diarrrhoea is often a result of gastric flu (gastroenteritis) which is 
usually of viral origin. The duration of acute diarrhea is usually less than 14 days 
and its associated symptoms are abdominal pain, nausea, vomiting and fever. 
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Gastroenteritis is caused in a few cases by bacteria and this is often times more 
fatal than viral diarrhea. The causative agents of acute watery diarrhea are 
viruses usually rotavirus in infants under 5 years (Greenberg and Estes, 2009) 
and norovirus in adults (Patel et al., 2009). Bacterial agents of gastroenteritis 
include enterotoxigenic E. coli and Vibro cholerae 01. Acute diarrhea can 
complicate nutritional status in children leading to malabsorption of nutrients and 
long-term effects of growth failure and malnutrition (Black et al., 1984; Lifshitz, 
1989). 
1.2.2.2. Acute Bloody Diarrhoea 
This is often passage of loose stool with visible blood. It is termed dysentery 
and is an indication of invasion of bowel tissue. Complications of dysentery 
include intestinal damage, sepsis, malnutrition and dehydration may also occur. 
The main causative agents of bloody diarrhea are Shigella spp., Salmonella spp., 
E. coli 0157, Campylobacter spp., and Entamoeba histolytica (Goldsmid, 2007). 
Ten percent of all episodes and 15% of deaths respectively from diarrhoea in 
children less than 5 years of age worldwide are due to acute bloody diarrhea 
(Esona et al., 2003). 
1.2.2.3. Chronic or Persistent Diarrhoea  
Persistent diarrhea is associated with loose or watery stools with or 
without visible blood lasting more than 14 days. The main complication of this 
disease is malnutrition and serious non-intestinal infection; dehydration may also 
occur. Infective diarrhea may persist with no visible symptoms in which case an 
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individual becomes a carrier, often the case with Salmonella infection. Apart from 
bacterial agents chronic infective diarrhea may be caused by parasites such as 
Cryptosporidium, Giardia lamblia, worms and amoeba.  However, some infants 
between the ages of 6 months to 3 years have chronic diarrhea for which no 
apparent medical cause can be found (Encyclopedia of Childhood and 
Adolescence, n.d). Chronic non infective diarrhea usually depicts more severe 
medical conditions mainly malabsorption in its various forms. These conditions 
which impede normal digestion include ciliac disease, in which the wheat protein 
gluten is intolerable to the gut. Others are cystic fibrosis, lactose intolerance, 
pernicious anemia and fibrosis due to cancer therapy. Antibiotic therapy may 
favour proliferation of the bacterium, Clostridium difficile. This bacterium can 
produce a toxin that damages the lining of the colon and causes mild to severe 
diarrhea (Encyclopedia of Childhood and Adolescence, n.d).   
1.2.3. Causes of Diarrhoea 
Diarrhoea though primarily a symptom of gastrointestinal infection, 
chemical irritation of the gut or non-infectious bowel disease can also result in 
this disease. Infectious diarrhoea is caused by a host of bacterial, viral and 
parasitic organisms most of which can be spread as a result of poor water quality 
(WHO, 2000). It is more common when there is a shortage of clean water for 
drinking, cooking and cleaning and basic hygiene is important in prevention. 
Water contaminated with human faeces such as municipal sewage, septic tanks 
and latrines is of special concern. Food is another major source of infectious 
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diarrhoea when it is prepared or stored in unhygienic conditions. Food 
contamination by irrigation water, fish and seafood from polluted water may also 
contribute to diarrhea and enteric infections (CDC, 2005b; Newman, 2005; WHO, 
2007). Diarrhoea can also spread from person to person, aggravated by poor 
personal hygiene (WHO, 2000). 
1.2.3.1. Non-infectious agents of diarrhea 
According to Levy (1988), diarrhoea as a result of non-infectious agents 
includes: 
i. Carbohydrate intolerance:  
a. Primary enzyme deficiencies (e.g. Lactose intolerance)  
b. Glucose-galactose malabsorption (e.g. immune disorders, mucosal 
diseases) 
ii. Gastrointestinal allergies to Cow’s milk protein, soy milk or gluten (wheat 
protein) 
iii. Pancreatic insufficiency: cystic fibrosis 
iv. Immune deficiencies: hypogamma globulinemia, IgA deficiency 
v. Metabolic: Abetalipoproteinemia, familial chloride diarrhoea, acid lipase  
deficiency. 
vi. Anatomic abnormalities: Enteric fistula, short bowel, pseudo-obstruction  
1.2.3.2. Infectious agents of Diarrhoea 
Enteric pathogens implicated in cases of diarrhoea may be bacterial, viral, 
fungal, parasitic or protozoal. Another infectious agent which has been 
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implicated particularly in food-related infection is prion (Mead et al, 1999; 
Collinge, 2001; Smith and Bradley, 2003). Table 1 below is a slight modification 
of various enteric pathogens with their clinical manifestations as summarized by 
Goldsmid (2007). However, the scope of this study is bacterial enteric pathogens 
and rather than providing a general overview of infectious agents of diarrhoea, 
this section of the review will focus on three enteric bacterial pathogens with 
vast human morbidity worldwide (Buzby and Roberts, 2009): 
 Salmonella 
 Shigella 
 Escherichia coli 
 
I. Salmonella 
The salmonellae are actively motile, gram-negative facultative, intracellular 
anaerobes which do not ferment lactose, but most form H2S or gas from 
carbohydrate fermentation. As with the closely related bacterium Escherichia coli, 
salmonellae are potential enteric pathogens and are leading causes of bacterial 
foodborne illness (Klotchko and Wallace, 2009). Salmonella species are also of 
public health significance worldwide causing a wide spectrum of disease ranging 
from a gastroenteritis, enteric or typhoid fever (caused by S. enterica serovar 
Typhi and S. enterica serovar Paratyphi serotypes), bacteremia, osteomyelitis 
and enterocolitis (primarily S. enterica serovar Typhimurium and S. enteritidis), 
to a convalescent lifetime carrier state (Owens, 2009; Klotchko and Wallace, 
2009).   
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Table 1.1. Summary of enteric pathogens by group 
PATHOGEN COMMENTS 
Bacteria  
Aeromonas spp. Can be dysenteric and/or persistent 
Bacillus cereus Food poisoning – often associated with rice 
Clostridium perfringens 
type A 
Food poisoning 
C. perfringens type C Enteritis necroticans 
C. botulinum May get diarrhoea in early stages 
C. difficile Antibiotic associated, may be bloody in 
pseudomembranous colitis 
Enteroaaggregative E. 
coli (EAggEC) 
May cause persistent diarrhoea 
Enterohaemorrhagic E. 
coli (EHEC)  
May cause a bloody diarrhoea; can proceed to 
haemolytic uraemic syndrome (especially serotype 
0157:H7) 
Enteroinvasive E. coli 
(EIEC) 
May cause bloody diarrhoea 
Entertoxigenic S. aureus Food poisoning intoxication 
Listeria monocytogenes Occasional cause of diarrhoea 
Plesiomonas 
shigelloides 
Can sometimes cause dysenteric illness 
Salmonella typhi 
S. paratyphi 
Presents initially with constipation but may develop 
diarrhoea later in infection 
Vibrio cholerae 01:0139 Rare in returned travelers 
Noncholera vibrios Some associated with seafood 
Yersinia enterocolitica  Mesenteric lymphadenitis; may cause bloody diarrhoea 
Virus  
Adenovirus Causes severe diarrhoea with dehydration 
Astroviruses Often transmitted via food than other viruses 
Caliciviruses Often transmitted via food than other viruses 
Hepatitis A,  
 
Hepatitis E 
Infect the gastrointestinal or respiratory tracts causing 
a wide range of illness, including diarrhoea, fever, 
hepatitis, paralysis, meningitis and heart disease 
Have the human liver as the primary target of 
replication and give rise to hepatitis or inflammation of 
the liver 
Norovirus Causes stomach flu, vomiting, diarrhea by 
inflammation of the stomach and intestines, and some 
stomach cramping 
Norwalk-like viruses Often transmitted via food than other viruses 
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Rotavirus Common cause of severe viral diarrhoea in infants and 
young children under 5 years old 
Protozoa  
Balantidium coli Zoonotic – causes colitis and dysentery 
Blastocystis hominis If large numbers present in faecal specimen and no 
other cause of diarrhoea detected 
Crptosporidium parvum Causes enteric illness that has received much attention 
as an infection of immunocompromised persons 
Cyclospora Emerging as opportunistic pathogens associated with 
diarrhoea. 
Entamoeba histolytica Mucoid diarrhoea commonly streaked with some 
amount of blood. 
Dientamoeba fragilis Causes low-grade inflammation coupled with mucous 
diarrhea and gastrointestinal disturbance 
Giardia 
intestinalis/lamblia 
Symptoms include diarrhoea (fatty, yellowish) 
weakness, weight loss, abdominal pain 
Isospora belli Watery diarrhoea in children and patients with AIDS 
Microsporidia Emerging as opportunistic pathogens associated with 
diarrhoea 
P. falciparum The initial presentation of complicated malaria may be 
diarrhoea-like illness 
Helminths  
Schistosoma mansoni Causes intermittent loose stools 
S. japonicum Causes fever, aching, cough, diarrhea, or gland 
enlargement 
Strongyloides stercoralis Especially in cases of internal autoinfection 
Taenia spp. Beef and pork tapeworms occasionally 
Trichuris trichiura With very heavy worm loads, may be bloody 
Trichinella spp. Diarrhoea in early infection 
 
Salmonella infections may be categorized into four clinical types. Firstly, 
gastroenteritis (ranging from mild to fulminant diarrhoea, nausea and vomiting) 
typical in most individuals infected with S. enterica serovar Typhimurium 
(Honish, 2000), secondly, bacteraemia or septicaemia (high spiking fever with 
positive blood cultures), thirdly, enteric fever (mild fever and diarrhoea) and 
lastly, a carrier state in persons with previous infections. Symptoms of 
gastroenteritis appear 4 to 5 days after ingestion of contaminated food or water. 
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Diarrhoea lasts 3 to 5 days and is accompanied by fever and abdominal pain. S. 
enterica serovars Typhi, Paratyphi A and Paratyphi B can cause enteric fever 
without any presentation of diarrhoea and are important causes of enteric fever 
in underdeveloped countries.  
Salmonellosis affects both humans and animals but S. enterica serovar 
Typhi is adapted to humans and does not occur in animals while non-typhoidal 
Salmonella serovars (NTS) have a broad vertebrate host range (Gordon, 2008). 
The dissemination of salmonellosis to various organs depends on the serotype, 
the size of the inoculum, and the status of the host. NTS display more severe 
and invasive presentation in immunocompromized individuals especially HIV 
carriers, including severe and progressive diseases such as chronic 
granulomatosis disease, blockade of IL-12/ IL-23 /IL-17 and TNF, suppurative 
foci and bacteremia which may be recurrent (Gordon, 2008). In the small 
intestine, Salmonella ingestion progresses to diffuse mucosal inflammation, 
edema, and microabscesses (Chatterjee et al., 2009). Generally, most NTS do 
not extend beyond the lamina propria and lymphatics of the gut. Exceptions 
include S. enterica serovar Choleraesuis and S. enterica serovar Dublin, which 
can cause bacteremia with little intestinal involvement (Chiu et al., 2006). S. 
enterica serovar Typhi causes intestinal necrosis which can ulcerate and result in 
perforation. In addition, this mucosal penetration allows uptake into the draining 
lymph nodes, contributing to blood stream infections and subsequent invasion of 
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the liver, spleen, and bone marrow. This process explains the delayed onset of 
symptoms in S. enterica serovar Typhi (Reller, 2008).  
Worldwide estimates of NTS range from 200 million to 1.3 billion, with an 
estimated death toll of 3 million each year (Coburn et al., 2007). However, 
typhoidal salmonellae lead to approximately 2.16 million cases of infections and 
216,000 deaths worldwide (Crum et al., 2004; Boyle et al., 2007; Sethuraman 
and Kamat, 2007). In the United States, an annual estimated 1.4 million cases of 
salmonellosis occur among humans (Mead et al., 1999). Additionally, an 
estimated 500 people are infected with typhoid Salmonella annually (Linam and 
Gerber, 2007). Typhoid fever is endemic in many developing areas of the world 
vis-à-vis Africa, Latin America and in particular five Asian countries namely: 
China, India, Indonesia, Pakistan, and Vietnam (Pickering et al., 2005; Miller et 
al., 2008).  
The genus Salmonella is highly polymorphic, occurring in several distinct 
forms. According to Janda and Abbott (2006), two species of Salmonella have 
been recognized, S. enterica and S. bongori. Eight subgroups or subspecies have 
been defined using a variety of molecular methods (Janda and Abbott 1998; 
Brown et al., 2002; Chan et al., 2003). However, in 2005, all Salmonella species 
became officially recognized as a single species S. enterica based on their close 
relationship by DNA hybridization studies (Su and Chui, 2007; Reller, 2008). 
There are currently 2,500 serotypes (serovars) of Salmonella (Su and Chui, 
2007). The Kauffmann-White scheme for Salmonella based on different 
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combinations of somatic O, surface Vi, and flagellar H antigens have been 
described (Popoff and Le Minor, 1997; Kenner et al., 2000). S bongori contains 
only a single subspecies or subgroup (subgroup V, bongori). S enterica contains 
the remaining 7 subgroups, 2 of which contain the clinically relevant salmonellae. 
S. enterica serovar Typhimurium and S. enterica serovar Enteritidis are the most 
frequently isolated serovars from food-borne outbreaks throughout the world 
(Herikstad et al., 2002) particularly from poultry products. Studies in some of the 
provinces of South Africa have implicated Salmonella spp. and other 
enteropathogens in diarrhoea cases linked especially to water contamination (Obi 
et al., 2002; 2004). 
Whether salmonellosis is confined to the intestinal form or progresses to 
systemic involvement, the ability of the organism to invade and penetrate 
intestinal epithelial cells is required (Altier, 2005). This invasion process is not 
merely a passive consequence of bacterial contact with epithelial cells, but 
instead requires the active participation of the bacterium, with the expression of 
numerous bacterial virulence genes. The process of cell invasion requires the 
production and transport of secreted effector proteins by a type III secretion 
apparatus encoded in Salmonella pathogenicity island I (SPI-1) (Altier, 2005).  In 
addition, invasion is induced by several factors of the host intestinal milieu. Many 
invasion regulators have been described, HilA (Lostroh and Lee, 2001), HilC 
(Schechter et al., 1999), invA gene, a gene associated with the invasive nature 
of Salmonella (Rahn et al., 1992), InvF (Darwin and Miller, 1999), PhoP/PhoQ 
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(Bajaj et al., 1996), HilE (Baxter et al., 2003), H-NS (Schechter et al., 2003). 
PhoP/PhoQ pair is essential to the expression of genes of Salmonella 
pathogenicity island 2 (SPI-2), which encodes a second type III secretion 
system. SPI-2 is required for intramacrophage survival, the cell type encountered 
by Salmonella immediately after the invasion of the epithelium. PhoP/PhoQ also 
serves to repress SPI-1 genes, a function mediated by hilA (Behlau and Miller, 
1993; Bajaj et al., 1996; Fahlen et al., 2000). PhoP/PhoQ may thus act as a 
genetic switch, activating traits required for macrophage survival while 
repressing those not needed for invasion (Altier, 2005). Reports have shown that 
mutations in phoP/Q result in a marked decrease in virulence (Fields et al., 1989; 
Miller et al., 1993). Other factors involved in Salmonella virulence are the MgtC in 
S. enterica serovar Typhimurium. This is required for growth at low-Mg2+ 
concentrations and intramacrophage survival. This gene is codified in a 
conserved region of the Salmonella pathogenicity island 3 (SPI-3), and is also 
present in the chromosome of other Salmonella serovars (Retamal et al., 2009). 
II. Shigella 
 
Shigella, the etiologic agent of bacillary dysentery or shigellosis is a 
facultative intracellular pathogen. This genus of Gram negative bacteria is 
composed of four species namely: Shigella dysenteriae, Shigella flexneri, Shigella 
boydii and Shigella sonnei (also designated as serogroups A to D) (Yang et al., 
2005). These are further subdivided into serotypes on the basis of O-specific 
polysaccharide of the LPS. Shigella dysenteriae type 1 produces severe disease 
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and may be associated with life-threatening complications (Niyogi, 2005). 
Shigellosis is endemic throughout the world where it is held responsible for some 
120 million cases of severe dysentery (Weekly Epidemiological Record, 2005).  
The annual number of Shigella episodes worldwide has been estimated as 165 
million, of which more than 100 million occur in the developing world with more 
than 1 million deaths (Kotloff et al., 1999; Dupont, 2005). In developing 
countries, 69% of shigellosis episodes occur in children under five years of age 
(Kotloff et al., 1999). Although Shigella is endemic worldwide, it affects certain 
populations more than others with varying species predominance in each region. 
Shigellae are responsible for mortality and or morbidity in high risk populations 
such as children under five years of age, toddlers in day-care centres, aged 
individuals, homosexual men and, people in war-ravaged and famine-engulfed 
region (Thong et al., 2005). The predominant serogroup of Shigella circulating in 
a community appears to be related to the level of socioeconomic development. 
S. sonnei , which has a single serotype, is the causative agent of most shigellosis 
in industrialized countries where it accounts for 77% of cases (compared to 15% 
in developing countries), but it also has become predominant in Thailand in 
recent years (WHO, 2009a). However, S. flexneri is endemic in developing 
countries followed by S. sonnei. The frequency of occurrence of S. dysenteriae 
and S. boydii are equal.  S. dysenteriae is seen most often in South Asia and 
sub-Saharan Africa (Kotloff et al., 1999). S. dysenteriae type 1, also known as 
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Shiga bacillus, has been recognized as the major cause of epidemic dysentery for 
nearly 100 years (WHO, 1999). 
Shigella spp. causes dysentery by invading the colonic mucosa and 
multiplying within colonic epithelial cells ultimately causing mucosal ulceration, 
inflammation and bleeding. This pathogen is usually transmitted by faecal-oral 
route via contaminated food and water or through person-to-person contact 
(WHO, 2009a). Shigellae are considered highly contagious due to the low 
numbers of infectious inoculum required to cause infection (Dupont et al., 1989). 
The incubation period for shigellosis is 1 to 4 days but may be up to 8 days in 
the case of infection due to S. dysenteriae (Levine et al., 1973) or last for weeks 
and months and result in chronic relapsing diarrhoea and a protein-losing 
enteropathy (Herrington and Taylor, 1991). The initial symptoms of shigellosis 
are fever, headache, malaise, anorexia, and occasional vomiting. S. flexneri and 
S. dysenteriae type 1 infections are usually characterized by frequent passage of 
small amounts of stool and mucus or blood. Whilst S. sonnei and S. boydii 
infections are less severe with watery faeces but little mucus or blood, the 
watery diarrhoea in S. dysenteriae type 1 may progress to typical dysenteric 
stool. Intestinal complications of shigellosis include toxic megacolon and rectal 
prolapse. All species of Shigella are known to produce varying quantities of 
cytotoxins which are biologically similar in properties (Bartlett et al., 1986).  
However, the term Shiga toxin is reserved for the highly potent protein cytotoxin 
produced in large quantity by S. dysenteriae type 1. Shiga toxin which have been 
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extensively studied have been shown to consist of a large A subunit and 5 
smaller B subunits, a structure similar to those of cholera toxin and heat-labile 
enterotoxin of E. coli (Herrington and Taylor, 1991). Whereas the A subunit is 
involved in inhibition of protein synthesis, the B subunits are involved in 
enterotoxic effects and cytotoxicity (Jacewicz et al., 1989).  Shiga toxin 
production is not required for virulence of invasive S. dysenteriae strains, but 
may increase the severity of disease (WHO, 1999). The virulence genes 
responsible for the pathogenesis of shigellosis may be chromosomal or plasmid-
borne. ShET1 and ShET2 are two chromosomal-borne enterotoxin genes which 
have been incriminated as the putative mediators of the early watery phase of 
shigellosis (Nataro et al., 1995; Rhee et al., 2001).  Other genes responsible for 
directing epithelial cell penetration by the bacterium and for the modification of 
host response to infection are ial and ipaH respectively (Hale, 1991; Ménard et 
al., 1996). Mild infections due to Shigella are often self-limiting in healthy 
individuals but complications may arise in high risk group. Shiga toxin-producing 
organisms can cause anemia to manifest as hemolytic uremic syndrome in 
children and as thrombotic thrombocytopenic purpura in adults (Koster et al., 
1978). Intestinal perforation is rare but has been reported in association with 
toxic megacoclon.  Shigella bacteremia is generally considered an unusual 
occurrence but has been reported among HIV-infected and other immuno-
compromised patients (Batchelor et al., 1996) and may be difficult to eradicate. 
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III.  Escherichia coli  
In contrast to the essential and beneficial role of most Escherichia coli 
isolates in the human intestine, pathogenic E. coli are responsible for a broad 
spectrum of human diseases. E. coli has emerged as an important cause of 
diarrheal related illnesses, with diverse phenotypes and pathogenic mechanisms. 
According to the updated report of World Health Organization (2009), numerous 
types of diarrheagenic E. coli have been identified worldwide namely; 
enteropathogenic (EPEC), enterohaemorragic (EHEC) or Shiga toxin-secreting 
(STEC), enteroinvasive (EIEC), enterotoxigenic (ETEC), diarrhoea-associated 
haemolytic (DHEC), entero-aggregative (EAggEC), enteroadherent E coli (EAEC) 
and cytolethal distending toxin-secreting (CDTEC) E. coli and diffuse adherent E. 
coli (DAEC) strains. These have been classified on the basis of serological 
characteristics – O (somatic), H (flagellar), and K (capsular) surface antigen 
profiles and virulence properties. The prevalence and the burden of diseases of 
the different pathotypes are uneven (WHO, 2009a). E. coli, though a major 
facultative inhabitant of the large intestine, has become recognized as both a 
harmless commensal and a versatile pathogen. It is the causative agent of 
infections ranging from enteric infections, neonatal meningitis, pneumonia, 
urinary tract infections (UTI), cholecystitis, and bacteremia. Other miscellaneous 
E. coli infections include septic arthritis, endophthalmitis, suppurative thyroiditis, 
sinusitis, osteomyelitis, endocarditis, and skin and soft-tissue infections 
(especially in patients with diabetes) (Madappa and Go, 2009). E. coli causes 12-
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50% of nosocomial infections and 4% of cases of diarrheal diseases. While 
EAggEC, EAEC and EPEC cause watery E. coli childhood diarrhoea which is non-
inflammatory and non-bloody, E coli dysentery is caused by EIEC or EHEC which 
is characterized by fever, bloody diarrhea, and dehydration (Madappa and Go, 
2009).  EPEC has also been described as diarrheagenic E coli which produce a 
characteristic histopathology known as attaching and effacing (A/E) on intestinal 
cells and that do not produce Shiga, Shiga-like toxins or verotoxins. However, 
Enterotoxigenic E coli (ETEC) strains remain a major cause of infantile diarrhoea  
 
Table 1.2. Summary of diarrheagenic E.coli pathotypes and clinical 
manifestations  
 
E.coli Pathotype Clinical manifestations 
Enterotoxigenic E coli 
(ETEC) 
Diarrhea is watery without blood, mucous, or fecal 
leukocytes and ranges from mild to severe 
Enterohemorrhagic E 
coli (EHEC) or  
Shiga toxin-secreting 
(STEC) 
EHEC infects the large bowel. Disease ranges from mild 
watery diarrhea to severe hemorrhagic colitis, often 
accompanied by abdominal cramping and vomiting. 
Diarrhea becomes bloody in 1-2 days in most patients but 
is usually not associated with fecal leukocytes. Fever is 
present in about a third of cases.  
Enteroinvasive E coli 
(EIEC) 
Causes watery diarrhea, dysentery, fever, vomiting, 
painful abdominal cramps, and tenesmus. Stools often 
contain blood and leukocytes.  
Enteropathogenic E 
coli (EPEC)  
EPEC infects the small intestine, causes watery diarrhea 
and dysentery. The resultant acute watery diarrhea may 
cause dehydration or become chronic and lead to failure 
to thrive. 
Enteroaggregative E 
coli (EAEC) 
Associated with persistent diarrhea (>14 days), usually 
watery, secretory and not accompanied by fever or 
vomiting 
Diffusely Adherent E. 
coli (DAEC) 
Majority of patients infected with this pathotype 
experience vomiting. 
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in developing countries and of travellers’ diarrhoeas in visitors to these countries 
(WHO, 2009a). Table 1.2 shows a summary of the clinical manifestations of 
different pathotypes of diarrheagenic E. coli. 
ETEC are the most frequently isolated bacterial enteropathogen in children 
below 5 years of age in developing countries, and account for approximately 300 
million diarrhoea episodes and 380 000 deaths annually (Black, 1993; Wennerås 
and Erling, 2004; Steffen et al., 2005). ETEC are the cause in up to 80% of cases 
of traveller’s diarrhoea (Kass, 2005; Peny, 2005). Each year, there are an 
estimated 10 million cases of LT-related ETEC travellers' diarrhoea worldwide  
(Steffen et al., 2005) with a median of 42% of travelers' diarrheal episodes in 
studies in Latin America, 36% in Africa, and 16% in Asia (Black, 1993). 
Surveillance of hospitalized cases of ETEC diarrhoea has shown that a large 
proportion of cases also occur in individuals over 10 years of age (WHO, 2009a). 
ETEC are prevalent in domestic and surface water sources in developing 
countries. In South Africa, Obi et al. (2007) reported a genetic relatedness in E. 
coli from stools of diarrhoeic HIV patients and their household drinking water. 
Similar result was obtained in Bangladesh by Begum and co-workers (2007) in 
which case there were antibiotic resistant patterns and clonal similarities 
between ETEC from the environment and those isolated from the stools of 
patient. This may explain the endemicity of the disease in these countries. Once 
attached to the intestinal epithelium, ETEC elaborate both the heat-labile (LT) 
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and the heat-stable (ST) toxins, which induce the watery diarrhoea (Freytag and 
Clements, 1999). 
E. coli O157 is sorbitol non-fermenting strain of E. coli causing 
Hemorrhagic uremic syndrome (HUS). The disease symptom is characterized by 
severe abdominal pain and bloody stools (Griffin et al., 1988; Boyce et al., 1995) 
and can also present as non-bloody diarrhea (Rodrigue et al., 1995). Of 
particular concern in pediatric populations estimated to occur in 8% of children, 
E coli 0157:H7 requires a relatively small inoculum for infection and spreads 
easily from child to child by the fecal-oral route. The incubation period of EHEC is 
1-5 days, with illness duration typically 4-10 days. Chronic renal failure develops 
in as many as 10% of patients with HUS, and HUS kills 3-5% of affected patients 
(Serna and Boedeker, 2008). E. coli O157 is an emerging cause of food-borne 
illness, particularly in the northern United States and Canada where sources 
identified in outbreaks have included ground beef, apple juice, and alfalfa 
sprouts, as well as feacally contaminated drinking water and swimming pools 
(CDC, 2005a, 2006, 2007, 2008). In the developing countries however, drought, 
carriage of E. coli O157 by cattle, and contamination of surface water were 
presumed to have been important sources of infection with E. coli O157.  In a 
household survey performed during a waterborne outbreak of E. coli O157 
infections in the United States, bloody stools were reported by only 35% of those 
with diarrhea (Swerdlow et al., 1992). The report of Effler and his co-worker 
(2001) provides comprehensive data on the first outbreak of E. coli O157 
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infections from the developing world. Before this outbreak, E. coli O157 had 
been isolated only once before in Southern Africa, from an elderly man 
undergoing surgery for lower gastrointestinal bleeding in Johannesburg in 1990 
(Browning et al., 1990). Thirty-one suspected E. coli O157 isolates obtained from 
clinical and environmental specimens were referred to CDC, and all were 
confirmed as E. coli O157: NM. All isolates had the uidA allele specific for E. coli 
O157:H7 and the genes encoding Shiga toxins 1 and 2 (Effler et al., 2001). Two 
other outbreaks of dysentery have been attributed to E. coli O157 elsewhere in 
Africa, the first in Central African Republic in 1996, and the second in Cameroon 
beginning in 1997 (Cunin et al., 1999; Germani et al., 1997). Both of these 
reports have some constraints, however; in the Central African Republic, E. coli 
O157 was not isolated at the outbreak site but only implicated from molecular 
tests. In the Cameroon outbreak, E. coli O157 and Shigella spp were each 
isolated in about half of the specimens tested. Although reported outbreaks of E. 
coli O157 in Africa have been few to date, available information indicates that 
the pathogen has wide geographic distribution. Since the 1992 outbreak, culture-
proven E. coli O157 diarrheal illness has been reported from several locations, 
including Kenya (Sang et al., 1996), Nigeria (Akinyemi et al., 1998), Côte d’Ivoire 
(Dadie et al., 2000) and Central Africa Republic (Germani et al., 1998). Because 
E. coli O157 is not detected by the usual methods used to isolate and identify 
traditional enteric bacterial pathogens, microbiology laboratories in many 
countries in Africa do not routinely test for this pathogen, hence E. coli O157 
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infections may go unrecognized (WHO, 1995; Wittenberg, 1999). Reports on 
African dysentery outbreaks attributed to Shigella spp. sometimes indicate that 
specimens were not tested until several months into the outbreak or do not 
describe laboratory methods that are suitable for detecting E. coli O157 (Aragon 
et al., 1995; Malakooti et al., 1997). The spectrum of clinical illness resulting 
from Shigella infection overlaps considerably with that of E. coli O157 and mixed 
outbreaks have been reported (Casburn-Jones and Farthing, 2004). 
Understanding the complex interaction of environmental and behavioral factors 
that enabled E. coli O157 to emerge so intensely in Africa is important for future 
diarrheal disease control efforts. 
The manifestation of clinical symptomology and pathology appears to be 
closely associated with the possession of certain virulence gene combinations 
in E. coli (Law, 2000; Grauke et al., 2002). Generally, the pathogenicity factors 
among E. coli strains include pili, k-antigen, haemolysin, adhesive factor, 
enterotoxins, cytotoxins, effacement factors and cytotoxic necrotic factors 
(Galane and Le Roux, 2001). Various genes encoding virulence markers among 
Escherichia coli were reportedly identified by Obi et al. (2004). These included 
cnf1 and cnf2 for necrotoxigenic; ST and LT for enterotoxigenic; stx1 and stx2 
for Shiga toxin producing; bfpA and eaeA for enteropathogenic, and EAEC for 
enteroaggregative E. coli. As much as the pathotypes of E coli have in common 
various virulence gene combinations for attachment and elaboration of 
hemolysins and enterotoxins, there are considerable polymorphisms and 
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sequence variations in the molecular identities of genes that code for these 
virulence factors (Nagy and Fekete, 1999; Bertin et al., 2001) while some factors 
are specific to some strains. For instance, it has been reported that adherence 
pili, (the bundle-forming pili, Bfp) may be involved in pathogenicity (Hacker, 
1992). A PCR method has been developed for the detection of the bfp genes of 
EPEC (Gunzburg et al., 1995) that showed no amplification of DNA from any 
other bacterial enteropathogens and was 100% specific for EPEC strains which 
exhibited the characteristic localized-adherence (LA) phenotype. According to 
Reece et al. (2001) variants of the outer membrane protein intimin, expressed by 
both pathotypes EHEC and EPEC, have been implicated as contributors to tissue 
tropism. EHEC and EPEC share genetic and phenotypic similarities, most notably 
the locus of enterocyte effacement (LEE), pathogenicity island (PAI), encoding a 
type III secretion system (TTSS), and the ability to form attaching and effacing 
(AE) intestinal lesions and intimate attachment to the host cell (Moon et al., 
1983; Nougayrede et al., 2003; Kaper et al., 2004; Caron et al., 2006). The 
attaching and effacing (A/E) lesions on epithelial cells caused by EPEC or EHEC 
are mediated by binding of intimin (encoded by the eae gene) to its receptor 
(Tir) on the host cell (Hess et al., 1999). Additional virulence factors in EPEC or 
EHEC include the expression of a plasmid (pO157)-encoded gene EHEC-hly (an 
enterohaemolysin distinct from the chromosomally encoded a-haemolysin, HlyA), 
and a b-glucoronidase-encoding uidA gene associated with O157:H7 strains 
(Paton and Paton, 1998).  The hair-like filamentous organelles called fimbrial 
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colonization factor antigens (CFAs), is known to assist ETEC strains in 
attachment to the small intestine (Raj, 1993). The CFA and enterotoxin genes 
are generally encoded on plasmids (Nataro and Kaper, 1998). Also in ETEC 
strains, both LT and ST genes are found and are specifically on transferable 
plasmids (Levine, 1987); LT is a protein that resembles cholera toxin in structure, 
function and mechanism of action. STs are monomeric plasmid-mediated toxins 
made up of an 18 to19 amino-acid polypeptide toxin that causes diarrhoea by 
binding to and stimulating intestinal -bound guanylate cyclase, leading to an 
intracellular accumulation of cyclic GMP (Sooka et al., 2004). EIEC strains are 
similar biochemically and in pathogenesis to Shigella spp. This involves epithelial 
cell penetration, lysis of the endocytic vacuole, intracellular multiplication (Sooka 
et al., 2004). Ipa A-D genes are located on the large invasive plasmid of all 
virulent Shigella and EIEC organisms and the gene sequences are referred to as 
the invasion-associated locus (ial). IpaH sequences are present at multiple sites 
on both the large invasive plasmid and on the chromosomes in Shigellae and 
EIEC (Sethabutr et al., 1993). EAggEC strains produce a heat-stable enterotoxin 
(EAST-I) which is non-specific but has also been detected in non-aggregative 
and non-pathogenic E. coli strains. These potential virulence factors are localized 
on a 60-MDa plasmid common to most EAggEC strains (Czeczulin et al., 1997). 
1.2.4. Treatment of Diarrhoea 
Enteric infections generally are self-limited conditions. However, early 
correction of fluid and electrolyte imbalance is the first consideration in diarrhoea 
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therapy. In many communities of sub-Saharan Africa, modern pharmaceutical 
agents are a commonly used first line of therapy for the home treatment of 
diarrhea or they serve as an alternative when traditional remedies fail.  
Diarrhoea therapy can broadly be classified as follows: Oral rehydration 
treatment (ORT), intravenous fluid replacement, anti-intestinal motility (e.g. 
Diphenoxylate-atropine- reduces duration of diarrhoea, Loperomide), 
antispasmodic, antimicrobial, antisecretory and probiotics (gut flora balance). 
However, the WHO case management strategy for acute diarrhea as reported 
previously (Richards et al., 1993) includes: 
i. early administration of appropriate fluids at home; 
ii. treatment of dehydration with WHO oral rehydration solution; 
iii. treatment of severe dehydration with intravenous electrolyte solution; 
iv. continued feeding throughout the diarrheal episode; 
v. selective use of antibiotics; 
vi. non-use of antidiarrheal drugs 
Oral rehydration therapy (ORT) in the child with mild-to-moderate 
dehydration consists of replacement of the child's fluid deficit and ongoing losses 
and provision of maintenance fluid, electrolyte, and nutritional needs. In severe 
dehydration or where oral replacement is not possible, intravenous fluids 
administered in the health care setting may be needed. This should be followed 
after at least the initial twenty-four hours of glucose electrolyte solution therapy 
with slow reintroduction of sugar-free fruit drinks, bland food such as vegetables 
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and then regular feeds (Walker-Smith, 1990). However, there are dangers in the 
home use of ORT, including inappropriate preparation (electrolyte concentration) 
or errors of administration (usually insufficient volume) particularly in the 
developing countries, where literacy level is low. A study in Nigeria found that 
only 12.7% of people interviewed were able to correctly describe how sugar-salt 
solution (SSS) is prepared although almost all of them were aware of ORT 
(Ikpatt and Young, 1992). In Zimbabwe, although nearly half the respondents 
were able to provide a recipe for SSS, only 12% gave the correct formulation (de 
Zoysa et al., 1984). The home management of childhood diarrhea with ORT or 
SSS can be increased positively with public health education (Blum et al., 1990; 
Touchette et al., 1994). 
Patients with diarrhea associated with certain bacterial and protozoal 
agents may benefit from therapy with an antimicrobial agent (Pickering and 
Cleary, 2002) In some instances, specific antimicrobial therapy may reduce 
morbidity and mortality associated with enteric illnesses, may prevent future 
complications, help to eradicate fecal shedding and to prevent transmission of 
enteric pathogens but antimicrobial agents should be prescribed with a 
consideration of their limitations (Pickering, 2003). In viral diarrhoeas for 
instance, hydration is the mainstay of treatment whether it be oral or parenteral, 
and specific pharmacologic therapy is not available. Antimotility drugs in some 
cases often complicate treatment. Pickering (1991) reported that antimotility 
medications worsen the clinical course in shigellosis and in antimicrobial-
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associated colitis and have the risks attendant with overdose. Other conjectured 
possible side effects include toxic megacolon and colonic hemorrhage (Northrup 
and Flanigan, 1994) and ileus (Avery and Snyder, 1990). 
Salmonella gastroenteritis is usually a self-limiting disease. Fluid and 
electrolyte replacement may be indicated in severe cases.  Antibiotics are not 
routinely used to treat uncomplicated non-typhoidal Salmonella gastroenteritis 
because they may rather prolong illness, the length of excretion of pathogen or 
actually prolong the duration of convalescent carriage (Klotchko and Wallace, 
2009). However, it has been suggested that infants and the elderly who are at 
risk for bacteremia or complications due to bacteremia deserve antimicrobial 
treatment (Cohen et al., 1978). Fluoroquinolones such as Ciprofloxacin have 
been suggested as more effective than standard antibiotics for treating patients 
with bacteremia due to Salmonella (Jacobson et al., 1989) and chronic 
suppressive therapy may be needed to prevent reoccurrence. The 4-quinolones 
are not only highly active in vitro against a broad range of enteric pathogens but 
generally also exhibit most of the other properties desirable for the treatment of 
these infections (Keusch, 1988). They are well tolerated, have good oral 
absorption and are more rapidly and reliably effective than earlier drugs (WHO, 
2005). Nevertheless, fluoroquinolones are not recommended for use in children 
due to the risk of central nervous system toxicity, cardiovascular toxicity, tendon 
or articular toxicity, and rarely hepatic toxicity (Nelson et al., 2006) even at 
therapeutic doses and adverse reactions may manifest during, as well as after 
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fluoroquinolone therapy has been completed (Saint et al., 2000). Third-
generation cephalosporins are widely used in children with serious infections. It 
has recently been suggested that the specific adverse-effect profile of quinolones 
must be considered when they are chosen for treatment of bacterial infections 
because of physiological changes in renal function (Stahlmann and Lode, 2010). 
The earlier drugs chloramphenicol, ampicillin and amoxicillin and trimethoprim-
sulfamethoxazole are used occasionally as alternative therapy for salmonellosis. 
Presently, apart from the quinolones, and third-generation cephalosporins, 
macrolide antibiotics are preferred for empiric therapy pending sensitivities. 
Regrettably, sensitivity to quinolones is declining, and these are no longer fool-
proof agents for typhoid fever (WHO, 2005a). A sentry antimicrobial surveillance 
program for North America (1997-2001) has shown that the level of susceptibility 
for ciprofloxacin, as the representative of other fluoroquinolones, was equal or 
slightly inferior to that of representative aminoglycoside (Jones, 2003). According 
to Ercis et al. (2006), nalidixic acid-resistant Salmonella strains are suggestive of 
reduced effectiveness of quinolone therapy in patients. In South Africa, the 
significantly increasing incidence of extended spectrum betalactamase producing 
Salmonella is set back in the use of extended-spectrum cephalosporins which are 
the preferred drugs for serious non-typhoidal Salmonella infections in children 
(Kruger et al., 2004). 
 As in other diarrhoeal diseases, correction of dehydration and 
maintenance of fluid and electrolyte balance is the first line of therapy in 
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shigellosis. Antibiotics have reportedly shortened the duration of symptoms in 
infections due to Shigella (Salam and Bennish, 1991; Sack et al., 2001) and can 
prevent relapse. Ampicillin and trimethoprim-sulfamethoxazole are good choices 
for sensitive strains of Shigella.  Nalidixic acid and the newer fluoroquinolones 
have been shown to be effective against multiply-antibiotic resistant Shigella spp. 
(Rogerie et al., 1986; Ericsson et al., 1987; Pichler et al., 1987).  Third 
generation cephalosporins, such as cefixime and ceftriaxone, have also been 
proven through clinical trials to be better than ampicillin or TMP-SMZ and safer 
for use in children (Varsano et al., 1991; Ashkenazi et al., 1993). The WHO 
recent recommendations for treatment of clinically diagnosed cases of Shigella 
dysentery are ciprofloxacin as first line treatment, and pivmecillinam, ceftriaxone, 
or azithromycin as second line treatment (WHO 2005b). Treatment of shigellosis 
with antibiotics should however, be done putting regional differences in 
sensitivity as well as local antibiotic sensitivity patterns of Shigella isolates into 
consideration (Christopher et al., 2010). In EIEC, treatment of significant 
symptomatic illness with fever and bloody diarrhoea should follow same course 
of treatment as Shigella diarrhoea (Herrington and Taylor, 1991). E coli 0157:H7 
are sensitive to most antibiotics in vitro, antibiotics have not been shown to limit 
duration or ameliorate symptoms (Carter et al., 1987). The illness is self limited 
and treatment is supportive (Herrington and Taylor, 1991). ETEC which is usually 
a disease of children in the developing countries is treated with ORT and 
intravenous fluids. Treatment of Traveller’s diseases is aimed at reducing 
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episodes of diarrhoea and number of days of illness. Trimethoprim-
sulfamethoxazole can be used both as prophylaxis and as treatment of travelers 
(DuPont et al., 1982; Steffen et al., 1988). 
Manipulation of gut flora to enhance its protective and beneficial role 
represents a promising field of new therapeutic strategies. Probiotics are non-
antibiotic formulations which are considered in diarrhoea therapy. Probiotics are 
live nonpathogenic microorganisms administered to improve microbial balance, 
particularly in the gastrointestinal tract. They are originally derived from cultured 
food, especially dairy products, and consist of Saccharomyces boulardii, a yeast, 
E. coli Nissle 1917 (a nonpathogenic E. coli strain), or lactic acid bacteria, such 
as Lactobacillus spp., Lactococcus lactis and Bifidobacterium spp, and are 
regulated as dietary supplements and foods (Damaskos and Kolios, 2008; 
Williams, 2010). There has been evidence for the clinical effectiveness of 
probiotics in the treatment of acute diarrhea, most commonly due to rotavirus, 
and pouchitis (Heydarian et al., 2010; Williams, 2010). Probiotics appear to be a 
useful adjunct to rehydration therapy in treating acute, infectious diarrhoea in 
adults and children (Allen et al., 2003). The mechanisms involved in the 
remediation effects of probiotics can be that of lowering intestinal pH, decreasing 
colonization and invasion by pathogenic organisms, or modifying the host 
immune response.  Studies have shown that the mechanisms of action of 
probiotics include antimicrobial activity and suppression of bacterial growth, 
immunomodulation and initiation of an immune response, enhancement of 
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barrier activity, and suppression of human T-cell proliferation (Resta-Lenert and 
Barrett, 2003; Nerstedt et al., 2007; Peluso et al., 2007).  The molecular aspects 
of probiotic mechanism of action have been shown experimentally, in which they 
have been found to induce their effect by means of their DNA (Jijon et al., 2007; 
Rachmilewitz et al., 2007). The beneficial effects of probiotics vary from one 
species or strain to the other. 
1.2.5. Some considerations on antibiotic therapy of enteric bacteria 
The classifications of antibiotics are based on their mechanisms of action, 
chemical structure, or spectrum of activity. Antibiotics which generally may be 
bactericidal (lethal to bacteria) or bacteristatic (prevent bacterial growth) 
perform their activities mainly by targeting bacterial functions or growth 
processes (Calderon and Sabundayo, 2007). Bactericidal antibiotics target the 
bacterial cell wall while bacteriostatic antibiotics target protein synthesis (Finberg 
et al., 2004). In terms of spectrum of activity antibiotics are also categorized 
either as "narrow-spectrum" based on their target specificity or “broad-spectrum” 
if active against a wide range of bacteria group. Table 1.3 gives a summary of 
some antibiotics that are used in the treatment of enteric infections by their 
classes and their modes of action. 
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Table 1.3. Some antibiotics that are used in the treatment of enteric  
infections and their mechanisms of action. 
 
*CLSI Subclass  Antimicrobial 
Agent  
Mechanism of Action 
 Aminoglycosides  Amikacin  Interfere with protein biosynthesis by 
binding to bacterial 30S ribosome 
subunit, inhibiting the translocation of 
the peptidyl-tRNA from the A-site to 
the P-site and also causing misreading 
of mRNA, leaving the bacterium 
unable to synthesize proteins vital to 
its growth. 
Gentamicin  
Kanamycin   
Aminopenicillins  Ampicillin  Inhibit bacterial cell wall synthesis by  
disrupting the synthesis of the 
peptidoglycan layer. 
β-Lactamase 
inhibitor 
combinations  
Amoxicillin-
Clavulanic acid  
Inhibit bacterial cell wall synthesis by  
disrupting the synthesis of the 
peptidoglycan layer. 
Carbapenems  
 
Imepenem Inhibit bacterial cell wall synthesis 
Meropenem 
Cephalosporins 
(2nd generation) 
Cephamycins  
Cefoxitin  Inhibit bacterial cell wall synthesis by 
disrupting the synthesis of the 
peptidoglycan layer. 
Cefuroxime 
Cephalosporins 
(3rd generation) 
Ceftazidime  
Ceftriaxone  
Cefotaxime 
Folate pathway 
inhibitors  
Trimethoprim- 
Sulfamethoxazole  
Inhibit bacterial folic acid metabolism 
Lincosamides Clindamycin Interfere with protein biosynthesis by 
binding to bacterial 50S ribosome 
subunit 
Macrolides Azithromycin Interfere with protein biosynthesis 
irreversibly to the subunit 50S of the 
bacterial ribosome, thereby inhibiting 
translocation of peptidyl tRNA. 
Erythromycin 
Phenicols  Chloramphenicol  interfere with protein biosynthesis 
including 50S ribosome inhibition 
Quinolones Ciprofloxacin  Bacterial DNA gyrase or topoisomerase 
IV enzyme inhibitors, thereby 
inhibiting DNA replication and 
transcription. 
Nalidixic acid  
Sulfonamides Sulfisoxazole Inhibit bacterial folic acid metabolism 
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Tetracyclines  Tetracycline  Interfere with protein biosynthesis 
including 30S ribosome inhibition 
 
*CLSI is Clinical and Laboratory Standards Institute formerly NCCLS 
 
 
The choice of drugs for the treatment of enteric diseases is based on 
some of the following known therapeutic principles (Keusch, 1988). 
i. the agent must be active in vitro  against the isolate,  
ii. the levels must be adequate for treating infections due to invasive 
pathogens both lumenal and tissue,  
iii. the drugs with good enterohepatic circulation may be especially well 
suited for the treatment of infections due to noninvasive pathogens, and 
iv. the drugs active intracellularly may have particular value in therapy for 
typhoid, especially in reducing the relapse rate.  
 
It is no gainsaying that antimicrobials have saved the lives and eased the 
suffering of millions of people. By helping to bring many serious infectious dis-
eases under control, these drugs have also contributed to the major gains in life 
expectancy experienced during the latter part of the last century (WHO, 2002).  
However, these gains seem to have been eroded as the emergence of drug 
resistance and multiple drug resistance (MDR) have become a threat in various 
nations of the world. The effectiveness of most drugs of choice has been 
jeopardized by many factors such as the incorporation of antibiotics into animal 
feeds. The authorization for the use of fluoroquinolones in food animals 
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enhanced the rates of fluoroquinolone-resistant Salmonella in animals and food, 
and then subsequently in human infections (FAO/OIE/WHO, 2003). The total 
consumption of antimicrobials has been viewed as one of the critical factors in 
selecting resistance even though the relationship between use and resistance is 
not a simple correlation (WHO, 2001) so also is under-use through lack of 
access, inadequate dosing, poor adherence, and substandard antimicrobials. In 
many developing countries particularly sub-Saharan Africa, some of the 
contributory factors to acquiring resistance are sources of obtaining drugs. 
Antimicrobial agents are readily available without a prescription hence, self-
prescribing of antimicrobials is common (Dua et al., 1994; Okeke et al., 1999). 
Some of the potential sources of medications include relatives or friends with 
unused supplies, locally trained nurses, shopkeepers, market sales people, and 
unlicensed drug salesmen who buy drugs in major cities and then sell them in 
rural villages (Bledsoe and Goubaud, 1985; Omotade et al., 1994). Other 
contributory factors are inadequate and inappropriate use of drugs and lack of 
education.  “Examples of inappropriate uses of antibiotics that exert selective 
pressure for resistance in various bacteria are: administering them to patients 
who have viral upper respiratory tract infections; feeding them to farm animals 
to enhance their growth” (Sack et al., 2001). In addition, antimicrobial agents 
may be of poor quality, due to degradation, counterfeiting, or lack of 
bioequivalence in the case of generic drugs. The use of such products results in 
sub-optimal serum concentrations, which promotes selection for resistance 
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(Okeke et al., 1999). The ease of modern transport systems and frequency of 
international travels have also contributed greatly to the spread of resistance. 
Other factors in the spread of resistance are overcrowding and improper sewage 
disposal which according to Okeke et al., (1999) promote the spread of resistant 
organisms among individuals and provide increased opportunities for genetic 
exchange among bacteria, facilitating the dissemination of antibiotic resistance 
determinants. 
Emerging drug resistance to ciprofloxacin and second line drugs such as 
pivmecillinam, ceftriaxone, and azithromycin is increasingly being reported in 
many parts of the world, as is multiple-drug resistance (Kosek, 2008; Kuo, 2008; 
Pazhani, 2008). Multi-resistance in Enterobacteriaceae is defined as resistance to 
three or more of the following classes of antibiotics: cephalosporins, 
carbapenems, quinolones, aminoglycosides and trimethoprim/co-trimoxazole 
(Rodriguez-Bano et al., 2004). MDR is a serious problem for the treatment of 
shigellosis, particularly those caused by S. dysenteriae type 1. Transferable MDR 
was first described among Shigella in Japan in the mid 1950s, (Watanabe, 1963), 
and has remained a major problem ever since. Multidrug-resistant (MDR) strains 
of Salmonella are also encountered frequently and the rates of multidrug-
resistance have increased considerably (WHO, 2005a). The emergence of drug-
resistant Salmonella is more of response to selective pressure from the use 
particularly in food animals. A recent global spread of a multidrug-resistant S. 
enterica serovar Typhimurium phage type DT104 in animals and humans showed 
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that other factors such as major shifts in the occurrence of Salmonella serotypes 
in food animal and humans do occur. In this particular case while antimicrobial 
usage may have facilitated the spread of DT104, international and national trade 
of infected animals is thought to play a major role in international spread (WHO, 
2005a). MDR strains of enteric bacteria were isolated with increasing frequency 
from various sub-Saharan nations at various times to date. In Central Africa, 
MDR strains of S. dysenteriae type 1 were isolated during the epidemics between 
late 1970s and early 1980s (Frost et al., 1981; Ebright et al., 1984). Multiple 
resistance to antibiotics including trimetoprim-sulfamethazole was also reported 
in Zambia (Tuttle et al., 1995). Data from Nigeria, Ethiopia, Senegal, Kenya, 
Malawi is suggestive of wide spread and increasing resistance to most commonly 
used drugs in the sub-Saharan African regions (Lamikanra et al., 1989; Awole et 
al., 2002; Sow et al., 2007; Onyango et al., 2009; Kingsley et al., 2009). In 
South Africa, the work of Kruger et al. (2004) on non-typhoidal Salmonella 
isolates showed increased resistance to extended-spectrum cephalosporin. Obi et 
al. (2007) reported multiple antibiotic resistance among enteric bacteria obtained 
from HIV patients and their drinking water and a relationship was established 
between clinical and environmental strains. A very recent data from South Africa 
(Keddy et al., 2009),  showed that most commonly expressed multiple antibiotic 
resistance profiles among non-typhoidal Salmonella were ACSSuNa and 
ACSSuTNa,  that is, resistance to a combination of 5 or 6 drugs combinations of 
ampicillin (A), chloramphenicol (C), streptomycin (S), sulfamethoxazole (Su), 
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tetracycline (T) and nalidixic acid (Na). Also, nalidixic acid-resistant with reduced 
susceptibility to ciprofloxacin was reported among human isolates of Salmonella 
enterica serovar Typhi from South Africa by Smith et al., (2010). The increasing 
prevalence of bacterial strains exhibiting multi-resistance to readily available and 
relatively cheap oral antibiotics constitutes a major obstacle to cost-effective 
therapy of diarrheas in sub-Saharan Africa.  
1.2.6. Mechanisms of antibacterial resistance  
Various mechanisms of antimicrobials inactivation have been reported (Neu, 
1993; Alekshun and Levy, 2000; Fluit et al., 2001; Sundsfjord et al., 2004) which 
invariably led to the emergence of multiple drug resistance pathogens. Some of 
the mechanisms are: 
a) enzymatic inactivation of the antimicrobial agent,  
b) prevention of access to the target pathogen or,  
c) change or mutation in the target site,  
d) novel penicillin-binding proteins (PBPs), 
e) altered membrane permeability. 
Enzymatic inactivation may result either into destruction of antimicrobial 
agent, such as occurs with the beta-lactamases, or lead to a major modification 
of the compound so that it does not bind to its target as is seen with the 
aminoglycosides and chloramphenicol. The second mechanism whereby access 
to the drug target is prevented may be by substitutions, amplifications or 
modifications of the drug target reducing the affinity of the drug to the target. 
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For example, in gram negative organisms the outer membrane proteins may be 
altered such that antibiotics are unable to cross the cell wall. The other 
mechanisms of resistance are intrinsic mechanisms not commonly specified by 
mobile elements such as efflux pumps that expel multiple kinds of antibiotics 
(Alekshun and Levy, 2007). These may lead to reduced access of the 
antimicrobial agents to the target by means of permeability barriers. For instance, 
diarrhoea causing E. coli, Salmonella and Shigella reportedly possessed plasmids 
which produce a new dihydrofolate reductase that has a low affinity for 
trimethoprim and sulfonamides (Nue, 1993). A very recent study on Salmonella 
spp. in South Africa by Smith and co-researchers concluded that amino-acid 
mutations in GyrA and ParC in combination with active efflux of antibiotic out of 
the bacterial cell are probable mechanisms conferring quinolone resistance 
(Smith et al., 2010). 
The genes coding for antibiotic resistance and virulence at times share 
common features of being located in the bacterial chromosome, as well as on 
plasmids. They are associated in gene clusters to form resistance or 
pathogenicity islands and are transferred by mobile elements (such as integrons 
or transposons) or phages (Villa and Carattoli, 2005).  
The most appalling resistant issue among the enteric bacteria is that of 
the declines in susceptibility for the fluoroquinolones and the third-generation 
cephalosporins. While resistance to the fluoroquinolones often emerges as a 
result of mutations in the bacterial genome (DNA), resistance to other 
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antimicrobials often spread by transfer of DNA between bacterial strains (WHO, 
2005a). The major mechanism of resistance to beta-lactam antibiotics among 
enterobacteriaceae involves production of β-lactamases or extended spectrum β-
lactamases (ESBLs). ESBLs have traditionally been defined as transmissible beta-
lactamases that can be inhibited by clavulanic acid, tazobactam or sulbactam. 
They are a group of enzymes that break down antibiotics belonging to the 
penicillin and cephalosporin groups and render them ineffective. The ESBLs are 
generally encoded by mobile genes that can be exchanged between bacteria. 
The prevalence of ESBL is high among some Enterobacteriaceae such as E. coli 
and K. pneumoniae (Winokur et al., 2001). The diverse geographic distributions 
and remarkably variable substrate affinities of ESBLs can produce confusing 
susceptibility testing results (Winokur et al., 2001). According to Jones (2003), 
the average ESBL phenotype rates for a 5 years SENTRY Program (1997-2001) 
showed the highest occurrence in Latin America, followed by Europe and North 
America. It has also been noted that when ESBL strains occur they often have 
co-resistances with the aminoglycosides (gentamicin), tetracyclines, and 
trimethoprim/ sulfamethoxazole (Winokur et al., 2001).  
Effective treatment of human infections has been limited by the 
emergence of MDR Salmonella strains with resistance to fluoroquinolones and 
third-generation cephalosporins (WHO, 2005a). Regional differences in ESBL 
type have also been found to reflect in the choice of therapeutic drug against 
ESBL strains of enteric pathogens. Jones (2003) reported that cefepime, a 
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fourth-generation cephalosporin, could be used against 88.0% of isolates in 
North America, but not for strains in the other regions. However, in all the 
regions of the study by Jones, only the carbapenems consistently inhibited ESBL-
producing strains. 
Another type of resistance affecting third-generation cephalosporins and 
aztreonam (a monobactam) has been the hyperproduction of an Amp C 
cephalosporinase an inducible enzyme by members of Enterobacteriaceae (Jones 
et al., 1997; Coudron et al., 2000). Amp C cephalosporinase is normally 
produced in modest amounts and does not significantly destroy the third-
generation cephalosporins; however, spontaneous mutations can derepress 
enzyme production generating enough enzymes to hydrolyze the cephalosporins 
and aztreonam (Jones et al., 1997). The drugs of choice against Amp C beta-
lactamase producing bacteria are the carbapenems while cefepime has been 
reported to possess physico-chemical characteristics that enable clinical use 
against the ceftazidime-resistant Enterobacteriaceae (Jones and Varnam, 2002).  
The role of integron in the acquisition and dissemination of resistance in 
enteric bacteria is very crucial. Integrons are DNA elements which contain 
collections of genes (gene cassettes) that are generally classified according to 
the sequence of the protein (integrase) that imparts the recombination function 
(Mazel, 2006). They have the ability to integrate stably into regions of other 
DNAs where they deliver, in a single exchange, multiple new genes, particularly 
for drug resistance (Nemergut et al., 2008). Many of the gene cassettes in 
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resistance integrons which probably originated from super-integrons (larger 
integron structures with hundreds of accessory genes), encode resistance 
against newer antibiotics such as cephalosporins and carbapenems (Fluit and 
Schmitz, 2004).  These genetic elements which can be carried by other mobile 
genetic elements such as plasmids and transposons assist in the rapid dispersion 
of resistance genes within bacterial species and between different species 
(Levesque et al., 1995; Hall, 1997).  Several gene cassettes and 4 distinct classes 
of integrons have been identified, some of which confer resistance to beta-
lactams, aminoglycosides, trimethoprim, chloramphenicol, sulfonamide and 
quaternary ammonium compounds used as antiseptics and disinfectants 
(Levesque et al., 1995; Hall, 1997; Mazel et al., 1998). Plasmid-borne integron 
have been implicated in MDR Salmonella enterica serovar Enteritidis (Brown et 
al., 2000). In 2008, the study by Rayamajhi and his group described a rise in 
trend of MDR S. enterica serovar Typhimurium with clinically important class 1 
integron in food animal. This may have a ripple effect of resistance dissemination 
on the human consumers (Rayamajhi et al., 2008). Recently, class 1 integrons 
for aminoglycoside and trimethoprim resistance were found to be widespread 
among members of Enterobacteriaceae in China. The study also identified class 2 
integron in Shigella isolates and believed that these play a role in antibiotic 
resistance (Gu et al., 2008). 
 
1.2.7. Trends in emergence and spread of antibiotic resistance  
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Antibiotic resistance is a rapidly growing problem in health care systems. 
It is a global public health concern that is impacted by both human and non-
human antimicrobial use. Alexander Fleming selected and described mutants 
resistant to penicillin soon after he had discovered the antibiotic. In 1946, a 
statement was credited to Fleming which reads thus “There is probably no 
chemotherapeutic drug to which in suitable circumstances the bacteria cannot 
react by in some way acquiring ‘fastness’ [resistance].” quoted by Alekshun and 
Levy (2007). More than 6 decades after the introduction of antibiotics into clinical 
practice, the prescience of Fleming has come to fruition as the infectious disease 
community has yet to identify an antibiotic that has managed to circumvent the 
development of resistanc (Alekshun and Levy, 2007).  Resistance usually emerge 
to each new antibiotic used as the drug of choice for treating diarrhoeal disease 
soon after introduction into clinical practice. In the 1940’s which marked the pre-
antibiotic era, resistance to penicillin drugs among staphylococci was noted 
(Barber, 1947). This was mediated by the production of penicillinases in the 
bacterial pathogens. In the seventies, resistance to ampiciillin, tetracycline and 
sulfonamides in Gram-negative bacteria was frequent (Willett and Radojcic, 
1976; Maselle et al., 1980). Resistance to trimethoprim-sulfamethazole quickly 
emerged soon after it becamce first-line drug of choice and this was soon 
followed by an explosion of resistance to nalidixic acid (Jesudason and Saaya, 
1997). The extensive use of ampicillin, chloramphenicol and trimethoprim-
sulfamethoxazole for the treatment of presumed cases of typhoid fever may 
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have contributed to the high prevalence of resistance to these drugs (Coovadia 
et al., 1992; Morpeth et al., 2009). Also, their use in the treatment of non-
typhoidal Salmonella infections in sub-Saharan Africa is of limited value since 
resistance have been reported in many cases (Lepage et al., 1990 ; Enwere et 
al., 2006 ; Gordon et al., 2008). In Nigeria, the prevalences of enteric bacterial 
strains resistant to tetracycline, ampicillin, chloramphenicol, and streptomycin 
among healthy individuals increased tremendously from between 9% to 35% in 
1986 to 100% in 1998 (Okeke et al., 2000). The increasing rate of gentamicin-
resistance in Enterobacteriaceae is critical considering the importance of this 
drug in the treatment of bloodstream infections. Increase in gentamicin-
resistance in E. coli was reported in Tanzania (Maselle et al., 1980; Blomberg et 
al., 2007) and Kenya (Slack and Wamola, 1977; Omari et al., 1997). In 
Bangladesh, the isolation of vibrio strains resistant to antibiotics such as 
tetracycline, ampicillin, kanamycin, streptomycin and trimethoprim-
sulfamethazole became noticeable from 1979 (Glass et al., 1980). In South 
Africa, gentamicin-resistant strains which have earlier been reported (Dalsgaard 
et al., 2001) have persisted even in environmental samples (Okoh and Igbinosa, 
2010). Increasing isolation of enteric pathogens with resistance to beta-lactam 
drugs have been reported over the years in South Africa (Essack et al., 2001; 
Bell et al., 2002; Kruger et al., 2004) and to date the status quo seems to have 
been maintained. Currently, isolation of gram negative bacterial strains resistant 
to newer cephalosporins and particularly imipenem-resistant Pseudomonas 
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aeruginosa are being reported (Essack et al., 2001; Bell et al., 2002; Kruger et 
al., 2004). This might be an indication that we have probably entered into the 
post-antibiotic era, unless drastic intervention strategies are put in place to 
reverse the trends. 
1.2.8. Consequences of antibiotic resistance 
Evidences have shown that adverse human health consequences due to 
the occurrence of resistant microorganisms are grave and may be felt harder in 
resource-poor settings. These main consequences of antibiotic resistance may be 
increased frequency of treatment failures and increased severity of infections and 
can have cost implications, morbidity as well as mortality repercussions.  
1.2.8.1. Morbidity and Mortality implications of antibiotic resistance  
Whilst some underlying conditions such as old age (>65 years) and 
immunosuppression may constitute risk factors for colonization and infection with 
an MDR gram-negative bacterium (Hsu et al., 2005), several studies both 
retrospective and prospective have shown that infections with MDR gram-
negative bacteria are more frequently associated with increased morbidity and 
mortality than those caused by susceptible pathogens (Helms et al., 2002; 
Travers and Barza, 2002; Varma et al., 2005). Increased hospitalization and 
bloodstream infections have been correlated to an increased relative frequency 
of antimicrobial-resistant Salmonella (Varma et al., 2005). Several studies have 
found similar correlation in other bacteria: ESBL-producing E. coli and Klebsiella 
spp., (Lautenbach et al., 2001), imipenem-resistant P. aeruginosa (Lautenbach et 
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al., 2010) and other bacteria pathogens (Angulo et al., 2004). In a Canadian 
study, the burden of illness associated with Salmonella enterica serotype 
Typhimurium infection was identified. Infections by definitive phage type 104 
(DT104) and R-type antimicrobial-resistance pattern (AK/CSSuT) were used as 
risk factor (Martin et al., 2004). The outcome of the study was a significant 
estimate of hospitalization attributable to the resistance patterns of the infections. 
Likewise, persons with infections caused by antimicrobial-resistant Salmonella 
have been found to be more likely to have bloodstream infection or die within 90 
days following specimen collection than control groups with susceptible 
infections. The death rate for persons with multi-drug resistant Salmonella 
infections was estimated to be 10 times higher in the two years following 
specimen collection than for the general population (WHO, 2005a). 
1.2.8.2. Cost implications of antibiotic resistance  
Besides the human health impacts of resistance to first-line drugs a huge 
economic cost is incurred in terms of procuring newer effective antibiotics which 
are usually expensive and may be unavailable to local health centers. 
Consequentially, inavailability of effective therapy leads further to increased cost 
due to the length of hospitalization, the cost of the illness, in terms of treating 
the patient, lost wages for patient and family members and salaries of health 
care personnel which may be substantial (Sack et al., 2001). The economic 
implications of drug resistant infections can be of significant value. Antibiotic-
resistant infections attributably cost the U.S. healthcare system in excess of $20 
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Billion annually while the medical costs per patient ranged from $18,588 to 
$29,069 (Boston and Durham, 2009). In Canada, Salmonellosis has been 
estimated to cause 627,200 cases of infection and cost Can$846.2 million 
annually (Todd, 1989). The finding of Broughton et al. (2010) was substantially 
longer stays and higher costs associated with non-typhoidal salmonellosis that 
was quinolone resistant. The study gave an indication that interventions that 
decrease quinolone resistant prevalence will lead to significant savings for the 
health system in the management of hospitalized salmonellosis cases.  
1.2.9. Prevention of diarrhoea 
The incidence of diarrhoea can be greatly reduced by proper preventive 
measures. The avoidance of the use of antibiotics, development and use of non-
antibiotic drugs such as anti-secretory drugs has been suggested to reduce 
diarrhea. Some preventive measures are highlighted below. 
 Breastfeeding: Exclusively breastfed babies are much less likely to get 
diarrhoea or to die from it than are babies who are not breastfed or are 
partially breastfed. Efforts should be made to improve weaning practices 
(Mahmood et al., 1989).  
 Use of safe water: The risk of diarrhoea can be reduced by using the 
cleanest available water, increased availability and accessibility to, and 
protecting domestic water from contamination (WHO, 2009b). 
 Handwashing: All diarrhoeal disease agents can be spread by hands that 
have been contaminated by faecal materials. The risk of diarrhoea is 
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substantially reduced when individuals practice regular handwashing. In 
addition, the risk of spread of resistant diarrhoeal pathogens, particular in 
the hospital setting, can greatly be reduced by handwashing of medical 
personnel (Khan, 1982). 
 Food safety: Food contamination by diarrhoeal agents can occur at all 
stages in the food production chain. These include: during the growing 
period (by use of human fertilisers), in public places such as markets, 
from processing plants to kitchens and food service establishments, and 
when kept without refrigeration after being prepared. Evaluations of 
improved food handling and storage methods and practices should be 
done on regular basis. Health education concerning good animal 
husbandry, good abattoir practice and good hygiene at all stages as well 
as individual food safety practices should also be emphasized (FAO/WHO, 
n.d). 
 Control of drug resistance through food: Control of drug-resistant enteric 
pathogens is most efficiently achieved through the reduction of 
antimicrobial use. Prudent usage in food animals combined with 
aforementioned food safety and hygiene practices should reduce the 
numbers of the relevant resistant bacterial strains in food animals and 
lower the risk of contamination at all stages in the food production chain 
(WHO, 2005a). This should be complimented with proper surveillance, risk 
assessment and International collaborative efforts need to be increased. 
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 Use of latrines and safe disposal of stools: An unsanitary environment 
contributes to the spread of diarrhoeal agents. Because the pathogens 
that cause diarrhoea are excreted in the stools of an infected person or 
animal, proper disposal of faeces can help to interrupt the spread of 
infection. Faecal matter can contaminate water where children play, 
where mothers wash clothes, and where they collect water for home use. 
Every family needs access to a clean, functioning latrine. If one is not 
available, the family should defecate in a designated place and bury the 
faeces immediately. Stools of young children are especially likely to 
contain diarrhoeal pathogens; they should be collected soon after 
defecation and disposed of in a latrine or buried (WHO, 2009b).  
 Immunization: Whenever new, effective vaccines become available for 
cholera and diseases caused by other enteric pathogens, immunization 
programs are vital. In 2008, two new vaccines; pneumococcal conjugate 
and rotavirus vaccines were made available and introduced into clinical 
practice in South Africa (Harries et al., 2009; Harrison, 2009) as 
intervention to decrease infant and child mortality from vaccine 
preventable causes. Measles immunization can substantially reduce the 
incidence and severity of diarrhoeal diseases. Every infant should be 
immunized against measles at the recommended age. Evaluation of the 
success rate of the vaccine should be carried out periodically. 
53 
 
 Health education: The likelihood of eradication of enteric pathogens such 
as Salmonella in domestic animals seems impossible in the foreseeable 
future (WHO, 2005b). There is a need to educate the general populace on 
the need to cook animal foods thoroughly prior to consumption so as to 
keep the incidence of drug-resistant pathogens in foods of animal origin to 
the barest minimum. Education of food handlers in the principles of safe 
food handling is an essential step towards reducing the incidence of food-
borne diseases resulting from cross-contaminations during processing and 
preparation of foods (WHO, 2009a). Educating farmers and their families 
regarding the risks of occupationally acquired infections is also an 
important step in the control of human infections from food sources. 
1.2.10. Medicinal plants: alternative/complementary diarrhoea therapy 
The unabated increasing antibiotic resistance has not only led to 
resistance to several antibiotic groups but has led to selection and development 
of multidrug-resistant bacterial strains which is a serious worldwide health 
menace. The need to find lasting solutions to the emerging infections which have 
become a global concern has necessitated the exploration of natural products in 
the form of medicinal plants in the treatment of various ailments, diarrhoea 
inclusive.  
In many developing countries particularly in sub-Saharan Africa, healers 
use a wide variety of plants in the treatment of gastrointestinal ailments. Several 
studies have reported the use of herbal plants as therapeutic agents in the 
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treatment of diarrhoea, even though most of the herbs are used in the treatment 
of various other ailments (Longanga Otshudi et al., 2001; Vieira et al., 2001; 
Agunu et al., 2005; Samie et al., 2005; Nair and Chanda, 2007; Mbagwu and 
Adeyemi, 2008). Some of the plants which have been used traditionally in the 
treatment of diarrhoea and or stomach disorders are listed in Table 4 below.  
1.2.10.1. Modes of Action of Medicinal Plants 
Medicinal plants generally exhibit multiple non-specific effects which are 
usually complementary or synergistic. More often than not, they tend to have 
several broad actions on a number of whole physiological systems at the same 
time. Investigations have described various modes of action of antidiarrhoeal 
herbs. These therapeutic agents can have antispasmodic effects, delay intestinal 
transit, suppress gut motility, inhibit intestinal motility, stimulate water 
adsorption or reduce electrolyte secretion (Palombo, 2006) and some of these 
effects have been attributed to the presence of numerous phytochemicals (such 
as alkaloids, tannins, flavonoids and terpenes). Tannins and flavonoids are 
believed to exhibit their antidiarrhoeal potentials by increasing colonic water and 
electrolyte re-absorption (Palombo, 2006). In an animal experimental study by 
Ojewole and his group, aqueous extract of Psidium guajava decreased the  
 
Table 1.4. Some medicinal plants commonly used as diarrhoeal remedy 
in South Africa 
 
Botanical Names Active Ingredient Traditional Usage Reference 
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Carpobrotus edulis N.E. 
Br. 
(Mesembryanthemaceae) 
Malic acid, citric 
acid, tannins  
Antiseptic, anti-
diarrhoeal, 
vasoconstrictive
  
Van Wyk et al. 
(1997); Wisura 
and Glen (1993) 
Elephantorrhiza 
elephantina Benth. 
(Fabaceae)  
Entagenic acid, 
tannins  
Antiseptic, anti-
diarrhoeal, anti-
ulcerative, emetic 
Van Wyk et al. 
(1997); 
Hutchings et al. 
(1996). 
Eucomis autumnalis 
(Mill.) Chit. (family) 
Homoisoflavanones, 
nortriterpenoids 
Urinary diseases, 
stomach ache, 
diarrhoea, enema 
for low back pain 
and healing of 
fractures 
Watt and Breyer-
Brandwijk 
(1962); 
Hutchings et al. 
(1996), Van Wyk 
and Gericke 
(2000) 
Pelargonium sidoides 
DC. (family) 
Saponins, tannins Tuberculosis, 
diarrhoea 
(bronchitis, 
infections of the 
upper respiratory 
tract) 
Watt and Breyer-
Brandwijk 
(1962); 
Hutchings et al. 
(1996) ; Van 
Wyk and Gericke 
(2000) 
Viscum capense L. 
(Viscaceae)  
Viscumside, 
flavonoids 
Anti-diarrhoeal, 
anti-bronchial, 
uterotonic, styptic 
Van Wyk and 
Gericke (2000) 
Xysmalobium undulatum 
R. Br. (Asclepiadaceae) Uzarin  
Anti-diarrhoeal, 
against painful 
menstrual cramps 
Van Wyk and 
Gericke (2000) 
 
propulsive movement and transit of charcoal meal through the gastrointestinal 
tract (GIT) (Ojewole et al., 2008). The study also showed that the aqueous 
extract of P. guajava at a dose of 50–400 mg/kg, significantly inhibited all the 
diarrhoeal parameters investigated: onset, frequency and severity of diarrhoea, 
total number of stools, number of wet stools, and weight of wet stools.   
 1.2.10.2. Further benefits of herbal plants 
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Exploring the efficacy of medicinal plants in the amelioration of infectious 
diseases may not only be a source of succor in abating multiple antibiotic 
resistance infections but will also make health care affordable and available at 
the door-step of all. According to Akerele (1978) “If there is to be any real 
improvement in the health of the under-served populations of the world, then 
there will have to be full utilization of all available resources, human and 
material….”  In Africa particularly in the rural areas, long waits for medical 
attention; misgivings about the effectiveness of Western medicine, and cultural 
dependency on traditional methods have made the people turn orthodox 
medicine to a last resort. In this instance, traditional medicine especially through 
the use of herbs has contributed immensely to the primary health care of the 
people. A study by the Roll Back Malaria Initiative found that in Ghana, Mali, 
Nigeria and Zambia, herbal medicines were the first line of home treatment for 
about 60% of children with high fever (Brieger et al., 2005). About 65% of the 
population in India regularly depends on traditional medicine. The developed 
countries are not spared in the use of medicinal plants and significant increase in 
usage over the past decade has been reported (Pagán and Pauly, 2005). In the 
USA and Australia 42 and 48 % of the populations respectively utilize 
complementary and alternative medicines (Eisenberg et al., 1998). A WHO 
estimate states that 70% of Canadians and 75% of people in France have tried 
complementary or alternative medicine, which often includes herbal remedies 
(WHO, 2008), and in Japan, 85% of doctors prescribe not only modern medicine 
57 
 
but also the traditional herbal medicine (called Kampo), which is covered by 
health insurance (Aschwanden, 2001). In San Francisco, London and South 
Africa, 75% of people living with HIV/AIDS use traditional medicine or 
complementary and alternative medicines. 
Medicinal plants can contribute immensely to the sustainable development 
of the poor but naturally endowed nations. The assertion of Geldenhuys and Van 
Wyk (2002) was that natural resources were fundamental in the socioeconomic 
development of the African continent. Africa is richly endowed with a vast 
diversity of plants. According to Van Wyk (2008) recent data have shown that a 
quarter of the total number of higher plants in the world is found in sub-Saharan 
Africa. Also, a total of 50,136 angiosperm taxa occur in tropical Africa and 
Southern Africa (Klopper et al., 2006). Medicinal usages in excess of 16,300 have 
been reported from a list of more than 5400 medicinal plant taxa on the African 
continent (Neuwinger, 2000). Herbal medicines are also profitable and are highly 
lucrative.  Worldwide, they represent a market value of about US$ 43 billion a 
year. According to WHO (2008) annual revenues in Western Europe reached US$ 
5 billion in 2003-2004. In China, sales of products totaled US$ 14 billion in 2005 
and herbal medicine revenue in Brazil was US$ 160 million in 2007. In South 
Africa, Dold and Cocks (2002) valued annual trade in plant material at 
approximately R27 million. 
Medicinal plants aside from being used directly as teas or in other 
extracted forms for their natural chemical constituents; they may serve as leads 
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in the discovery of new drugs.  Herbs may be used as agents in the synthesis of 
drugs or the organic molecules and constituents may be used as models for 
synthetic drugs. Data have shown that a number of drugs are derived from plant 
materials (Newman et al., 2003). Twenty-five percent of modern medicines are 
made from plants first used traditionally. The search for new molecules according 
to Gurib-Fakim (2006) has taken a slightly different route whereby the science of 
ethnobotany and ethnopharmacognosy are being used as guides to lead the 
chemist towards different sources and classes of compounds. Some examples of 
commonly used pharmaceutical products which are of botanical origin are aspirin 
from willow bark (Salix spp.), digitoxin, digitalin or digoxin from Common 
foxglove (Digitalis purpurea) and quinine from Cinchona ledgerian (El-Baz, 2007). 
A recent example is the endoperoxide-based antimalarial drug Artesunate that 
originated from artemisinin, first isolated from the Chinese herbal medicine 
Artemisia annua L (Camacho et al., 2000). A number of patented products have 
been obtained from studies involving medicinal herbs. 
1.2.10.3. Safety issues in medicinal herb therapy 
The issue of toxicity in natural products applies not only to herbs but also 
to some ordinary food substances. The constituents of  many foods could be 
regarded as poisonous, such as the alpha gliadin produced by gluten in wheat 
oats and rye, the cyanogenic glycosides in many fruit seeds, the thiocyanates of 
the brassica vegetables, alkaloids of the Solanaceae and lectins of many pulses 
including soya and red kidney beans.  
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Medicinal plants have reportedly cause serious illnesses ranging from 
allergy to liver or kidney malfunction, to cancer, and even death. The toxicity 
effects of medicinal plants may be acute or long term. These effects may range 
from diarrhoea, hypersensitivity reactions, nausea or vomiting, to organ-targeted 
toxicity, immunotoxicity, embryo/fetal and prenatal toxicity, mutagenicity/ 
genotoxicity, hepatotoxicity, nephrotoxicity, presence of epileptogenic 
compounds, cardiac toxins, gastrointestinal toxins to carcinogenicity (Smolinske, 
2005). According to US toxicologist, Dr Lois Gold, the carcinogenicity or 
toxicological potentials of natural plant chemicals are comparable to those of 
synthetic chemicals (Ames et al., 1990; Gold et al., 1991). Several studies have 
reported varying level of cytotoxicity of medicinal plants, cytopathic defects and 
organ dysfunction in animal experiments. The ethanol extracts of Athrixia 
phylicoides DC. (bush tea) which is widely used as a beverage, cough remedy 
and purgative were relatively toxic (McGaw et al., 2006). Extract and a flavonol 
glycoside from Bauhinia galpinii were cytotoxic to Vero cells (Aderogba et al., 
2007; Samie et al., 2010). Pyrrolizidine alkaloids which are not toxic per se, but 
can be converted to toxic metabolites in the liver are reported to be contained in 
several medicinal plants (Eloff and Rösemann, 2009). Examples are 
hepatotoxicity of pyrrolizidine-alkaloid-contained in Comfrey (Symphytum), 
Dryopteris (Male Fern), Viscum (Mistletoe) and Corynanthe (Yohimbe).  
Michellamine B one of the atropisomeric naphthylisoquinoline alkaloid dimers 
isolated from Ancistrocladus korupensis was inhibitory to several laboratory and 
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clinical strains of HIV-1, including the AZT resistant strain G910-6 and the 
pyridinone-resistant strain A17; as well as strains of HIV-2. However, the high 
toxicity of this compound to several human cell lines prevented its further 
evaluation (Boyd et al., 1994). In South Africa, mutagenic effects in the 
Salmonella microsome assay have been reported in Crinum macowanii, 
Chaetacme aristata Planch. (Celastraceae), Plumbago auriculata Lam. 
(Plumbaginaceae), Catharanthus roseus (L.) G.Don. (Apocynaceae) and Ziziphus 
mucronata Willd. (Rhamnaceae) (Elgorashi et al., 2003). In another study, the 
induction of genotoxicity on bacterial or human cells has been observed 
(Elgorashi et al., 2002). Comfrey, Lobelia and Sassafras tea has been implicated 
in liver disease, vomiting, breathing problems, convulsions, cancer,  and even 
death (Snider, 1991). Blindness has also been attributed to the use of herbal 
medicines. In the United Republic of Tanzania, a study by Yorston and Foster 
(1994) linked 25% of corneal ulcers to the use of traditional eye medicines, of 
which many are based on herb extracts. Another study, in Malawi found that 
herbal medicines were associated with 26% of childhood blindness (Courtright et 
al., 1994). 
Another safety issue is that of contamination problems. Heavy metals, 
pesticide residues, microbes and microbial metabolites such as aflatoxin 
contaminants of herbs constitute additional safety problems. Cumin seeds 
commonly given by Egyptians to their children to relieve coughs, aches, or 
itching were among five spices purchased at a local market in Egypt and 
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examined for toxic content. High level of the organophosphate pesticide 
(profenofos, 0.37g/kg) or nearly twice the residue the WHO and Codex 
Alimentarius Commission permit in vegetables was detected in the cumin seeds 
(Ahmed, 2001). According to Roy et al. (1988) aflatoxin contamination was 
detected in 14 out of the 15 common drug plants in India. Contamination of 
dietary and medicinal plants with exposure to fumonisin B1 is widespread than 
expected in the Eastern Cape Province of South Africa (Sewram et al., 2006). 
Fungal microbes and Fumonisin B1 contamination of commercial traditional 
African medicines in South Africa have recently been reported (Katarere et al., 
2008). A lack of proper sterilization, along with inclusion of components such as 
urine, saliva, or breast milk in some of medicinal herbs used as eye remedy in 
Malawi, gives pathogens ample opportunity to thrive in eyes already hard hit by 
injury or infection  (Courtright et al., 1994). Perhaps the biggest problems with 
herbal medicines are a lack of standardization and of safety regulations. 
However, a very recent study conducted in Ghana suggested that rather than 
have heavy metal toxicity effects, the metals found in the plants of study may 
offer beneficial effect in case of micronutrient deficiency in herb consumers since 
metals are readily bioavailable (Annan et al., 2010). 
 The foregoing literature review underlines the scale, magnitude and 
health associated parameters of infective diarrhea, the problems of escalating 
antibiotic resistance, the forays to uncover the genetic basis of antibiotic 
resistance and virulence of the designated bacterial pathogens, including the 
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potentials of the use of medicinal plants and their possible safety related issues. 
In spite of these challenges, comprehensive studies on updated antibiogram 
profiles, genetic landscape and activity of medicinal plants against 
enteropathogens, particularly, Salmonella species and E. coli have received little 
attention in South Africa. 
 
1.3. Objective of the study 
i. To characterize and determine the antibiograms of Salmonella and 
diarrheogenic E. coli isolates from clinical samples of patients. .  
ii. To determine extended spectrum beta-lactamases (ESBL’s) production 
and the genetic determinants among the Salmonella and diarrheogenic E. 
coli isolates.  
iii. To identify the gene encoding virulence factors in Salmonella and E. coli 
isolates. 
iv. To identify and screen various medicinal plants used by herbalists within 
the Oliver R. Tambo District Municipality (ORTDM) in the treatment of 
diarrhea and related diseases for their antimicrobial activities. 
v. To isolate pure compounds, elucidate and characterize active ingredients 
of selected medicinal plants and investigate their cytotoxicity effects.  
 
1.4. Approach 
The study involved clinical, field and laboratory studies.  
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 The first stage of the study was clinical-based and involved gathering 
demographic information about patients, history of diarrhoea, HIV status 
(from hospital records and surveillance data), self-medication and the 
usage of herbal medicine. Clinical specimens analyzed included stool and 
blood samples which were collected from patients through the help of 
qualified health care-givers, and from those deposited into the NMAHC 
laboratory. 
 The second stage was the laboratory analysis of clinical samples obtained 
from the selected human subjects for the isolation of Salmonella and E. 
coli using standard microbiological techniques. These included the 
susceptibility testing of the enterobacteria using standard drugs and the 
identification of the resistance and virulence factors of the isolates using 
molecular techniques. 
 The third stage of the study involved identification and selection of 
ethnomedinal plants used in folklore practice in ORTM for diarrhea and 
associated diseases. This was guided by the information from the 
interview of traditional healers and informed elders of the communities. 
 The last stage of the research involved analysis of the crude extracts of 
the medicinal plants for their antidiarrhoeal activities and, the isolation 
and characterization of the active ingredients, including cytotoxicity 
testing. 
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CHAPTER 2 
EXTENDED-SPECTRUM BETA-LACTAMASES AND CLASS 1 INTEGRON MEDIATED 
RESISTANCE IN CLINICAL ISOLATES OF ESCHERICHIA COLI AND SALMONELLA  
 
 
2.0. Abstract 
 
Molecular characterization for the presence of specific antimicrobial resistance 
mechanisms was carried out on 119 Salmonella and 90 Escherichia coli isolates 
from patients with diarrhoea in the Eastern Cape Province, South Africa. PCR and 
sequencing were used to verify the genetic determinants responsible for 
extended spectrum beta-lactamases (ESBLs) phenotypes. Of the 119 Salmonella 
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isolates, 61 (51.2 %) were ESBL, positive by genotypic determination. A total of 
9 (14.7 %) and 54 (88.5 %) of the 61 isolates were CMY-2 and TEM b-lactamase 
producers, respectively. Only 1 of the Salmonella spp. was CTX-M ESBL’s 
producer. Among the E. coli isolates the mediators of resistance were 13 (68.4 
%), 9 (47.4 %) and 2 (10.5 %) of blaSHV, blaTEM and blaCTX-M respectively. Class 
1 integron (Int1) gene occurred significantly among the Salmonella species, 
mostly among isolates expressing TEM genes.  This study reports the presence 
of the blaCMY-2, blaSHV-1, blaTEM-20 and blaTEM-1 genes and the involvement of class 1 
integrons mediated resistance in Salmonella and Escherichia spp. from the 
Eastern Cape, South Africa. Results suggest that integrons contribute 
significantly to antimicrobial resistance among the enteric gram-negative bacilli 
studied. Molecular genotyping of pathogens is fundamental to tracking disease-
associated and drug-resistant strains in various populations. 
Key words: ESBLs; Salmonella; resistance; phenotypes, genotypes, integrons 
 
 
2.1. Introduction 
 
Among the agents causing gastroenteritis, Salmonella, Shigella and Escherichia 
coli are important bacterial pathogens. Salmonellae are regarded as ubiquitous 
food-borne pathogens causing widely distributed infections with the consumption 
of especially raw and undercooked foods of animal origin, such as beef, poultry, 
milk, and eggs. Salmonellae can be differentiated by their somatic (O) antigens, 
composed of lipopolysaccharides, and the flagellar (H) antigens (Kaye, 1996). 
More than 2,500 Salmonella serotypes have been identified to date (WHO, 
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2005). Various species of Salmonella cause varying types of infectious diseases. 
While some are host-specific some have a broad range of hosts; S. enterica 
serovar Typhi is adapted to humans and does not occur in animals while non-
typhoidal Salmonella serovars (NTS) have a broad vertebrate host range 
(Gordon, 2008). S. enterica serovar Typhimurium and S. enterica serovar 
Enteritidis are the most frequently isolated serovars from food-borne outbreaks 
throughout the world (Herikstad et al., 2002) and are the two most important 
serotypes for salmonellosis transmitted from animals to humans. Salmonella 
enterica serovar Dublin is associated with cattle while Salmonella enterica 
serovar Choleraesuis is linked with pigs (WHO, 2005). 
Salmonellosis affects a significant portion of human population causing 
approximately 2.16 million cases of infections and 216,000 deaths worldwide 
(Crump et al., 2004; Boyle et al., 2007). Public health concerns involving 
Salmonella include sporadic outbreaks of infections due to the pathogen even in 
the so called developed countries despite advanced technology and infection 
controls (Bisi-Johnson et al., 2007). In the US, a recent outbreak of Salmonella in 
ready-to eat sausages linked to spices has been reported (Gifford, 2010). 
Salmonellosis manifests as diarrhoea, fever, and abdominal cramps between 12 
and 72 hours after eating contaminated food. The illness which usually lasts 4–7 
days and is self-limiting in most people may spread in vulnerable groups, such as 
infants, the elderly and immuno-compromised individuals beyond the intestine to 
the bloodstream and cause a more severe systemic disease.  
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Escherichia coli is recognized as both a normal intestinal floral with 
beneficial roles and a versatile human pathogen causing a wide range of 
infections including diarrhoeal diseases. Based on the strain and pathogenic 
mechanisms, different pathotypes of diarrheagenic E. coli are recognized. These 
include Enterotoxigenic E. coli (ETEC) which is a cause of traveler's diarrhea, 
Enterohemorrhagic E. coli (EHEC) which cause hemorrhagic colitis or hemolytic-
uremic syndrome (HUS), Enteropathogenic E. coli (EPEC) which cause either a 
watery or bloody diarrhea, Enteroinvasive E coli (EIEC) a cause of Shigella -like 
dysentery, while Enteroaggregative E. coli (EAggEC) is often associated with 
persistent diarrhoea in children in developing countries. The main reason 
advanced by Chatterjee et al. (2009) for the occurrence of many of the strains of 
diarrheagenic E. coli in the developing nations is inadequate sanitary conditions. 
However, the most common enteropathogen in developing countries is ETEC. 
This pathotype is reported to account for approximately 210 million diarrhoea 
episodes and approximately 380,000 deaths (WHO, 2008; Gupta et al., 2008).  
Antibiotics are often not recommended in the treatment of enteritis. It is 
believed that antibiotics prolong the carrier state of enteritis due to Salmonella. 
Nevertheless, systemic Salmonella infections and infections in the vulnerable 
groups qualify for antibiotic therapy (DuPont, 2003). Fluoroquinolones are often 
the drug of choice in the treatment of gastrointestinal infections in humans. 
Resistance to fluoroquinolones has emerged worldwide during the last decade 
and is associated with increased illnesses and deaths (Helms et al., 2004). 
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Extended-spectrum cephalosporins are important for treating persons with 
severe Salmonella infections (Hohmann, 2001). The emergence of Salmonella 
isolates resistant to oxyiminocephalosporins has become a cause for concern due 
to the fact that cephalosporins are the alternatives to fluoroquinolones in 
children because of toxicity issues (Aarestrup et al., 2005). The resistant 
mechanism involves the production of extended-spectrum β-lactamases (ESBLs).  
ESBL’s have traditionally been defined as transmissible beta-lactamases 
that can be inhibited by clavulanic acid, tazobactam or sulbactam. They are a 
group of enzymes that break down antibiotics belonging to the penicillin and 
cephalosporin groups and render them ineffective. The ESBL’s are generally 
encoded by mobile genes that can be exchanged between bacteria. The first 
plasmid-mediated ampicillin-hydrolyzing beta-lactamases was described in a 
strain of E. coli by Datta and Kontomichalou (1965) in Greece soon after the 
broad-spectrum penicillin was introduced in the 1960’s and was named TEM-1 
after the patient, whose name was Temoniera from whom the E. coli strain was 
isolated. This was soon followed by another common plasmid-mediated β-
lactamase SHV-1 (for sulphydryl variable) found in Klebsiella pneumoniae and E. 
coli.   
The first extended-spectrum beta-lactamase (ESBL), SHV-2; capable of 
hydrolyzing expanded-spectrum β-lactam antibiotics (third-generation 
cephalosporins) was found in an isolate of Klebsiella ozaenae (Kliebe et al., 
1985). These enzymes have spread over various regions of the world, across 
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members of Enterobacteriaceae with almost 200 different types identified to date 
(Bradford, 2001). Other ESBLs are the CTX-M, VEB, PER, GES, OXA groups and 
the inducible chromosomal class C (AmpC) betalactamases. AmpC beta-
lactamases which emerged in Enterobacter spp. have also migrated from 
chromosomal locations to plasmids and are spreading into E. coli and Klebsiella 
spp. Hence, it is pertinent to investigate the mechanisms of antibiotic resistance 
which is one of the arsenals of pathogenicity in enteric pathogens. This study 
was embarked upon to identify and characterize the array of ESBLs involved in 
drug resistance in clinical isolates of E. coli and Salmonella spp. 
 
 
 
 
 
 
 
2.2. Materials and methods 
 
2.2.1. Data collection and ethical approval 
 
Written informed consents were obtained from all patients, parents or 
guardians as the case may be and questionnaires were administered by trained 
volunteer health care workers (appendices 1A-1D). The study protocol and data 
handling were approved by the WSU ethics committee (Protocol No. 0003/08) 
as well as the Department of Health, Eastern Cape, South Africa.  
2.2.2 Bacterial isolates 
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 One hundred and nineteen Salmonella spp and 90 Escherichia coli isolated 
from clinical specimens of patients attending the Nelson Mandela Academic 
Hospital Complex, a tertiary hospital in the Eastern Cape Province, South Africa 
and satellite clinics were characterized by standard microbiological procedures. 
Minimum inhibitory concentrations (MICs) of standard antibiotics were 
determined with an automated antimicrobial susceptibility system according to 
the manufacturer’s instructions (Autoscan-4 antimicrobial susceptibility system; 
Siemens). Comprehensive antibiograms were determined for the isolates, using a 
customized antimicrobial panel of 24 antibiotics (Gram Negative combo panel 
NUC 45). The interpretation of susceptibility was according to the Clinical and 
Laboratory Standards institute (CLSI) standards for broth microdilution methods 
(CLSI, 2007). 
 
 
 
 
2.2.3. Identification and characterization of resistance genes 
 
Polymerase chain reaction (PCR) was used to confirm the presence of 
antibiotic resistance genes in the E. coli and Salmonella species. Testing for 
extended-spectrum cephalosporin-resistance mechanisms included susceptibility 
testing of additional β-lactams, such as ceftazidime and cefotaxime, and 
molecular characterization of β-lactamases and β-lactamase genes. Isolates were 
examined for the presence of ESBL enzyme blaTEM, blaSHV, blaCMY-2 and blaCTX-M 
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types (Arlet and Philippon, 1991; Gallego et al., 1990; Gazouli et al., 1988) as 
well as the involvement of class 1 integron intI1 genes. 
2.2.4. DNA extraction and primer synthesis 
 
DNA template for PCR was obtained from pure overnight bacterial culture 
using Fungal/Bacterial DNA extraction kitTM (Zymo Research) following 
manufacturer’s instructions. Eluted DNA verification and concentration 
measurements were carried out using NanoDrop 2000 spectrophotometer 
(Thermo Scientific). All primers used in amplification and sequencing reactions 
were synthesized by Inqaba biotechnology Industries Pty. Ltd., Pretoria, South 
Africa. 
2.2.5. DNA amplification 
 
PCR amplifications were performed in a final volume of 25 µL containing: 
0.5 to 2 μL of DNA template depending on concentration, 8.5 to 10 μℓ of 
Nuclease free water, 1 µL of each primer and 12.5 µL Master mix (EconoTaq 
Green, Fermentas). Amplifications were carried out in a GeneAmp PCR System 
9700 Thermocycler (Applied Biosystems). The PCR conditions were 94°C for 5 
min followed by 40 cycles of: 94°C for 30 s, 59°C for 1 min, 72°C for 1 min and 
final 72°C for 7 min for the ESBL primer sets used and 94°C for 5 min followed 
by 30 cycles of: 94°C for 1 min, 55°C for 1 min, 72°C for 1 min and final 72°C for 
7 min for the integron (intI1) gene. Table 2.1 shows the primers for the target 
genes. Amplification products were separated by electrophoreses on 2 % 
agarose gel (TopVision TM, Fermentas) in 1X TBE Buffer and ethidium bromide 
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(5 µL) with a 100-bp ladder (Fermentas) as molecular weight marker.  Agarose 
gels were visualized under UV illumination (TFM-26 Ultraviolet Transilluminator, 
UVP, Upland, CA) and the images were captured using a digital gel 
documentation system (DigiDoc-It imaging system, UVP, Upland, CA). 
2.2.6. Sequencing reaction 
 
PCR products were sequenced using an Applied Biosystems 3500xL Genetic 
analyzer (AB Biosystems).  Prior to PCR products sequencing, the unincorporated 
dNTPs were dephosphorylated with a commercial kit from Zymo Research 
Corporation (Orange, CA). Subsequently, the PCR products were sequenced with 
the ABI PRISM BigDye terminator cycle sequencing ready reaction kit (AB 
Biosystems) using the same primers as employed in the PCR reactions. The 
products were then subjected to the following conditions: 94°C for 2 min, 
followed by 40 cycles of denaturation at 85°C for 1 s, annealing at 53°C for 10 s 
and extension at 60°C for 2 min 30 s, with a final extension at 4°C for 0 s.  
 
 
Table 2.1. Primer sets for ESBLs and class I integron and the PCR conditions. 
 
Target 
gene 
Primer  Nucleotide Sequence 
 (5’- 3’) 
Amplico
n size 
(bp) 
References 
blaCMY-2 Amp3 (F)  
 
Amp2 (R)  
ATGATGAAAAAATCGTTATG
CTGC 
TTATTGCAGCTTTTCAAGAA
TGCGCCA 
 
1,145 Pitout et al., 
1988 
blaCTX-M CTX-MA  
 
CTX-MB 
CGCTTTGCGATGTGCAG 
 
ACCGCGATATCGTTGGT 
 
 
550 
Bell et al., 2002 
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blaSHV SHV-1 (F)  
 
SHV-3 
(R)  
ATGCGTTATATTCGCCTGTG 
 
GTTAGCGTTGCCAGTGCTCG 
 
846 Fey et al.,2000 
blaTEM TEM-1 
(F)  
 
TEM-4 
(R)  
ATGAGTATTCAACATTTCCG
TG 
TTACCAATGCTTAATCAGTG
AG 
 
840 Fey et al., 2000 
intI1 
 
INT1F 
 
INT1R 
AAGGATCGGGCCTTGATGTT   
 
AGCGCATCAAGCGGTGAGC 
471 Pongpech et al., 
2008 
 
The sequencing reaction products were cleaned up using ZR-96 DNA 
sequencing clean-up kitTM. Thereafter, the ultra-pure products were analyzed on 
the sequencing machine. Sequences were aligned with known ESBL and integron 
sequences by a blast search of the National Center for Biotechnology 
Information (NCBI) data base (www.ncbi.nlm.nih.gov/BLAST/) using Staden 
package version 1.6.0-beta4 (MRC.WTSI) and comparison and confirmation were 
also done with known ESBLs (www.lahey.org/studies/) compiled by Jacoby and 
Bush (n.d). 
2.2.7. Statistical analysis 
Patients’ data were analyzed using Microsoft Excel version 2003. 
Continuous variables were summarized as mean and standard deviation (SD). 
Demographic information was obtained from subjects using questionnaire. 
 
2.3. Results 
 
2.3.1. Demographic features 
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Our subjects were predominated by male patients 165/315 (52.4%) and 
no age group was excluded, with the youngest patient being 3 months and the 
oldest 91 years. The median age ± IQR equals 36 ± 22 years where IQR (inter-
quartile range) is a measure of the dispersion or how widespread out the values 
are. In all, there were 55 (17.5%) pediatrics patients. Information obtained from 
the questionnaires administered indicated that a sizeable number of our subjects 
depended on domestic and drinking water from unwholesome sources like rivers 
and streams. Prior to the clinic visit, 13 persons with diarrhea (4.1%) took some 
form of medicine. Three of the instances were complementary therapy with an 
instance of antimicrobial active against enteric gram-negative rods (GNRs) and 
the remaining 10 instances involved the use of concoction of medicinal plants. 
Most of the persons who took medicinal plants were HIV positive. 
2.3.2. Characterization and antibiogram of isolates 
 
Various serovars of Salmonella were identified with S. enterica serovar 
Typhi being the highest followed by S. enterica serovar Typhimurium. Resistance 
to 5 or more CLSI antibiotics subclasses was detected in 59/119 (49.6 %) of the 
Salmonella isolates and 18/90 (20 %) of E. coli.  Eighty-seven (73.1 %) of the 
Salmonella isolates mostly S. enterica serovar Typhi were invasive strains. 
Salmonella isolates were resistant to amoxicillin, ampicillin, aztreonam, 
piperacillin/tazobactam, trimethoprim/ sulfamethoxazole and tetracycline with 
reduced susceptibility to ciprofloxacin. E. coli strains were also identified and 
showed resistance mostly to ampicillin, ampicillin/sulbactam, cephalothin, 
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trimethoprim/sulfamethoxazole and tetracycline. No quinolone, carbapenem or 
gentamicin resistant strain was found among the E. coli isolates. Eight out of ten 
Salmonella isolates which were resistant to the quinolone of choice 
(ciprofloxacin) besides being resistant to the second and third generation 
cephalosporins tested also exhibited resistance or intermediate resistance to at 
least 2 or all 3 carberpenems (ertapenem, imipenem and meropenem) drugs 
tested. Extended spectrum cephalosporins resistant phenotype was exhibited by 
25/119 (21.0 %) of the Salmonella spp.  
2.3.3. Detection of genes mediating ESBL resistance 
 
PCR characterization and sequencing showed that the β-lactam resistance 
was mediated majorly by blaTEM with the involvement of class 1 integron gene, 
intI1. β-lactam genes blaCMY-2 and blaSHV were also expressed but in lower 
percentages. Of the 119 Salmonella isolates, 61 (51.2 %) were ESBL positive by 
genotypic determination. A total of 54 (88.5 %) and 9 (15.7 %) of the 61 
isolates were TEM and CMY-2 (Amp-C) ESBL producers, respectively.  Nine (11 
%) isolates were positive for both blaCMY-2 and blaTEM while only one was positive 
for blaCTX-M genes. Of the 61 Salmonella isolates with one or more β-lactams, 45 
(73.8 %) were S. enterica serovar Typhi; 9 (14.7 %) were S. enterica serovar 
Typhimurium; and 2 (3.3 %) were S enterica serovar Isangi. Out of the 90 
Eshcherichia isolates, 19 (21.1 %) were ESBL positive by genotypic 
determination, 13 (68.4 %), 9 (47.4 %) and 2 (10.5 %) of the 19 ESBL positive 
E coli isolates were blaSHV, blaTEM and blaCTX-M genes respectively.  Class I 
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integron genes were expressed in 83 (39.7 %) of all the isolates, 64 (77.1 %) of 
these were Salmonella spp. while 19 (22.9 %) were E. coli. Representative 
positive samples are shown in Figures 2.1a and 2.1b. The alignment and blast 
search results of representative sequenced products showed in most cases 100% 
correlation confirming the identity of our isolates, the ESBLs and the integron 
genes involved in the resistance mechanisms. Among the 4 representative 
isolates, sequencing for the specific blaTEM genes type revealed the presence of 
one blaTEM-20, two were blaTEM-1 and the fourth was blaTEM-4 gene. The SHV genes 
were of the blaSHV-1 type found only in the Escherichia spp while the Amp-C was 
confirmed as blaCMY-2. The designations of the enzymes were as confirmed 
(http:www.lahey.org/studies/webt.htm). Figure 2.2 shows the results of the blast 
search of the integron genes among the Salmonella isolates. The phylogenetic 
correlations of the integron gene sequences revealed a monophyletic clustering 
(Figure 2.3).  
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Figure 2.1.  PCR products analysis of the genomic DNA from selected E. coli and 
Salmonella isolates. Figure 2.1A: 100 bp molecular weight marker (lanes 1 and 
10), fragment from blaCMY-2 (lanes 2 to 4), blaSHV (lanes 5) and blaTEM (lanes 7 to 
9). Figure 2.1B: 100 bp molecular weight marker (lanes 1 and 8) Int1 (lanes 2 to 
9). The relative positions in the gel of predicted size of PCR products are 
indicated by arrowheads on the right sides. 
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2.4. Discussion 
 
The emergence of ESBL producing isolates has become a task which 
requires drastic interventions. Bacteria strains exhibiting ESBLs are often 
resistant to a wide variety of commonly used antibiotics. These isolates often are 
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not phenotypically resistant according to CLSI guidelines with the consequential 
avoidable treatment failures in patients who received inappropriate antibiotic 
therapy (Karas et al., 1996; Paterson et al., 1998). For this reason, ESBL 
producing organisms are to be reported as resistant to all extended-spectrum β-
lactam antibiotics with the exception of the cephamycins (NCCLS, 2000; 
Manickam and Alfa, 2008). Apart from ESBLs, plasmid-mediated AmpC beta-
lactamases are also typically associated with broad multidrug resistance 
(Thompson, 2001). The high frequency of resistance to drugs such as ampicillin, 
tetracycline and trimethoprim/sulfamethoxazole were not unexpected since, 
these are some of the oldest drugs used in infectious disease, and some level of 
resistance would have emerged over time (Salyers and Whitt, 2005).  
Often time, clinically relevant ESBL-mediated resistance goes undetected 
in routine susceptibility tests. Molecular methods, particularly PCR have become 
widely used techniques for the determination and confirmation of ESBL genes. 
Our study investigated clinical isolates of Salmonella and E. coli for the presence 
of blaampC, blaCTX-M, blaSHV, blaTEM and class 1 integron (intI1) by monoplex PCR. 
This study found that the percentage of ESBL detected phenotypically were only 
21.0 % and 5.5 % for Salmonella and E. coli respectively, while the percentage 
detected genotypically were 51.2 % and 21.1 % respectively. AmpC type enzyme 
was expressed by 11 % of our isolates while blaSHV and blaTEM were noted in 6.2 
% and 33.4 % of isolates, respectively. The joint occurrence of AmpC-type 
enzyme and ESBL in the same strain can mask the expression of ESBL (Bradford 
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et al., 1997; Moland et al., 2006). This is due to the fact that the AmpC-type 
beta-lactamase will not be inhibited by clavulanic acid, thus giving high MICs to 
both the single antimicrobial agent and the clavulanic acid combination. The 
result of this is that phenotypic confirmatory test may be falsely negative leading 
to inability to confirm the presence of ESBLs (Moland et al., 2006). In a previous 
study conducted in South Africa, 15.6% isolates produced SHV or TEM and 1.9% 
produced CMY-2 ESBLs (Kruger et al., 2004). Comparing this previous study with 
our results, an increase in the spread or expression of ESBL genes was noted, 
particularly the TEM and AmpC, also while the previous study failed to identify 
blaCTX-M our study observed the expression of this gene in a Salmonella isolate 
identified to be S. choleraesuis and 2 E. coli isolates.  Paterson et al. (2003) had 
shown the significance of blaCTX-M ESBL type in Klebsiella pneumoniae isolates. 
CTX-M enzymes which predominantly hydrolyze cefotaxime over ceftazidime are 
reportedly increasing in recent years. Furthermore, more resistance was 
observed in the Salmonella isolates than in the E. coli isolates. At the onset, the 
recognition of β-lactamases conferring resistance to the extended-spectrum 
cephalosporins, were particularly with resistances among Klebsiella species and 
Escherichia coli strains, but other species of the family Enterobacteriaceae now 
also express ESBLs activities (Goldstein et al., 1993; Cheng and Chen. 1994; 
Mariotte et al., 1994; Philippon et al., 1994; Morosini et al., 1995). The spread of 
ESBL’s genes have been reported to either be via epidemic bacterial strains or by 
plasmid dissemination between unrelated strains (Ben-Hamouda et al., 2004). 
113 
 
Carbapenems are the drugs of choice against AmpC beta-lactamase producing 
bacteria (Jones, 2003; Jones and Varnam, 2002).  
Int1 genes were expressed in 83 (39.7 %) of all the isolates, 64 (77.1 %) 
of these were Salmonella spp. while 19 (22.9 %) were E. coli. There were 
simultaneous occurrence of blaTEM, blaSHV and class 1 integron in a few isolates. It 
was also noted that the expression of blaTEM and class 1 integron (intI1) seem to 
co-occur in most positive isolates. Integrons are known to play a vital role in the 
resistance mechanisms of many pathogens.  These mobile gene cassettes are 
carriers of one or more resistance genes and are inserted into various 
arrangements between 2 conserved DNA regions, generating various 
antimicrobial resistance genes (Levesque et al., 1995). As with other mobile DNA 
elements, integrons assist in the rapid dispersion of resistance genes within 
bacterial species and between different species (Levesque et al., 1995; Hall, 
1997). We may hence attribute a significant role to these genes in the spread 
and increasing multidrug resistance isolates in our setting. 
 
2.5. Conclusion 
 
The study showed more resistance in Salmonella isolates than E. coli.  The 
increasing rates of multi-drug resistant strains and particularly the emerging 
resistance to penem drugs are regrettably leading gradually to fewer options of 
effective antimicrobials, especially for the treatment of infants and very small 
children. It is pertinent to increase awareness of clinical laboratories to isolates 
that exhibit ESBL phenotypes and make adequate diagnostic facilities available. 
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This may be a serious challenge particularly in the setting of this study where like 
in other sub-Saharan African countries, such resources are scarce. Molecular 
genotyping of pathogens is fundamental to tracking disease-associated and drug-
resistant strains in various populations. 
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CHAPTER 3 
 
MOLECULAR BASIS OF VIRULENCE IN CLINICAL ISOLATES OF ESCHERICHIA 
COLI AND SALMONELLA SPECIES FROM A TERTIARY HOSPITAL IN THE 
EASTERN CAPE, SOUTH AFRICA 
 
3.0. Abstract  
This study investigated the virulence factors of Escherichia coli and Salmonella 
species in clinical specimens from patients with diarrhoea presenting to health 
care centres in Oliver R. Tambo District Municipality, Eastern Cape Province, 
Republic of South Africa by the use of cultural and molecular techniques. Out of 
a total of 315 samples screened, Salmonella isolates were obtained in 119 
(37.8%) of cases and these comprised:  S. typhi (52%), S. typhimurium (25%), 
S. isangi (8%), S. choleraesuis (6%), S. enteritidis (4%), S. eppendorf (1%), S. 
hadar (1%), S. panama (1%), and untyped Salmonella spp. (2%). Using 
molecular diagnostic methods, diarrheagenic E. coli were detected in 90 cases 
(28.6%): the greater proportion of this were enteroaggregative E. coli (EAEC) 
37 (41.1%), enteropathogenic E. coli (EPEC) 21 (23.3%) and 
enterohemorrhagic E. coli (EHEC) 21 (23.3%). The virulence factors identified 
in the Salmonella strains were 105 (88.2%) inv, 15 (12.6%) flic, and 2 (1.7%) 
sef genes. The amino acid identity of the representative genes matched 95 to 
100% with corresponding blast searched sequence. This study underlines the 
importance of understanding the virulence composition and diversity of 
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pathogens for enhanced clinico-epidemiological monitoring and health care 
delivery.  
Key: Escherichia coli; Salmonella; virulence; genes; diarrhoea. 
 
3.1. Introduction 
Gastrointestinal infections due to pathogenic Enterobacteriaceae in 
particular Escherichia and Salmonella species are significant causes of morbidity 
and mortality worldwide. These infections which usually are self-limiting may be 
fatal in hosts with debilitating immune systems (Amar et al., 2007). The fatality 
of infections due to these enteric pathogens depends on their serotypes, the 
size of the inoculum, and the status of the host (Gordon, 2008).  Escherichia 
and Salmonella species were reported  to have diverged from a common 
ancestor based on the evolutionary rate estimates from 5S and 16S rRNA 
sequence analyses while Shigella spp. are considered clonal lineages of 
Escherichia coli (Falkow, 1995). Salmonella species are mainly pathogenic, with 
differing host ranges; S. enterica serovar Typhi is adapted to humans and does 
not occur in animals while non-typhoidal Salmonella serovars (NTS) have a 
broad vertebrate host range (Gordon, 2008). Even though E. coli is generally 
known as commensal normal flora of the gut, some E. coli strains are the 
causative agents of neonatal meningitis, urinary tract infections, bacteremia, 
and infectious diarrhoea.  
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The major distinguishing factor between pathogenic and non-pathogenic 
strains of E. coli strains is the occurrence of virulence genes, which code for the 
various known strategies for pathogenecity. Analysis have shown that 
pathogenic E. coli strains from diarrhoea cases and those involved in urinary 
tract infections are more of a distinct subsets of E. coli, rather than a reflection 
of the random faecal flora (Selander and Musser, 1990). Some of the virulence 
factors of E. coli include ability to adhere, colonize, and invade the hosts’ cells. 
Further to these are the secretion systems, production of cell surface molecules, 
transport and siderophore formation (Finlay and Falkow, 1997). According to 
Kaper et al. (2004), E. coli has been categorized based on the type of virulence 
factors present and host clinical symptoms basically into the following 
pathotypes: enteropathogenic E. coli (EPEC); enterohemorrhagic E. coli (EHEC); 
enterotoxigenic E. coli (ETEC); enteroaggregative E. coli (EAEC) and diffusely 
adherent E. coli (DAEC), a subclass of enteroaggregative E. coli; enteroinvasive 
E. coli (EIEC); uropathogenic E. coli (UPEC) and neonatal meningitis E. coli 
(NMEC). 
The ability of the enteric pathogen to invade and penetrate intestinal 
epithelial cells is required in salmonellosis whether it is confined as the intestinal 
form or progresses to systemic involvement (Altier, 2005). The attribute to direct 
their internalization by the epithelial cells which are not normally phagocytic is a 
striking Salmonella-host cell interaction. According to Galan and Curtiss (1989) 
this remarkable phenotype known as invasion allowed for identification and 
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characterization of invasion genes. The key mechanism involves type III 
secretion systems which are encoded by pathogenicity island 1 (SPI-1) 
(McCormick, 2004). Salmonella also possess the ability to alter phagocytosis in 
order to circumvent the process. S. enetrica serovar Typhimurium is known to 
delay significantly the fusion of the phagosome to the lysosome (Buchmeier and 
Heffron, 1991); thereby hibernating in phagocytic cells and hence adapt to resist 
the antimicrobial activity of the fused phagolysosome (Pizzaro-Cerda et al., 
1997).  Bacterial survival in phagocytic cells has been observed as an alternate to 
invasion in accessing privileged sites in hosts. Rescigno et al. (2001) postulated 
that CD18+ expressing phagocytes are alternate route and these cells have been 
observed by Vasquez-Torres et al. (1999) as vehicles for reaching the spleen in 
an invasion-independent manner by S. enterica serovar Typhimurium. 
Molecular analysis is known to give a better picture of epidemiology of 
infectious diseases. Studies have demonstrated the sensitivities of molecular-
based methods to be greater compared to current conventional methods of 
analysis (Amar et al., 2007). Molecular studies have led to the understanding of 
the genomic make-up of bacteria which generally consist of stable regions and 
variable regions, the flexible part that is composed of bacteriophages, plasmids, 
transposons as well as unstable large regions, called genomic islands. The so-
called genomic islands are a gene pool required for encoding virulence factors of 
pathogenic bacteria and these have been designated “pathogenicity islands” 
(Hacker et al., 2003). The concept of pathogenicity islands (Pais) was first 
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identified through the genetic and molecular analysis of virulence genes in 
uropathogenic E. coli and EPEC (Blum et al., 1994; Morschhauser et al., 1994). 
Pais which are specific regions of chromosomal DNA have been described in 
more than 30 bacterial species (Hacker et al., 2003). It is a well known concept 
that bacterial pathogenicity is an organized multifactorial process involving 
numerous chromosomal and extrachromosomal genes directed by complex 
regulatory circuits (Mahan et al., 1996; Mellata et al., 2010).  
There are various shared genetic strategies for pathogenicity in enteric 
bacilli. Type III secretion is dedicated secretion machinery whose components 
are coded for by numerous homologous gene sequences shared by enteric 
pathogens (Falkow, 1995; Galán and Wolf-Watz, 2006). Nevertheless, there has 
been understanding that the similarities between EPEC virulence attributes and 
Salmonella invasion genes are more than homologous genes associated with 
secretion (Collazo et al., 1995).  Most virulence factors of pathogenic E. coli, 
Shigella, and Salmonella strains are plasmid-borne however; one or more of the 
essential virulence determinants are borne on an extrachromosomal element 
(Galan and Collmer, 1999; Madden et al., 2001; Naum et al., 2009). In both E. 
coli and Salmonella spp fimbriae might play a role in adhesion and invasion 
(Townsend et al., 2001; Guo et al., 2007). The curli fimbriae of these strains 
were proven to bind to several tissue-matrix proteins as well as plasminogen and 
its activator t-PA (Falkow, 1995).  
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Bacteria are emerging with new means of circumventing human efforts at 
curbing their nefarious schemes and various evolvement patterns and 
innovations are certainly put in place by these pathogens. A myriad combination 
of virulence genes against indiscriminate genetic transfer and recombination are 
required for a successful emergence of pathogen (Musser, 1996; Bansal, 2008). 
Profiling the expression of these genes will give impetus to understanding the 
mechanisms by which enteric bacterial pathogens colonize, spread and at times 
persist in the hosts (Gonzalez-Escobedo et al., 2011). This study investigated the 
genetic determinants of virulence in E. coli and Salmonella spp. which are 
significant pathogens involved in enteric diseases. 
 
3.2. Materials and Methods 
3.2.1. Specimens’ collection and bacterial isolation 
Salmonella isolates deposited at the National Institute of Communicable 
Diseases (NICD), Johannesburg under the surveillance study of 2005 to 2008 
from this tertiary health facility were obtained. For 2009, One hundred and 
twenty–five fresh stool samples obtained from patients presenting with acute 
diarrhoea in the tertiary referral facility and surrounding clinics and 75 
apparently healthy school pupils in three different schools within OR Tambo 
District Municipality, Eastern Cape Province, South Africa were collected in 
sterile stool jars or rectal swabs placed in Cary-Blair transport medium and 
transported on ice pack to the laboratory where analyses were done within 24 
hours. Where this was not possible specimen were kept frozen. Written 
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informed consents were obtained from all patients, parents or guardians as the 
case may be and a questionnaire was administered by trained volunteer health 
care workers (appendices 1A-1D). The study protocol and data handling were 
approved by the WSU ethics committee (Protocol No. 0003/08) as well as the 
Department of Health, Eastern Cape, South Africa.  
3.2.2. Bacteriological analyses  
 
NICD Isolates: Bacteriological analyses of the specimens for the presence of E. 
coli and Salmonella using standard conventional methods and commercial anti-
sera (BiowebSA), were carried out at the National Health Laboratory Services, 
Nelson Mandela Academic Hospital, Mthatha prior to banking at NICD from 
where isolates were collected for this study.  
E. coli: The faecal samples were cultivated on MacConkey agar. After overnight 
incubation at 37°C, lactose fermenting colonies (LFC) with the typical 
appearance of E. coli were selected for further analysis. Isolates were identified 
by biochemical assays using Microscan Gram negative combo panel NUC 45 
(Siemens/ Dade Behring).  
Salmonella: Specimens were cultivated for the isolation of Salmonella species 
on MacConkey agar. After 24 h of incubation at 37°C, suspected colonies with 
typical characteristics of Salmonella were sub-cultured on XLD (xylose lysine 
deoxycholate) agar for 24 h at 37°C. Confirmation was carried out using 
Microscan Gram negative combo panel NUC 45 (Siemens/ Dade Behring). 
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3.2.3. DNA extraction 
DNA template for PCR was obtained from pure overnight bacterial culture 
using Fungal/Bacterial DNA extraction kitTM (Zymo Research) and following 
manufacturer’s instructions. The concentration of the eluted DNA was measured 
using NanoDrop 2000 spectrophotometer (Thermo Scientific). 
3.2.4. DNA amplification 
  
PCR amplifications were performed in a final volume of 25 µL containing: 
0.5 µL to 2 µL of DNA template depending on concentration, 8.5 to 10 µLof 
Nuclease free water, 1 µL of each primer and 12.5 µL Master mix (EconoTaq 
Green, Fermentas). Amplifications were carried out in a GeneAmp PCR System 
9700 Thermocycler (Applied Biosystems). All oligonucleotide primers were 
synthesized by Inqaba Biotechnology (Pretoria, South Africa) and the sequences 
are as shown in Table 3.1. The PCR cycling conditions for the E. coli  strains 
consisted of 95°C for 5 min while for the Salmonella isolates consisted of 95°C 
for 1 min, which were followed by 40 cycles of denaturation at 95°C for 30 s, 
annealing at 60°C for 30 s, and elongation at 72°C for 30 s. Amplification 
products were separated by electrophoreses on 2 % agarose gel (TopVision TM, 
Fermentas) in 1X TBE Buffer and ethidium bromide (5 µL) with a 100-bp ladder 
(Fermentas) as molecular weight marker. 
3.2.5. Sequencing reaction 
 
PCR products were sequenced using an Applied Biosystems 3500xL Genetic 
analyzer (AB Biosystems).  Prior to PCR products sequencing, the unincorporated  
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Table 3.1. Primer sets for the pathotypes and virulence genes for the E. coli and 
Salmonella spp. 
 
Isolate 
species/ 
subgroups 
Target 
gene 
Primer  Nucleotide Sequence 
 (5’- 3’) 
Amplicon 
 size (bp) 
Reference 
E. coli 
EPEC and 
EHEC 
 
eaeA  
 
EAE-a 
 
EAE-b 
ATGCTTAGTGCTGGTTTAGG 
 
GCCTTCATCATTTCGCTTTC 
 
248 
 
Wang et al., 
2002  
EHEC stx1  
 
JMS1-F 
 
JMS1-R 
 
GTCACAGTAACAAACCGTAACA 
 
TCGTTGACTACTTCTTATCTGGA 
 
95 
 
Jothikumard 
and Griffiths 
2002  
ETEC LT 
 
 
 
ST  
 
LT-1 
 
LT-2 
 
STa-F 
 
STa-R 
AGCAGGTTTCCCACCGGATCACCA 
 
GTGCTCAGATTCTGGGTCTC 
 
GCTAATGTTGGCAATTTTTATTTCT
GTA 
AGGATTACAACAAAGTTCACAGCAG
TAA 
 
132 
 
 
 
190 
Ito et al., 
1992  
 
 
 
Franck et 
al., 1998 
 
EAEC 
 
aggR  
 
 
 
astA 
 
AggRks1 
 
aggRkas2 
 
EAST-1S 
 
EAST-1AS 
GTATACACAAAAGAAGGAAGC 
 
ACAGAATCGTCAGCATCAGC 
 
GCCATCAACACAGTATATCC 
 
GAGTGACGGCTTTGTAGTCC 
 
254 
 
 
 
106 
Ratchtrache
nchai et al., 
1997  
 
 
Yatsuyanagi 
et al., 2002 
 
EIEC 
 
VirA 
 
virA-F 
 
virA-R 
CTGCATTCTGGCAATCTCTTCACA 
 
TGATGAGCTAACTTCGTAAGCCCTC
C 
215 Villalobo 
and  Torres 
1998  
Salmonella 
 invA  invA 139 
 
invA 141 
GTGAAATTATCGCCACGTTCGGGCA
A 
TCATCGCACCGTCAAAGGAACC 
 
284 Rahn et al., 
1992 
 sefA 
 
S1 
 
S4 
GCC GTA CAC GAG CTT ATA GA 
 
ACC TAC AGG GGC ACA ATA AC 
 
250 Soumet et 
al., 1997 
 fliC 
 
Fli15 
 
Typ04 
CGG TGT TGC CCA GGT TGG TAA 
T 
 
620 Joys 1985 
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ACT GGT AAA GAT GGC T 
 
 
KEY: flic-flagellin H1; invA-invasion; sefA- fimbrial antigen; aggR- transcriptional 
activator for EAEC aggregative adherence fimbria I expression; eaeA-E. coli 
attaching and effacing; astA–EAEC heat-stable enterotoxin; LT- heat-labile 
enterotoxin; ST- heat-stable enterotoxin; VirA-virulence plasmid. 
 
dNTPs were dephosphorylated with a commercial kit from Zymo Research 
Corporation (Orange, CA). Subsequently, the PCR products were sequenced with 
the ABI PRISM BigDye terminator cycle sequencing ready reaction kit (AB 
Biosystems) using the same primers as employed in the PCR reactions. The 
products were then subjected to the following conditions: 94°C for 2 min, 
followed by 40 cycles of denaturation at 85°C for 1 s, annealing at 53°C for 10 s 
and extension at 60°C for 2 min 30 s, with a final extension at 4°C for 0 s. The 
sequencing reaction products were cleaned up using ZR-96 DNA sequencing 
clean-up kitTM. Thereafter, the ultra-pure products were analyzed on the 
sequencing machine. Sequences were aligned with known E. coli and Salmonella 
virulence gene sequences by a blast search of the National Center for 
Biotechnology Information (NCBI) data base (www.ncbi.nlm.nih.gov/BLAST/) 
using Staden package version 1.6.0-beta4 (MRC.WTSI). 
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3.3. Results 
3.3.1. Bacteriological identification and molecular analysis 
 Results showed that Salmonella spp. were isolated from 119 (37.8%) of 
cases while diarrheagenic E. coli was found in 90 (28.6%) of the cases. The 
distributions of the different pathotypes are as shown in Figures 3.1A and 3.1B. 
Of the Salmonella isolates, 87 (74.1%) were invasive. The most common 
virulence factor detected among the Salmonella strains was invA found in 105 
Salmonella spp. while fliC and sef genes were detected in 15 and 2 Salmonella 
isolates respectively. The predominant virulence gene among the diarrheogenic 
E. coli was 24 EAEC heat-stable enterotoxin astA genes. Table 3.2 shows the 
distribution of the various genes among cases and controls.  
 
 
 
Figure 3.1A. Frequency of the various Salmonella isolates 
 
Figure legend: S = Salmonella 
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Figure 3.1B. Frequency of the diarrhoegenic E. coli isolates 
Figure legend: EPEC= Enteropathogenic Escherichia coli; EHEC= 
Enterohemorrhagic E. coli: EAEC= Enteroaggregative E. coli: Enterotoxigenic E. 
coli: EIEC= Enteroinvasive E. coli. 
 
 
Table 3.2. Distribution of virulence genes among the E. coli and Salmonella spp. 
 
Bacterial 
Strain 
Number 
of 
isolate 
Virulence genes 
fliC invA sefA aggR eaeA EAST LT ST virA 
Salmonella 
spp. (case) 119  15 105 O ND ND ND ND ND ND 
Salmonella 
(control) 8  0 7 0 ND ND ND ND ND ND 
E coli (case) 90  ND ND ND 13 21 24 5 0 2 
E coli (control) 85  ND ND ND 10 11 19 0 0 0 
 
KEY: ND-Not determined. 
 
 
The representative gels for PCR amplification of DNA extracted from 
selected E. coli and Salmonella isolates showing the presence of diverse 
virulence genes are indicated in Figures 3.2A and 3.2B. One hundred and eighty 
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isolates were obtained from the 150 control subjects. E. coli was the 
predominant bacterial species being 85 (47.2%) while Salmonella spp. was 8 
(12.1%). Other recovered bacteria species were Proteus mirabilis 45 (25.0%), 
Klebsiella pneumonie 23 (12.8%) and Enterobacter cloacae 19 (10.5%). 
Sequencing analysis of the genes showed 95 to 100% conformation of the 
various virulence genes with corresponding blast search sequence and 
confirmed the strain. 
 
3.4. Discussion 
 
Gastroenteritis is a major concern in sub-Saharan Africa as with other 
developing countries (Mandeville et al., 2009). South African National Burden of 
Disease study of the year 2000 found that diarrhoea accounted for nearly 3% of 
all deaths in South Africa (Bradshaw et al., 2004). According to the South African 
health review of 2007, death due to gastroenteritis among children was put at 
15% (Rispel et al., 2007) showing increasing mortality. The developed countries 
are not spared in the global burden of enteric-related diarrhoea. Salmonellosis 
was considered a major public health problem in the United States (Voetsch et 
al., 2004). E. coli and Salmonella are among the bacterial pathogens implicated 
in gastroenteritis. These enteric pathogens have evolved different strategies for 
subverting normal host cellular functions (Galán and Sansonetti, 1996).  
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Figure 3.2. Representative gels for PCR amplification of DNA extracted from 
selected E. coli and Salmonella isolates showing the presence of diverse virulence 
genes. Figure 3.2A: 100 bp molecular weight marker (lanes 1 and 10), fragment 
from aggR (lanes 2 to 4), eaeA (lanes 5 to 6) and astA (lanes 7 to 9). Figure 
3.2B: 100 bp molecular weight marker (lanes 1 and 8) fliC (lanes 2 to 4) and 
invA (lanes 5 to 7). The relative positions in the gel of predicted size of PCR 
products are indicated by arrowheads on the right sides. 
 
These pathogens cause various intestinal and extraintestinal diseases by means 
of virulence factors that affect a wide range of cellular processes. These 
virulence induced infections usually involve complex mechanisms with various 
specific, interdependent interactions between hosts and pathogens (Tang and 
Holden, 1999). The present study provides information on the pathotypes and 
some virulence factors associated with local isolates of E. coli and Salmonella 
species. E coli is more than just a harmless intestinal microflora; it can also be a 
highly versatile, and frequently deadly, pathogen (Kaper et al., 2004).  E. coli 
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strains cause diarrhoea by several distinct pathogenic mechanisms and differ in 
their epidemiology. Virulence genes were expressed in diarrhoegenic E. coli from 
both cases and controls. EAEC was detected in 37 (41.1%) cases involving 
diarrhoegenic E. coli. Studies conducted in Thailand and Brazil, reported a 
frequency of 12% and 11% EAEC respectively among children with acute 
diarrhoea (Souza et al., 2001; Ratchtrachenchai et al., 2004).  Although the 
prevalence of EAEC is believed to be considerably higher in the developing 
countries compared to industrially developed countries, a Switzerland study, 
reported that EAEC was encountered in a signiﬁcant proportion of diarrhoea 
cases among children (Pabst et al., 2003). As evident in this study and previous 
studies, EAEC seems to be endemic within our study population and other 
locations in sub-Saharan Africa (Geyid et al., 1998; Okeke and Nataro, 2001; 
Okeke et al., 2003), emerging as a significant diarrheal agent worldwide with the 
pattern of infection changing from persistent diarrhoea to include acute 
diarrhoea (Scaletsky et al., 2002). 
The second diarrheogenic E. coli type detected was EHEC constituting 21 
(23.3%) of all diarrheogenic E. coli.  Enterohaemorrhagic E. coli (EHEC) is a 
subset of Shiga toxin-producing Escherichia coli (STEC) which is associated with 
severe systemic disease as haemorrhagic colitis, haemolytic-uremic syndrome 
(HUS) and thrombotic thrombocytopenic purpura, particularly in infants, young 
children and in the elderly (Nataro and Kaper, 1998; Paton and Paton, 1998). 
EHEC infects the large bowel and inflict damage to the colon with infectious dose 
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estimated to be less than 100 CFU (Griffin and Miner, 1995; Mellies et al., 2007). 
Of the various virulence factors associated with pathogenicity in the EHEC strain, 
this study failed to detect both Shiga toxin 1 (stx1) and Shiga toxin 2 (stx2) but 
only detected intimin which is encoded by the eaeA gene (Dean-Nystrom et al., 
1997; Kang et al., 2004). Intimin is known to facilitate the adherence of 
pathogen to intestinal villi producing attaching and effacing lesions (Holland et al., 
1999; Caprioli et al., 2005). Previous studies have implicated EHEC in outbreaks 
and sporadic infections both in the United States and around the world (Waters 
et al., 1994; Bell et al., 1994; Dundas et al., 2001). 
Intimin (eaeA) gene was also detected in 21 (23.3%) of EPEC. Unlike 
most studies where ETEC often take the lead in bacterial enteritis due to E. coli, 
a study by Weggerhof (1987) also reported a higher incidence of EPEC from the 
screening of some pediatric patients with diarrhoea in Mpumalanga Province of 
South Africa. Another study in 1990 in Iran reported EPEC as the most frequently 
detected strain of diarrhoegenic E. coli (Katouli et al., 1990). More recent studies 
described the contributions of EPEC to the human disease burden as significant 
(Kenny, 2002; Clarke et al., 2003; Kaper et al., 2004; Scaletsky et al., 2010).  
Thus EPEC plays a vital role in acute diarrhoea. EPEC is known to cause illness 
manifesting as watery diarrhoea with little inflammation of the intestinal mucosa 
(Koneman et al., 1997). Virulence is initiated in EPEC by the induction of a 
characteristic ultrastructural lesion in which the bacteria make intimate contact 
with the apical plasma membrane, causing localized destruction of the intestinal 
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brush border and distortion of the apical enterocyte membrane (Clarke et al., 
2003) as is in the classical  attaching and effacing (AE) lesion. 
The ETEC and EIEC strains were found only in 9 (10.0%) and 2 (2.2%) of 
cases with diarrheagenic E. coli respectively. Although ETEC strains have been 
described as a major contributor to infantile diarrhoea in developing countries 
and of travellers’ diarrhoea in visitors to these countries (Ako-Nai et al., 1990; 
Sooka et al., 2004; WHO, 2009a), our findings were different showing a decline 
in the involvement of these strains in our setting. ETEC strains cause secretory 
diarrhoea similar to that of Vibrio cholerae by forming plasmid encoded heat-
labile (LT) or heat-stable (ST) enterotoxins genes (Levine, 1987; Koneman et al., 
1997). ETEC engage strain-specific antigenic, hair-like fimbriae in attachment to 
specific receptors on the surface of enterocytes in the intestinal lumen (WHO, 
2009a). EIEC on the other hand produce dysentery-like diarrhoea similar to that 
caused by Shigella species by invading and multiplying within epithelial cells of 
the colonic mucosa, resulting in an intense inflammatory response characterized 
by abscesses and ulcerations that damage the integrity of the epithelial cell lining 
of the colon (Hale, 1998). EIEC was not a major enteric bacterial pathogen 
observed in this study, with prevalence similar to that reported in Mexico City by 
Paniagu et al. (2007). This pattern is not consistent with studies in other 
developing countries where EIEC strains were important causes of pediatric 
diarrhea and dysentery (Taylor et al., 1986; Pacheco-Gil et al., 2006). 
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Salmonella species are an important cause of varying food and water-
related infections. This study detected Salmonella as a major cause of 
gastroenteritis in our setting. Salmonella has previously been described as one of 
the common causes of gastroenteritis particularly in the developing countries 
(Guerrant et al., 1990; Galanis et al., 2006). On the contrary, infectious 
diarrhoea in the developed world is often due to viruses (Jafari et al., 2008). The 
most common species isolated in this study were S. enterica serovar Typhi 
(52%) and S. enterica serovar Typhimurium (25%). This report is consistent with 
other studies conducted in Iran and South Africa where S. enterica serovar Typhi 
and S. enterica serovar Typhimurium were described as major aetiological agents 
of infectious diarrhoea (Jafari et al., 2008; Keddy et al., 2009). S. enterica 
serovar Isangi was third in ranking of frequency of isolation. Kruger et al. (2004) 
described the increasing importance of this serotype of non-typhoidal Salmonella 
(NTS) which was a rare serotype in South Africa until 2002. Other species 
identified were S. enterica serovar Choleraesuis, S. enterica serovar Enteritidis, S. 
enterica serovar Eppendorf, S. enterica serovar Hadar, S. enterica serovar 
Panama and untyped Salmonella spp. The virulence factor detected among the 
majority (105) of the Salmonella spp. was invA. This gene which is 
chromosomally located aids attachment of the pathogen to the epithelial cells 
(Gallan and Curtiss, 1989). The other detectable virulent gene was fliC detected 
in 15 isolates. The flagellin gene, fliC is known to aid systemic spread of 
pathogen and is specific for S. enterica serovar Typhimurium (Soumet et al., 
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1999).  Enteric bacteria possessing sefA genes were not encountered in this 
study.  The sefA gene which encodes the SEF14 fimbrial antigen is a virulence 
plasmid specific for S. enterica serovar Enteritidis (Doran et al., 1996). 
 
3.5. Conclusion 
 
This study showed the diversity of virulence gene expression in two major 
enteric pathogens. It was observed among other things that some diarrhoegenic 
E. coli isolated from apparently asymptomatic subjects expressed some virulence 
genes at frequency as high as seen in diarrhoegenic cases. This is a pointer to 
the fact that asymptomatic individuals serve as reservoirs of pathogenic strains 
of enteric bacteria and may play a role in the spread and acquisition of virulence 
genes.   
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CHAPTER 4 
AN ETHNOBOTANICAL SURVEY OF INDIGENOUS PLANTS USED AS DIARRHOEA 
REMEDY IN O.R.TAMBO DISTRICT, EASTERN CAPE PROVINCE, SOUTH AFRICA 
 
 
 
4.0. Abstract  
Indigenous health system and the use of herbal plants have been recognized as 
pivotal in primary health care and a system to reckon with in achieving one of 
the targets of the Millenial Goals on health. An ethnobotanical survey was 
conducted to identify indigenous herbal remedies for diarrhoea and associated 
stomach ailments in rural areas of O.R. Tambo district municipality in the Eastern 
Cape province of South Africa. The main objective of the study was to gather 
ethnomedical data on potentially valuable indigenous medicinal plants for the 
eventual development of new pharmaceuticals and also emphasize the role of 
ethnomedicine in primary health care. The use of herbal remedies in the 
treatment of diarrhoea and dysentery was investigated using interviews. The 
survey was conducted among traditional healers and knowledgeable local elders 
who use medicinal plants to treat common illnesses.  Data from the survey 
indicated the names of plants commonly used in the treatment of diarrhoea and 
associated ailments, the methods of preparation, parts used and administration. 
A total of 32 plant species belonging to 26 families were reportedly used as 
diarrhoea remedy in the study area. The most predominant families of medicinal 
plants employed and most frequently recommended were Fabaceae 16.67%, 
followed by Hyacinthaceae and Hydnoraceae 8.33% each. The most commonly 
147 
 
utilized portions of plants for medicinal purposes included roots and leaves. 
Other parts were corms, bulbs, tubers, fruits and bark. The methods of 
preparation often employed were decoctions and infusions whilst medication was 
frequently administered orally or as enema. Some of the plants were used singly 
or mixed with other plant(s) while some edible ones are consumed as food. The 
survey documented a diversity of plants employed as remedy for diarrhoea. 
Integration of this form of health care system into western medicine is warranted 
but propagation of such medicinal plants is vital to sustainability of the use of 
medicinal plants. 
 
Key words: Ethnobotany; Herbal remedy; Indigenous; Diarrhoea, Primary health 
 
4.1. Introduction 
One of the targets on Health in the Millennium Development Goals (MDG) 
declared in 2000 is to provide quality and affordable health for all by the year 
2015 (UN, 2000). With the MDG target date only 6 years away, this vision is 
bound to fail unless further concerted effort is made to improve the health of 
poor people. According to the World Health Organization (WHO,1978), traditional 
medicine has been described as one of the surest means to achieve total health 
care coverage of the world’s population, yet this form of health care system has 
long been relegated to a marginal place. The importance of traditional medicine 
as a source of primary health care was first officially recognized by the World 
Health Organization in the Primary Health Care Declaration of Alma Ata (1978) 
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and has since been given a global attention under Traditional Medicine 
Programme of the health body. Recently, WHO commitment to the Millennium 
Declaration has been reaffirmed by its governing bodies (WHO, 2002a, 2002b) 
and Ministers of Health of the WHO African Region (WHO, 2007) have also made 
a declaration to recognize the role of traditional medicine in Primary Health Care. 
In the rural and remote parts of most African countries, hospitals and 
clinics are often sparsely located far away from dwellers and where there is 
accessibility to clinics, other factors such as finance and mobility make orthodox 
medicine far fetched from these people. It has been estimated that up to 80% of 
the world’s rural populations depend on plants for their primary health care, 
since western pharmaceuticals are often expensive, inaccessible or unsuitable 
(Cunningham, 1993; WHO, 1978). Considering the relative ratios of traditional 
practitioners and university-trained doctors in relation to the whole population in 
African countries, traditional healers and remedies made from plants play an 
important role in the health of millions of people. The people are reliant on 
traditional healers who usually reside among them trusting their ingenuity about 
the use of herbs and some other cultural and traditional beliefs. These facts thus 
provide a role for traditional healers among the rural dwellers' trust.  
It is becoming increasingly urgent to document the medicinal use of 
African plants because of the rapid loss of the natural habitat for some of these 
plants due to anthropogenic activities. The migration factor especially among the 
youths to urban areas as well as the demise of most of the local practitioners 
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along with their wealth of knowledge are sources of threat to the future of most 
of the important cultures including knowledge on the use of plant species 
(Akerele et al., 1991; Bodeker, 1994; Schlage et al., 1999).  
Several studies have been conducted in the Eastern Cape to identify and 
document biodiversity and ethnomedicinal value of the province (Van Wyk et al., 
1997; Grierson and Afolayan, 1999; Dold and Cocks, 2001; Van Wyk and Smith, 
2001; Kambizi et al., 2004; Mucina and Rutherford, 2006; Kambizi and Afolayan, 
2008). Nevertheless, circumstances still warranted a survey of O.R. Tambo 
District Municipality (ORTDM). Why is it necessary to conduct the study in this 
area? What makes this district municipality peculiar? To answer these and some 
other questions, a grasp of what ORTDM is made up of is necessary.  
4.1.1. A brief description of O.R. Tambo District Municipality 
O.R. Tambo District Municipality (ORTDM) is located in the east of the 
Eastern Cape Province along the Indian Ocean coastline of South Africa. It is 
situated in the former Transkei homeland area of the province which falls within 
the latitudes 30° 00' and 34° 15' South and longitudes 22° 45' and 30° 15' East. 
ORTDM is bordered by the Alfred Nzo District to the North, Ukhahlamba district 
to the Northwest, Chris Hani to the West and Amathole District to the Southwest 
(Figure 1). From the East to the West, the District measures 170 143 km, North 
to South 121 725 km and it measures 12857 km2 in extent 
(http://isrdp.dplg.gov.za/documents/IDP/ISRDP/OR_Tambo_IDP.pdf). It is more 
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than 2,700 m above sea level, and descends southward from the great interior 
plateau to form a relatively narrow coastal plain along the Indian Ocean.  
The population of the District Municipality stands at 1.7 million persons 
and covers an area of 16,617 square km2.  A total of 93% of the District Municipality’s 
population reside in rural areas while an estimated 77% of the population is 
unemployed (STATSSA, 2001). The mother-tongue of the majority of the 
dwellers is isiXhosa, an Nguni language while the rest of the people speak 
Afrikaans and English.  
The region is predominantly rural with large tracts of arable land, 
nevertheless, agriculture in ORTDM is inadequately developed and largely 
subsistence. Traditionally, Eastern Cape is known for rearing livestock which 
represents 70% of the province’s gross agricultural income. Wheat, corn (maize), 
and sorghum are grown inland with irrigation, while oranges, pineapples, 
tobacco, and potatoes are cultivated along the coast (Encyclopædia Britannica, 
2009). The Langeni Forest and Magwa Tea are the major contributors to the 
primary sector of the economy with an oncoming Mondi Forests reaching its 
maturity state soon.  
This study area includes moderate and high rainfall areas, principally 
along its sub-tropical coast, but also in pockets of mountainous areas receiving 
an annual rainfall of above 800 mm. ORTDM has a diversity of vegetation, from 
grasslands and thicket to forests and bushveld including coastal and marine 
habitats. The district is considered to have the richest natural resources and the 
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most fertile areas in the country, with good soils and climatic condition 
(http://isrdp.dplg.gov.za/documents/ IDP/ISRDP/ OR_ Tambo _IDP. pdf).  The 
vegetation of our study region has been previously described (Acocks 1988; 
Dahlgren and Van Wyk 1988; Van Wyk 1990; Hartmann 1991; Cawe et al., 1994; 
Van Wyk 1994; Low and Rebelo, 1998; Van Wyk and Smith, 2001; Mucina and 
Rutherford, 2006; Clark et al. 2008).  
This district falls within regions (namely-Maputaland, Pondoland and the 
Drakensberg Alpine) singled out in a world atlas of centres of plant diversity 
(CPD’s) (Pooley, 1998). The area now classified as a Global Hotspot (Steenkamp 
et al., 2004), a Global Hotspot being defined on the basis of irreplaceability and 
threat (Myers 1988). Of great significance are the coastal forests, bushveld and 
grassland of the Pondoland. This area has been identified as a Centre of Plant 
Endemism, which is floristically species-rich and contain high numbers of species 
endemic to them (Van Wyk and Smith 2001). It has more than 130 species of 
plants that occur nowhere else in the world, and including the well-known 
Pondoland coconut palm (ORTDM, 2009). 
However, due to the rich flora of this study area coupled with the 
disappearing traditional knowledge on medicinally useful plants a lot of grounds 
still needs to be covered in the documentation of the indigenous knowledge on 
medicinal plants. Thus, it is critical to preserve the plants and knowledge of their 
uses.  
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Diarrhoeal diseases are often associated with low living standard, poor 
sanitation infrastructure and poor access to potable water sources. This in 
particular is a prevalent feature in the area of study owing to a high percentage 
of unemployment as previously reported (STATSSA, 2001). The predominantly 
rural Eastern Cape Province (ECP) is noted for lack of proper sanitation and 
piped or clean water (ECDOH, 2009). Hence, water-borne diseases are not far-
fetched from ORTDM with its predominant rural dwellers depending largely on 
spring, pond or river water which are often shared with domestic animals. 
According to a previous study in South Africa (Obi et al., 2007) incidence of 
diarrhoea could be linked to poor quality of household drinking water. A recent 
Eastern Cape Department of Health statistics (2009) confirm a significant number 
of deaths due to diarrhoea among children, with the highest number of deaths 
reported in the ORTDM. Of grave health consequences is cholera disease within 
the region. Kwa-Zulu Natal (KZN) Province of South Africa was designated as 
endemic for cholera (Henninger and Snell, 2002). ORTDM shares border with 
KZN and as indicted in figure 2, it is worthy of note that the blue arrow indicating 
direction of spread of cholera is towards ORTDM. A recent outbreak of cholera 
which ravaged Zimbabwe rapidly spread into South Africa between November 
2008 and April 2009 and claimed 65 lives whilst there was >12, 000 case 
definition of the disease (Archer et al., 2009).  With the high incidence of 
HIV/AIDS and multidrug resistant TB in South Africa (Cohen, 2006), diarrhoea 
can pose a serious challenge to the public health in terms of burden of diseases. 
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As a result of the high incidence of diarrhoeal diseases, poor water quality and 
large dependence on medicinal plants due to the vast rural area, this study 
aimed to document information on plants commonly prescribed as diarrhoeal 
remedy in the ethnomedicinal practice of the indigenous people of OR Tambo 
District Municipality and environs. 
 
4.2. Materials and methods 
Ethnobotanical survey for medicinal plants employed in the treatment of 
diarrhoea and associated ailments was conducted within ORTDM. Areas visited 
included Port St. Johns, Lusikisiki, Flagstaff, Tabankulu, Bizana, Ugie and Coffee 
bay from June 2008 to February 2009. The investigation was carried out using 
interviews among traditional healers and knowledgeable local elders who use 
medicinal plants to treat common illnesses. Questionniare employed for the 
interview is shown in Appendix 1C.  The survey elicited information on the names 
of plants commonly used in the treatment of diarrhoea and associated ailments, 
the methods of preparation, parts used and administration. With the assistance 
of the local practitioners samples of the plant material used as diarrhoeal remedy 
were collected from the wild. Scientific identification of samples was aided by 
staff of the herbarium, Walter Sisulu University, where voucher specimens were 
deposited. Further characterization of plants and their usage was established by 
consultation of literatures and monographs (Hutchings et al., 1996; Pooley, 
1993, 1998; Van Wyk et al., 1997). For data analysis, plant species were 
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grouped into their respective families along with local and common names. An 
inventory of plant species was compiled from this fieldwork. 
 
4.3. Results 
Ethnobotanical information obtained from the study area on medicinal 
plants used in the treatment of diarrhoea has revealed 33 medicinal plants 
scattered in 26 families. Table 4.1 shows the diverse families of the various 
indigenous medicinal plants. Among the families, Fabaceae provided the highest 
proportion of medicinal plants prescribed at 16.67% followed by Hyacinthaceae 
and Hydnoraceae, 8.33% each.  
Most traditional healers claimed never to use cultivated plants but depend 
on sourcing from the wild. The frequently utilized portions of plants for medicinal 
decpurposes included roots, corms, leaves, and bark but roots were mostly used 
for the preparation of medicine in the treatment of diarrhoea, followed by the 
use of leaves. The methods of preparation varied considerably from one healer 
to the other. Plant remedies were often utilized in the form of decoctions and 
infusions. Extraction may be hot by boiling in water or mere soaking plant parts 
in cold water. Plant part may be eaten raw in some cases whilst medication is 
frequently administered orally or as enema. Some of these plants were used 
singly or mixed with other plant(s) or even with western mixtures such as salt, 
vinegar and in a particular instance Amsphogel (Aluminum hydroxide) was 
mixed with plant part by the traditional healer.  The surveys also revealed that 
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dosage of plant extracts were not consistent. The analysis has revealed the 
diversity of indigenous plants used as diarhoeal remedy in OR Tambo. These 
medicinal plants which are of value in the treatment of diarrhoea are also used 
to treat different other ailments while some edible ones are consumed as food.  
 
4.4. Discussion 
Traditional medicine is the most widely used medical system in the rural 
setting of ORTDM. Orthodox medicine is costly and often inaccessible. Not only is 
ethnomedicine popular and acceptable due to their important role in primary 
health-care delivery systems, but also in many areas, it has been the only system 
available. Likewise, medicinal plants need more attention because it forms an 
essential component of the total well-being of humans particularly the rural 
dwellers whose major sources of food, shelter, energy and medicines are forest 
plants (Akerele, 1988; Hamayun et al., 2003). Furthermore, the emerging global 
problem of multidrug resistant pathogens (Alekshun and Levy, 2007; Bisi-
Johnson et al., 2005; Levy 2005; Obi et al., 2007) and the need for the discovery 
of lasting and sustainable therapy to combat diseases such as HIV/AIDs, malaria 
and cancer which have defied available treatments has led to a paradigm shift to 
natural herbal product for succor.  
This study documented a diverse list of plants used as remedy for 
diarrhoea in ORTDM.  Previous reports have also linked some of the plants 
encountered in the course of this survey with remedy of diarrhoea, dysentery or 
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stomach ailments (Watt and Breyer-Brandwijk, 1962; Bigalke, 1967; Hutchings, 
1989; Van Wyk and Gericke, 2000; Van Wyk and Wink, 2004;). The parts of the 
plants commonly used were roots and leaves. The problem of inconsistent 
dosaging is a critical set back which is crucial in standardization of medicinal 
plants. Another factor which may impact on the traditional therapy 
standardization is the work place hygiene and the quality of water used in 
preparation particularly with cold extraction. Most of the traditional healers boast 
of treating some ailments that have defied modern medical practice. While some 
of the healers embrace the idea of both western medicine and traditional 
medicine complementing each other, a few others do not. Some of the traditional 
healers tend to hide the information on plants used for different ailments largely 
for fear of losing patronage to the investigators or interested persons. By a way 
of mystifying the native trade, the vast majority of plants are collected from the 
wild and cultivation of the plants is often not encouraged by the traditional 
healers. Some participants believed that cultivated plants would have been 
attacked by evil spirit and hence will not be potent for use. This is similar to the 
findings of Keirungi and Fabricius (2005). Scientific evaluations of the therapeutic 
claims as well as toxicological data are still underprovided for many of the plant 
species. This study will form the basis for microbiological and phytochemical 
research on selected diarrhoeal medicinal plants. 
An observation in the course of this study which poses a sort of concern is 
some of the methods used in harvesting these medicinal plants. For instance, 
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root excavation and bark striping of plants pose a threat to the continued 
existence of such plants. These two methods have been reported as most 
harmful harvesting methods for plants (Akerele 1991; Cunningham et al., 2002). 
The tendency for extinction of scavenged species is obvious going by the 
unsustainable handling and the habit of not cultivating medicinally valuable 
species. For conservation to be effected, planting of designated valuable herbal 
plants in small gardens in the homesteads is strongly recommended. Large scale 
farming of commercially viable plants should be encouraged whilst scientist are 
implored to undertake studies on various factors affecting growth of the plants 
such as soil conditions, temperature, seasonal variations and disseminate best 
propagation methods. Conclusively, it is pertinent for scientists to urgently 
salvage this cheap and alternative health care system from extinction, help 
preserve indigenous knowledge and conserve nature. 
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Figure 4.1. Map of O.R. Tambo District Municipality   
 
(Source: http://isrdp.dplg.gov.za/documents/IDP/ISRDP/OR_Tambo_IDP.pdf).  
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Figure 4.2. WHO Cholera endemic zone 
(Source: www.who.int/entity/heli/tools/en/gridmap2.jpg; Henninger and Snell, 
2002). 
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Table 4.1. Herbal remedies used for the treatment of diarrhoea and associated ailments. 
 
FAMILY/SCIENTIFIC NAMES 
COMMON NAME 
LOCAL NAMES PLANT PART USAGE & 
PREPARATION 
OTHER USAGE 
ALLIACEAE 
Tulbaghia alliacea L.f.  
Wild Garlic 
 
  
 
Umwelela (X) 
ivimba-mpunzi (X) 
Sikwa (Z) 
 
Bulb 
 
Stomach ailments, bulb 
infusion taken orally to 
treat fever. 
 
Remedy for tuberculosis 
(TB) and influenza, as an 
antihypertensive or to 
expel intestinal worms 
(Watt & Breyer-Brandwijk, 
1962). As a medicated 
bath to treat paralysis, 
rheumatism and reduce 
fever temperature (Watt & 
Breyer-Brandwijk, 1962). 
AMARANTHACEAE 
Hermbstaedtia odorata Wild     
      Cockscomb 
Rooi-aarbossie 
 
Ubuphuphu (X,Z) 
 
 
Leaves 
 
Leaves eaten as food 
and infusion for 
diarrhoea. 
 
 
 
Root cleansing stomach 
wash alone or with 
Acaccia xanthophloea and 
Cappa (Hutchings et al., 
1996). 
AMARYLLIDACCEAE  
Scadoxus puniceus (=Hemanthus   
    magnificus, H. natalensis) 
Bloody Lily, Snake Lily 
 
Umphompho –
wezinja, 
Isiphompo, umgola 
(Z) 
 
Bulb & roots 
 
Stomach ailments, 
diarrhoea, nausea. 
 
 
Bulb poisonous, use for 
poultices (Batten & 
Bokelmann, 1966). 
Coughs (Bryant, 1966), 
headaches, poisoning 
antidote (Hutchings et al., 
1996). 
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ANACARDIACEAE 
Protorhus longifolia (Bernh. ex C. 
Krauss) Engl. 
Red Beech 
 
Izintlwa, ikubalo, 
umkupati (X) 
 
Bark  
 
Bark dried powdered + 
guava + Qangazani 
boiled & taken orally 
for diarrhoea and 
bloody stool. 
 
Heart burn and stomach 
bleeding (Hutchings et al., 
1996). 
 
APOCYNACEAE 
Acokanthera oppositifolia (Lam.) 
Codd=  A. venenata   
Common Poison-bush 
 
 
 
inHlungunyembe  
Intlungunyembe  (X, 
Z) 
 
Leaves 
 
Leaf decoction for 
stomach ache, 
diarrhoea, antihelmintic 
 
Treat snakebite (Gerstner, 
1939). Spider bite, aches, 
intestinal worms, cold 
(Pooley, 1993). Powder 
from dried roots as snuff 
for headache (Bhat and 
Jacobs, 1995). 
ASCLEPIADACEAE 
Xysmalobium undulatum (L.) 
W.T.Aiton 
 
Milkwort, Uzura 
 
Ishongwe (X,Z), 
Itsongwe 
 
Roots 
 
 
Boil root for diarrhoea, 
stomach ailments or 
pain. 
 
Dysentery, Headaches 
(Pujol, 1990). Flower and 
seed decoction for colic, 
poison antidote (Watt & 
Breyer-Brandwijk, 1962) 
ASPHODELACEAE 
Aloe candelabrum Berger. 
Candelabrum  Aloe 
 
 
Bulbine abyssinica,  
Bushy Bulbine, 
 
 
Ikhalana 
Inkalane (X) 
Uphondonde (Z) 
 
Utswelana 
Intelezi (X) Ibhucu 
(Z), 
 
Leaves  
 
 
 
Leaves, tubers 
 
Leaf decoction for 
diarrhoea. 
 
 
Boil leaves for 
vomiting, diarrhoea, 
TB. 
 
 
 
 
 
Treat bilharzias, 
dysentery, cracked lips, 
skin ailments, urinary 
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Incelwane (X); 
  
complaints, rheumatism, 
as a charm (Pooley, 
1998). Tuber decoctions-
antispasmodic to quell 
vomiting (Hutchings et al., 
1996). 
ASTERACEAE 
Bidens bipinnata 
Spanish-black jack, Spanish 
needle 
 
 
Uvelemampondweni 
uvelegoli 
 
Leaves 
  
Leaves edible, infusion 
for diarrhoea. 
 
Rheumatism (Watt & 
Breyer-Brandwijk, 1962). 
Hemorrhage, reduce 
cancer, flu, cold and fever 
(Pooley, 1998).  
CORNACEAE  
Curtisia dentata (Burm.f.) C.A.Sm. 
       = C. faginea 
Assegaai 
       
 
Umlahleni (X,Z), 
Unsirayi (X), 
Umgxina, 
Umlahleni (Sefile), 
Uzintlwa 
 
Bark, Root 
 
Diarrhoea, stomach 
ailments. 
 
Stomach ailments 
including diarrhoea, blood 
strengthener, aphrodisiac 
(Pajol, 1990). 
EUPHORBIACEAE 
Euphorbia cooperi N.E.Br. ex. 
Berger 
Euphorbia or Milkweed, Spurge, 
Transvaal Candelabra Tree   
 
 
Umhlonhlo (X) 
 
 
 
 
 
Bark of root  
 
Bark of root ground dry 
boiled, then mix with a 
sachet epsom salt, cool 
& add 2 spoons 
vinegar for diarrhoea, 
stomach disorders. 
For infants, mix equal 
portion of decoction 
with Amsphojel 
to flavour milk.  
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FABACEAE  
    subfamily MIMOSACEAE  
Acacia mearnsii De Wild    
Blackwood,Black Wattle 
 
 
FABACEAE (LEGUMINOSAE) 
Elephantorrhiza elephantina 
(Burch.) Skeels 
Elephant’s Root 
 
 
 
 
 
Ublekwana (X) 
Udywabasi (X, Z) 
Indywabasi 
 
 
Intolwane (X,Z) 
 
 
Bark  
 
 
 
 
Root, stem 
 
 
 
Bark infusion taken 
orally for diarrhoea, 
dysentery  
 
 
Boil equal part plant + 
Acokanthera 
oblongifolia for 
diarrhoea, stomach 
ailment. Infusion of 
ground stem alone for 
diarrhoea and 
menstrual disorder. 
 
 
Sore throat, coughs, 
children fever, tooth ache 
(Hutchings et al., 1996). 
 
 
Syphilis, stop bleeding 
(Jacot Guillardmod, 1971), 
chest complaints, heart 
conditions (Watt & Breyer-
Brandwijk, 1962). Fever, 
ulcers, dysentery, 
diarrhoea, dysmenorrhoea 
(Bryant, 1966). 
GERANIACEAE 
Pelargonium sidoides   
Rose-scented Pelargonium 
 
 
 
P. luridum  
Wild geranum 
 
 
 
 
Umsongelo (X) 
 
 
 
 
Umsongelo, ishwaqa 
 
Leaves, roots 
 
 
 
 
Leaves 
 
 
Infusion of leaves or 
root enema for 
diarrhoea, dysentery 
and vomiting. 
 
Eaten raw as 
vegetable, treat 
dysentery, nausea, 
vomiting, fever 
 
Bruised leaves soothes 
skin rashes, in tea to treat 
kidney & bladder ailments, 
nausea, gonorrhoea, root 
decoction severe 
diarrhoea in Transkei 
(Hutchings et al., 1996). 
Leaf paste for wound, 
powdered root mixed with 
food for dysentery (Watt 
& Breyer-Brandwijk, 
1962). 
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HYACINTHACEAE  
Eucomis autumnalis (Mill.) Chitt. 
Common Pineapple Flower 
 
 
 
 
 
 
 
Scilla nervosa (Burch.) Jessop  
White Scilla 
 
 
Scilla sp. 
 
Ubuhlungu becanti 
Isithithibala (X) 
Umathunga (Z) 
 
 
 
 
 
 
Umagaqana, 
magaqana (X), 
Imbizankulu ingema 
(Z) 
Umasixabane (X) 
 
Bulb 
 
 
 
 
 
 
 
 
Bulb 
 
 
 
Root 
 
Boil bulb for abdominal 
problems. 
 
 
 
 
 
 
 
All purpose herb. For 
diarrhoea, TB, various 
diseases, cleans blood. 
 
Infusion of ground 
tuber + H. africana + 
Curtisia dentate for 
diarrhoea 
 
Decoctions of bulb and 
roots for coli, flatulence 
(Cunningham, 1993). 
Syphilis (Watt & Breyer-
Brandwijk, 1962). Treat 
urinary & pulmonary 
ailments, fever (Hutchings 
et al., 1996; Roberts, 
1990). 
Purgative, sprain, fracture, 
cancers (Watt & Breyer-
Brandwijk, 1962). 
Rheumatic fever, 
dysentery (Rood, 1994; 
Silayo et al., 1999). 
HYDNORACEAE  
Hydnora africana  
Warty Jackal Food, 
Jakkalskos Kanip 
 
 
 
 
Ubuklunga (X)  
Umavumbuka(Z), 
Umafumbuka (X) 
 
Fruits, tuber, 
leaves 
 
 
Boil handful of ground 
dried tubers + 
blackwood + peach for 
diarrhea 
 
Parasitic on Euphorbia 
roots. Fruit pulp like 
potato eaten by people 
birds jackal, plant dried 
ground raw for dysentery, 
amenorrhoea. Swollen 
glands or inflamed throat 
(Watt & Breyer-Brandwijk, 
1962). 
HYPOXIDACEAE     
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Hypoxis latifolia Hook.  
African potato (Eng.) 
Small Yellow star-flower 
 
H. hemerocallidea = H. rooperi 
Star-flower 
Inongwe 
Ilabateka (X) 
 
 
Inongwe 
Ilabateka (X) 
Tuber Boil ground dried tuber 
for diarrhoea. 
Treat benign prostrate 
(van Staden, 1981). 
Headaches, dizziness, 
mental disorders, 
inflammation, HIV (Singh, 
1999; van Wyk, 2000). 
IRIDACEAE  
Gladiolus sericeo-villosus Hook.f.    
   forma sericeo-villosus 
Natal Lily, parrot’s beak gladiolus 
 
Umnunge (X) 
 
 
 
 
Corm 
 
Corm’s decoction for 
cold and dysentery, TB 
(use with care) 
 
 
Corms for dysentery oral 
and enema (Hutchings et 
al., 1996). Impotence 
(Watt & Breyer-Brandwijk, 
1962). Menstrual pain 
(Bryant, 1966). 
MESEMBRYANTHEMACEAE 
Carprobotus edulis  
Hottentot’s fig, ghaukum, rankvy 
 
 
 
 
 
 
Ikhambi-lamabulawo, 
umgongozi, 
Igcuthuma 
Unomatyumtyum, 
igcukuma 
 
Leaves 
 
 
 
Various diseases, 
diarrhoea 
 
Allergies, diabetes, sore 
throats (Hutchings et al., 
1996). Juice from 
pounded leaves as gargle 
for sore throats, thrush, 
diphtheria, treat digestive 
troubles, diarrhea & 
dysentery (Watt & Breyer-
Brandwijk, 1962). 
MYRTACEAE  
Psidium guajava  L. 
Guava 
 
Ugwava (X,Z) 
 
 
Leaves 
 
 
Leaves boiled for alone 
or mixed with other 
plants for diarrhea. 
 
 
Infusion of leaves for 
bloody diarrhea 
(Hutchings et al., 1996). 
Roots for veneral disease 
by Vhavenda (Mabogo, 
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1990) The Ethnobotany of 
the Vhavenda. 
Unpublished Master of 
Science Thesis, University 
of Pretoria). 
OLEACEAE 
Olea europaea subsp. Africana 
Wild Olive 
 
 
Uzintlwa (X) 
 
 
Fruit 
 
Infusion for diarrhoea 
and bloody Stool 
 
Leaves for urinary and 
bladder infections 
(Roberts, 1983; Pooley, 
1993). Immature fruits as 
astringents against 
diarrhea (Iwu, 1993). 
POLYGONACEAE 
Rumex obtusifolius 
Dock 
 
Idololenkonyane 
(X,Z) 
 
Leaves 
 
Leaf  extract for 
diarrhea 
 
Infertility in women (Watt 
& Breyer-Brandwijk, 
1962). Leaf decoction for 
worms (Watt & Breyer-
Brandwijk, 1962). Scabies, 
powdered root as gargle 
for laryngitis 
ROSACEAE  
Prunus africana (Hook.f.) Kalkman 
Red Stinkwood, Bitter Almond, 
Peach 
 
 
Umkhakhazi (X), 
Umkakase (X) 
 
 
Roots 
 
Root of peach + bark 
of blackwood + leaves 
of guava + roots of 
umswaninge for 
diarrhoea, abdominal 
ailments. 
 
The bark extracts have 
become popular in Europe 
for the treatment of 
benign prostate 
hypertrophy (Van Wyk et 
al. 1997) 
RUBIACEAE 
Pentanisia prunelloides 
 
Icishamlilo, Icimamilo 
 
Roots, leaves, 
 
Boil grated dried bulb, 
 
A range of ailments, root 
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  (Klotzsch ex Eckl. & Zeyh) Walp 
Broad-leaved Pentanisia 
 
 
 
 
 
 
 
RUBICEAE Pavetta – Bride’s Bush 
Psychotria capensis (Eckl.) Vatke 
Black Bird-berry 
 (X,Z) 
 
 
 
 
 
 
 
 
Isithitibala (Z), 
UmGono-gono (X) 
bulb 
 
 
 
 
 
 
 
 
Fruits 
 
 
a spoon taken orally to 
stop vomiting, 
diarrhoea in children. 
For adult, a wine shot 
3 times daily. Expose 
face to steam from 
boiling herb fro 
pimples. Rub leaves to 
soothe swollen body. 
For diarrhoea and 
vomiting. 
 
 
 
as enema for stomach 
pain (Hutchings et al., 
1996). 
Hemorrhoids, snakebite, 
rheumatism (Bryant, 
1966; Gerstner, 1941). 
 
 
 
Unspecified part for 
tuberculosis (Batten & 
Bokelmann, 1966). Leave 
paste for wound. For 
gastric complaints and 
root infusions are taken to 
cause vomiting (Hutchings 
et al., 1996). 
SAPINDACEAE  
Atalaya – Krantz Ashes 
Hippobromus pauciflorus (L.f.) 
Radilk. 
False Horsewood 
 
 
 
Ulwathile (X) 
 
 
Bark, root, 
leaves 
 
 
Diarrhoea, dysentery 
 
 
Coughs, catarrh related 
headaches (Bryant, 1966). 
Eye problems (Watt & 
Breyer-Brandwijk, 1962). 
SCOPHULARIACEAE 
Physalis peruviana 
Cape gooseberry 
 
Igquzu (X) 
 
Leaves 
 
Leaf edible, stomach 
disorders. 
 
Leaf infusion as enema to 
relieve abdominal ailment 
in children (Watt & 
Breyer-Brandwijk, 1962). 
Treat high blood pressure, 
173 
 
diabetes (Watt & Breyer-
Brandwijk, 1962). 
SOLANACEAE 
Solanum aculeastrum Dun 
Apple of Sodom, poison apple, 
Goat apple 
 
 
 
 
 
 
Umthuma (X,Z) 
 
 
Fruits, roots, 
leaves. 
 
Fruit decoction orally 
for haemorrhoids & 
dysentery, fruit as 
enema for diarrhoea. 
 
Fruit pulp as enema. 
Rheumatism, ringworm in 
cattle (Pooley, 1993). Root 
& leaves for coughs, fever, 
sore throats, colic, 
indigestion, abdominal 
pain, venereal diseases 
(Watt & Breyer-Brandwijk, 
1962; Kokwaro, 1976). 
VERBENACEAE 
Clerodendrum glabrum E.mey = 
C. rehmannii 
Cat’s Whiskers or Verbena Tree or 
Tinderwood 
 
 
 
 
Umqangazani   
Uqangazana (X), 
iNunkisiqaqa(X) 
Umqangazane 
 
 
Leaves 
 
 
 
Bloody stool, chest 
infections. 
 
 
Snakebite (Roberts, 
1990). Leaf infusion for 
intestinal parasites (Watt 
& Breyer-Brandwijk, 
1962). Leaf + root of 
Cymbopogon marginata 
(Steud.) for roundworms, 
threadworms, cough, 
fevers (Hutchings et al., 
1996). 
 
KEY: X = Xhosa; Z = Zulu. 
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CHAPTER 5 
 
PHYTOCHEMICAL ANALYSIS AND ANTIBACTERIAL SCREENING OF CRUDE 
EXTRACTS OF SOME HERBAL PLANTS OF THE EASTERN CAPE PROVINCE, 
SOUTH AFRICA  
 
5.0. Abstract 
 
This study was conducted to identify and evaluate the antibacterial activity of 
indigenous herbal remedies for diarrhoea and associated stomach ailments in 
rural areas of O.R. Tambo district municipality in the Eastern Cape Province, 
South Africa. The crude aqueous, methanolic and acetone extracts of twelve 
selected medicinal plants were screened against clinical isolates of Salmonella 
isangi, S. typhi, S. Typhimurium, Shigella flexneri type 1b and Sh. sonnei phase 
II. The herbs which were selected based on high frequency of prescriptions by 
the traditional healers were Acacia mearnsii, Aloe arborescens, Aloe striata, 
Cyathula uncinulata, Eucomis autumnalis (Mill.) Chitt., E. comosa (Houtt.) 
Wehrh. Hermbstaedtia odorata, Hydnora africana, Hypoxis latifolia, Pelargonium 
sidoides, Psidium guajava, Scilla natalensis. A qualitative phytochemical 
screening of the plants extracts was by thin layer chromatography. Plants 
extracts were screened for antibacterial activity using two types of bioassays: 
serial dilution microplate technique and bioautography. The preliminary 
screening revealed that most of the tested organisms were sensitive to the crude 
acetone extracts with MIC values ranging from 0.078–2.5 mg/mL. Acetone and 
methanolic extracts of Aloe striata, Cyathula uncinulata, E. autumnalis and P. 
guajava were more active against enteropathogens matching up to gentamicin in 
175 
 
terms of the MIC. Water extracts showed minimal or no activity in most cases. 
The presence of terpenoid and flavonoids in some herbs were inferred from the 
TLC fingerprint. The bioautograms revealed different fractions of the extract 
mainly responsible for the antibacterial activity. S. enteric serovar Typhi was the 
most sensitive of the tested organisms to the crude extracts. This preliminary 
study has revealed the antibacterial activities of some of the selected herbs used 
in the treatment of diarrhoea and related diseases and corroborates assertions 
by traditional healers on their efficacies. 
  
Key words: Herbal remedy; Indigenous; Diarrhoea; Antibacterial 
 
 
5.1. Introduction 
  
Diarrhoea is a disease which remains a problem worldwide, leading to 
nearly 19% of the 10 million under-5 deaths that occurred in the world in 2004 
(World Health Statistics, 2006). Studies have shown that diarrhoea, HIV/AIDS, 
water and food-borne diseases account for a high percentage of morbidity and 
mortality in different age groups but mostly in children 0-5 years (WHO, 2003; 
Bryce et al., 2005).  Every individual has at least an episode or more of diarrhoea 
in a lifetime.  Children may have up to 10 episodes before their fifth birthday. 
Alarmingly, a child dies every 15 seconds from diarrhoea, caused largely by 
unsafe water and inadequate sanitation (WHO, 2005).  Despite advancement in 
technology in the industrialized nations, diarrhoea continues to be an important 
cause of morbidity and incurs substantial health-care costs (World 
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Gastroenterology Organisation, 2008). The greatest burden of the disease 
however, is in sub-Saharan Africa and Asia (Morris et al., 2003). 
Treatment failures of enteric diseases, particularly, the emerging 
multidrug resistant enteric bacteria is a big challenge. Multiple antibiotic 
resistances is on the increase among clinical isolates of bacteria (Bisi-Johnson et 
al., 2005; Obi et al., 2007) and the emergence of resistance to the 3rd and 4th 
generation beta-lactam drugs has made therapy more complicated. The burden 
of resistance to extended-spectrum cephalosporin and other beta-lactam drugs 
among the Enterobacteriaceae is enormous both in the hospital and community 
(Bradford, 2001). Pharmaceutical industries have produced a number of new 
drugs in the last three decades. Currently, an estimated 122 drugs from 94 plant 
species have been discovered through ethnobotanical leads (Fabricant and 
Farnsworth, 2001). Some of these include Ephedrine (bronchodilator) derived 
from Ephedra sinica, Quinine (antimalarial) from Cinchona ledgerian (El-Baz, 
2007) and recently is the antimalarial compound Artemisin, derived from 
Artemisia annua L (Camacho et al., 2000). Despite these big strides, resistance 
to antimicrobials by microorganisms is still on the increase due mainly to the 
remarkable genetic plasticity of the microorganisms (Kunin, 2009), inappropriate 
use: high selective pressures of use or under use through inaccessibility, poor 
quality drugs, inadequate dosing, poor adherence, and the increased mobility of 
the world population (Okeke et al., 2007). In addition, the incorporation of 
antimicrobials as growth promoting additives in animal feed is also a contributory 
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factor to the emergence of drug-resistant bacteria (WHO, 2005; Foley and 
Lynne, 2007). The sub-therapeutic use leads to bacterial exposure to sublethal 
concentration of drugs over a period of time leading to selection of resistance 
strains (Burt and Reinders, 2003). The rate at which new drugs are developed is 
way behind compared to the changing virulence and drug resistant patterns of 
microbes. According to Kunin (2009) review of the book by Owen and 
Lautenbach (2008), antimicrobial resistance is the inevitable result of Darwinian 
evolution — natural selection and survival of the fittest.  While there is a 
continuous modification of strategies by microbes in the ‘no victor no vanquish’ 
fight for survival, drug resistance and development according to Ridley (2001) 
takes 10 to 15 years and hence the quest for new drugs should be a continuous 
process  (Hostettmann et al., 2000).  
Medicinal plants have been acknowledged as potential sources of new 
compounds of therapeutic value and as sources of lead compounds for drug 
design and development (Newman et al., 2003). The use of traditional herbs in 
the treatment of various ailments has been as long as the history of man even 
though the mechanisms of actions of many herbs are unknown. The Fossil date 
of plant use as medicines is put at approximately 60, 000 years ago (Fabricant 
and Farnsworth, 2001). Traditional medicine has been reaffirmed by the WHO 
(2007) as one of the surest means to achieve total health care coverage of the 
world’s population. Various studies have documented the use of medicinal plants 
in various parts of the world including developed countries (Van Wyk et al. 1997; 
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Aschwanden, 2001; WHO, 2008) and more than 80% of the populace are 
reportedly dependent on traditional remedies (WHO, 1978). In South Africa, a 
sizeable number of both the rural and urban dwellers rely on traditional medicine 
for their primary health care (Fennell et al., 2004). In most cases, a plant is often 
used for a variety of ailments which may then suggest a concerted or wholesome 
therapy. This postulation is corroborated by the review of Gurib-Fakim (2006) 
where medicinal plants are said to be made of mixture of chemical components 
which may act individually, additively or synergistically.  Some of the 
documented use of plants in stomach related ailments includes that of Iwu 
(1993) in which immature fruits of Olea europaea subsp. Africana (Wild Olive), 
was reported to be used as astringents against diarrhoea. Pentanisia prunelloides 
(Klotzsch ex Eckl. & Zeyh) Walp is being used for a range of ailments and the 
root serves as enema for stomach pain (Hutchings et al., 1996). However, many 
herbs are yet to be explored scientifically and moreover, the need to find a 
lasting solution to the problem of infectious diseases with lingering treatment 
failures necessitated further exploration of natural products to uncover new 
grounds in drug production. This study screened and evaluated the antibacterial 
activity of selected medicinal plants used in ethnomedicine in the Oliver R. 
Tambo municipality of Eastern Cape South Africa against some enteropathogenic 
bacteria. 
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5.2. Materials and Methods 
All reagents and chemical used in this study were of technical grade and 
were obtained from Merck Pty Ltd, and Biorad Pty Ltd, South Africa except 
otherwise stated. Standard aseptic techniques were observed in all cases.  
5.2.1. Plant material   
Various plant parts used in the treatment of diarrhoea and related 
diseases in Oliver R. Tambo District municipality in the Eastern Cape province of 
South Africa were collected over a period of 12 months (June 2008 to July 2009).  
These were corms, bulb, tuber, leaves and bark of Acacia mearnsii, Aloe 
arborescens, Aloe striata, Cyathula uncinulata, Eucomis autumnalis (Mill.) Chitt., 
E. comosa (Houtt.) Wehrh. Hermbstaedtia odorata, Hydnora africana, Hypoxis 
latifolia, Pelargonium sidoides, Psidium guajava, Scilla natalensis. The common 
names and ethnomedical usage of the selected plants are listed in Table 5.1. 
5.2.2.1. Preparation and extraction 
Plant parts were washed with distilled water, air-dried and milled into a fine 
powder with a Jankel and künkel Model A10 mill. Fifty gram portion of ground 
dried material macerated in 500 ml of each of acetone, methanol and water on 
an orbital shaker for 2-3 h. The samples were suction-filtered through a 
Whatman No 1 filter paper. The filtrate was concentrated at 45°C using a 
Rotavapor (Eyela N-1100, Rikakikai, China). The reduced extract was transferred 
to a pre-weighed glass vial and sunction-dried at room temperature with a 
vacuum pump (ULVAC KIKO, Tokyo). Working stock solutions of extracts were  
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Table 5.1. Names, plant parts and Traditional usage of herbs investigated 
 
Plant Name Common 
name 
Plant 
part  
Traditional usage References 
Acacia mearnsii De 
Wild.    
Family: Fabaceae  
     
Blackwood 
Black Wattle 
 
Bark 
 
Diarrhoea, 
dysentery, sore 
throat, coughs, 
children fever, 
tooth ache 
 
Hutchings et al., 
1996 
Aloe arborescens 
Family: 
Asphodelaceae 
Aloe Leaves Vomiting, Skin 
ailments, 
diarrhoea, urinary 
complaints, 
rheumatism, 
tuberculosis 
 
Castleman, 
1991; Hutchings 
et al., 1996. 
Aloe striata 
Family: 
Asphodelaceae 
Aloe Leaves Treatment of 
constipation 
Haller, 1990 
Cyathula uncinulata 
(Schrad.) Schinz 
Family: 
Amaranthaceae 
 
NA Leaves Antidiarrhoea, 
philter or medicine 
for love 
Tomani et al., 
2008; Yamada, 
1999. 
 
Eucomis autumnalis 
(Mill.) Chitt. 
Family:Hyacinthaceae 
Common 
Pineapple 
Flower 
 
Bulb Decoctions of bulb 
and roots for colic, 
flatulence  
Cunningham, 
1993. 
Eucomis comosa 
(Houtt.) Wehrh. 
Family:Hyacinthaceae 
Pineapple 
lily 
Bulb Help teething in 
children and to 
treat rheumatism 
Watt and 
Breyer-
Brandwijk ,1962  
 
Hermbstaedtia 
odorata  Wild     
Cockscomb 
Family: 
Amaranthaceae 
 
Rooi-
aarbossie 
Leaves Cleansing stomach 
wash alone or with 
Acaccia 
xanthophloea and 
Cappa  
Hutchings et al., 
1996 
Hydnora africana 
Thunb. 
Family: Hydnoraceae  
Warty 
Jackal Food, 
Jakkalskos 
Kanip 
 
Tuber Diarrhoea, plant 
dried ground raw 
for dysentery, 
amenorrhoea, 
swollen glands 
Watt and 
Breyer-
Brandwijk ,1962  
 
181 
 
Hypoxis latifolia 
Hook.  
Family: 
Hypoxidaceae 
 
African 
potato 
Tuber Headaches, 
dizziness, mental 
disorders, to treat 
cancers, 
inflammation, HIV, 
diarrhoea 
Singh, 1999; 
van Wyk, 2000 
Pelargonium sidoides 
Family: Geraniaceae 
 
Rose-
scented 
Pelargonium 
 
Root Gonorrhoea, 
diarrhoea, 
dysentery, root 
decoction severe 
diarrhoea, stomach 
ailment in children 
 
Hutchings et al., 
1996 
Psidium guajava 
Family: Myrtaceae 
Guava Leaves Leaves used for 
diarrohea, 
Infusion of leaves 
for bloody 
diarrhoea, infusion 
as enema for 
severe diarrhoea 
 
Hutchings et al., 
1996 
Scilla nervosa 
(Burch.) Jessop 
Family:Hyacinthaceae 
 
White Scilla 
 
Corms Rheumatic fever, 
dysentery. All 
purpose herb. 
 
Rood, 1994; 
Silayo et al., 
1999 
 
Key: NA= Not available 
 
obtained by re-dissolving in acetone or methanol as the case may be to yield 10 
mg/ml solutions. Plant materials were kept in air-tight containers while extracts 
were kept at 4°C in the dark. 
5.2.3. TLC analysis of extracts 
Thin layer chromatography (TLC) was used to determine the composition 
of extracts. The TLC plates were prepared in duplicate and developed in different 
solvent systems according to Eloff (1998): Benzene: ethanol: ammonium 
hydroxide (BEA) (36:4:0.4); Ethylacetate: methanol: water (EMW) (40:5.4:4); 
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Chloroform: ethylacetate: formic acid (CEF) (20:16:4). An aliquot of 10 µℓ of 
extract was separated by TLC (Merck, Kieselgel 60 F254) in a closed, saturated 
TLC tank. Chromatograms were visualized under visible and ultraviolet light (254 
nm and 360 nm, Camac Universal UV lamp TL-600). One TLC plate per solvent 
system was then sprayed with Vanillin-sulphuric acid (0.1 g vanillin, 28 ml 
methanol, 1 ml sulphuric acid) for the detection of higher alcohols, phenols, 
steroids and essential oils (Stahl, 1988). The plates were heated at 105°C until 
the colours of chromatograms were completely developed. 
For the qualitative evaluation of a given substance, the Rf value (retention 
factor) on TLC was used as the parameter for comparison. Rf values of 
substances = ratio of distance start – substance zone to distance start – solvent 
front and specific chemical reactions.  An hypothetical TLC plate showing this is 
seen in figure 5.1. 
Rf values of substances = distance starting line – middle of spot   = b 
                               distance starting line – solvent front       a 
A further qualitative assignment is by the visualisation of native fluorescence of 
separated substances which is excited by UV (Ultraviolet) light at 254 nm and 
366 nm but mostly long-wave UV. 
5.2.4. Determination of minimum inhibitory concentration 
The minimum inhibitory concentration (MIC) values of plant extracts 
against the enteric pathogens were determined in 96 well microtiter plates (Eloff, 
1998). The test organisms used were Escherichia coli, Enterococcus faecalis, 
Pseudomonas auruginosa, Staphylococcus aureus, S. typhi, S. enterica serovar 
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Typhimurium, Shigella flexneri type 1b and Sh. sonnei phase II. A McFarland No1 
standard suspension of bacteria inoculum was prepared in Mueller-Hinton Broth. 
After filling each well with 100 µL sterile distilled water and a series of two-fold 
dilutions of extract (10 mg/mL), 100 µL of the inoculum was added to the well to 
make a final volume of 300 µl. Plates were incubated at 37°C for 18 h. An hour 
before the end of incubation, 40 µL of 0.2 mg/mL INT (p-iodonitrotetrazolium 
salt) solution was added to each well.  The lowest concentration where growth 
was inhibited was recorded as the minimum inhibitory concentration (MIC). This 
was indicated by a clear well after incubation with INT as against pink 
colouration.  
 
 
 
 
 
 
 
Figure 5.1. A hypothetical TLC plate showing parameters for Rf value 
5.2.5. Bioautographic assay 
5.2.5.1. Preparation of TLC plates for bioautography 
The bioautography procedure as described by Begue and Kline (1972) was 
used to identify bioactive chromatograms of plant extracts. The duplicate of TLC 
a 
b
solvent front 
substance spot 
starting line 
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plates prepared in section 2.3 were dried overnight under a stream of air to 
remove residual TLC solvents which may be harmful to bacteria.  
5.2.5.2. Preparation of bacteria 
A 10 ml of overnight broth culture of test bacteria in Mueller Hinton broth 
(Merck) was centrifuged at 5300 x g for 20 minutes. The supernatant was 
discarded and the pellet was re-suspended in 2– 4 ml of fresh broth. 
5.2.5.3. Bioassay method 
The dried chromatographic plates were sprayed with the test bacteria until 
they were completely wet. The plates were incubated overnight at 37°C in a 
clean chamber at 100% relative humidity. After overnight incubation, plates were 
sprayed with a 2 mg/mL solution of INT (p-iodonitrotetrazolium violet, Sigma 
Chemicals). Plates were returned into incubator and monitored for colour 
development. Inhibition of growth was indicated by clear or yellow zones on 
chromatogram.  
 
5.3. Results  
Acetone and methanol extracts of plants yielded upon separation more 
compounds than the aqueous extracts; hence, water was not a good eluting 
solvent. This is similar to the observation of Eloff et al. (2005). The 
chromatograms of most extracts were best eluted by the medium polar (CEF) 
and polar extractants (EMW) separating compounds in extracts into bands based 
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on polarities. The TLC fingerprints of the different chromatograms with the 
various solvent systems are shown in figures 5.2, 5.3, 5.4 
 
 
Figure 5. 2. TLC separation of components of the different plant extracts with BEA as eluent and 
vanillin-sulphuric acid spray reagent. For name of extracts lanes from left to right see list of 
abbreviations. 
 
 
 
 
Figure 5. 3. TLC separation of components of the different plant extracts with CEF as eluent and 
vanillin-sulphuric acid spray reagent. For name of extracts lanes from left to right see list of 
abbreviations. 
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Figure 5. 4. TLC separation of components of the different plant extracts with EMW as eluent and 
vanillin-sulphuric acid spray reagent. For name of extracts lanes from left to right see list of 
abbreviations. 
 
 
 
 
 
Figure 5.5. Bioautograms of components of the different plant extracts with CEF as eluent sprayed with 
S. Typhimurium. For name of extracts lanes from left to right see list of abbreviations. 
 
  
The TLC plates as captured under short and long-wave UV were as shown 
in figures 5.6A and 5.6B respectively. The characteristic green and blue 
fluorescence in lanes 5 to 8 and 10 under long-wave UV light (366 nm) 
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presumptively indicated presence of flavonoids according to the TLC evaluation 
scheme of Wagner and Bladt (1996), whereas spots of quenching of the TLC  
 
 
Figure 5. 6A. TLC separation of components of the different plant extracts with CEF as eluent viewed 
under UV 254 nm before vanillin-sulphuric acid reagent spray and heat treatment. Lanes from left to 
right: AC-Acacia mearnsii, AA, AS, HY, CU, MB, SC, PE, PS, UM, E1, E2, E3. 
 
 
 
 
 
Figure 5. 6B. TLC separation of components of the different plant extracts with CEF as eluent viewed 
under UV 366 nm before vanillin-sulphuric acid reagent spray and heat treatment. Lanes from left to 
right: AC-Acacia mearnsii, AA, AS, HY, CU, MB, SC, PE, PS, UM, E1, E2, E3. 
 
  
fluorophor appeared as dark zones against light green fluorescent background 
with short-wavelength UV light (254 nm).  These evaluation methods were 
further augmented with the non-specific post-chromatographic charring 
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detection technique (spraying with vanillin-sulphuric acid and heat treatment) 
(Jork et al., 1989). Based on the chosen visualization spray reagent, most 
solvents extracted at least seven compounds with the exception of extract of 
Acacia mearnsii.  The Rf values of major compounds eluted with CEF (Figure 5.3) 
were AA (0.59, 0.67, 0.89), AS (0.57, 0.89), HY (0.59, 0.88), CU (0.26, 0.65, 
0.86), MB (0.18, 0.48, 0.84),  SC (0.18, 0.24, 0.48, 0.86), PE (0.26, 0.30, 0.57, 
0.88), PS (0.18, 0.47, 0.57, 0.64, 0.88), UM (0.18, 0.56, 0.77, 0.84, 0.88), E1 
and E3 (0.24, 0.59, 0.65, 0.71, 0.79, 0.89), E2 (0.26, 0.50, 0.60, 0.68, 0.71).   
The bioautography results revealed different fractions of the extracts 
which were responsible for the antibacterial activity. EA, EC and P. guajava gave 
one or two major bands of bioactive compounds (Figure 5.5). There were two 
major antibacterial compounds from PG with Rf values of 0.64 and 0.79, two 
from EA with Rf values of 0.65 and 0.88, and one from EC with Rf values of 0.68 
which inhibited the growth of S. enterica serovar Typhimurium with CEF used as 
the solvent system. Active antibacterial compound was shown as clear or 
yellowish spot of inhibition of the growth of test organism by bioautogram. The 
pinkish contrasting area of bacterial growth was indicative of non-cleavage of the 
tetrazolium salt to yield the pinkish or purplish formazan product seen in the 
background (Begue and Kline, 1972). Little or no correlation existed between the 
MIC values and bioautography of some plant extracts because many of the 
components extracted did not show area of antibacterial activity, even though 
there were several chromatograms shown with the chemical detection. For 
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instance A. arborescens and A. striata had impressive MIC values but no 
bioactive bioautogram was shown for these plant species. This observation may 
be attributable to volatility, decomposition or instability of bioactive components 
during the course of the bioassay. For the extracts showing bioactive compounds 
(PS, E1 and E2) the antibacterial activity resided mostly in non-polar compounds.  
The MIC values of the plants extracts ranged from 0.039 mg/mL and 2.5 
mg/mL after 24 h of incubation. The average MIC values vary for the different 
bacterial species with the lowest in S. typhi (Table 5.2.). Of all the crude plant 
extracts evaluated, A. arborescence, C. uncinulata, E autumnalis and P. guajava 
showed considerable antibacterial activities having minimal MIC between 0.039 
mg/mL and 0.078 mg/mL (red highlights, Table 5.2.) which were comparable to 
that of the reference antibiotic (gentamicin).  
 
5.4. Discussion  
It is a known fact that non polar bioactive compounds may not be extracted with 
water, however in traditional practice, water is used as extractant in most 
preparations hence water was also included as extraction solvent for the selected 
plants. However, water was not a good eluting solvent compared with acetone or 
methanol which yielded upon separation more compounds than the aqueous 
extracts. This is similar to the observation of Eloff et al. (2005). Acetone and 
methanol extract of these plants also possessed better bioactivity than the 
aqueous extracts. The very limited activity of the aqueous extracts agreed with  
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Table 5.2. Average MIC values of plant extracts at 2 h and 24 h 
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the findings of Alanis et al. (2005) where aqueous extracts activity was minimal 
compared with other extracts. The separation and qualitative analysis of crude 
extracts of plants were based on the microanalytical separation TLC method. The 
principle of TLC as an analytical tool is known for more than 100 years now and 
was enhanced by the pioneering work of Egon Stahl (1988). For the qualitative 
evaluation by TLC, the parameter used is not only the the Rf value (retention 
factor) but also the 100fold value hRf. The Rf values are between 0 and 1 but 
best between 0.1 and 0.8 (i.e. 10 – 80 for hRf). The Rf values of most of the 
separated compounds ranged between 0.18 and 0.8 except for a few 
compounds, hence these values were within the stipulated best Rf value range 
(Nagel, n.d.).  
The presence of compounds such as flavonoids and triterpenoids as 
indicated by the TLC plates are in accordance with some other previous studies 
(Heller and Tamm, 1981; Della Loggia et al., 1989; Amschler et al., 1996; 
Koorbanally et al., 2006). A total of seven homoisoflavonoids of varying sub-
classes including a novel benzylidene type and two spirocyclic nortriterpenoids 
were isolated from three species of Eucomis by Koorbanally et al., (2006). The 
occurrence of homoisoflavonoids (homoisoflavanones or 3-benzyl-4-
chromanones) is said to be restricted largely to the Hyacinthaceae. Several 
reports on the biological activity of homoisoflavonoids indicated their anti-
inflammatory, antibacterial, antihistaminic, antimutagenic and angioprotective 
qualities, and value as potent phosphodiesterase inhibitors (Heller and Tamm, 
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1981; Della Loggia et al., 1989; Amschler et al., 1996). Aloe species are known 
to elaborate various phenolic compounds, including anthrone-C-glycosides, 
phenylpyrone derivatives and chromones (Reynolds, 1985). Of the root samples 
of 172 species of Aloe, aloesaponarin I, aloesaponarin II and laccaic acid o-
methyl ester, together with their corresponding pre-anthraquinones were 
detected in 129 species (van wyk et al., 1985). Furthermore, the study revealed 
that 1,8 - Dihydroxyanthraquinones (chrysophanol and asphodelin) were in all 
the tested species except three. A. striata Haw was positive for the presence of 
chrysophanol and asphodelin while A. arborescens Mill was positive for the 
presence of chrysophanol, asphodelin, laccaic acid D-methyl ester and 
aloesaponol 1 (van wyk et al., 1985). The laxative effects of Aloe are said to be 
due primarily to the 1, 8-dihydroxyanthracene glycosides, aloin A and B (formerly 
known as barbaloin) (Tyler et al., 1988; Tyler, 1994). Aloe emodin, chrysophanol 
and aloin have been reported from Aloe ferox (Kambizi et al., (2004) and these 
compounds were shown to possess antibacterial activities.   
In most cases plant extracts were reportedly more active against Gram-
positive (GP) pathogens (Vlietinck et al., 1995), a similar observation was found 
in this study but in addition, most of the extracts had substantial activity against 
the selected Gram-negative (GN) enteric bacteria. P. sidoides gave a moderate 
antibacterial activity in particular against E. faecalis, S. aureus and Shigella 
species. Similarly, anti-infective properties of the commercially important 
Pelargonium have been investigated (Lalli et al., 2008). H. latifolia did not show 
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good   antibacterial activity against most of the tested bacteria and this is in 
harmony with the findings on H. decumbens (Chiappeta et al., 1984). Even 
though the sterols in Hypoxis spp. had  been reported to reduce plasma viral 
loads and stabilized CD4 cell counts in HIV positive patients (Bouic et al., 1999), 
while an aqueous extract of Hypoxis hemerocallidea (H. rooperi) (62.5 µg/ml) 
inhibited some microorganisms, the inhibitory concentration was less potent than 
ciprofloxacin, the reference antibiotic (Steenkamp et al., 2006). 
 
5.5. Conclusion 
This preliminary screening showed that the crude extracts of some of the 
herbs used in traditional medicine in our area of study have potentials as 
antibacterial agents. A. arborescens, A. striata, C. uncinulata, E. autumnalis and 
P. guajava are particularly promising in the context of this study since the 
activities of the crude extracts compared reasonably with gentamicin. This gives 
scientific credence to the use of these plants. Further studies on the active 
compounds and evaluation of the safety of the plants and or their components 
are warranted. The need for continued screening of indigenous plants is 
inevitable because of the dynamic nature of infectious agents and their 
continued development of resistance over time. 
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CHAPTER 6 
 
ISOLATION, CHARACTERIZATION AND STRUCTURAL ELUCIDATION OF 
BIOACTIVE FRACTIONS OF CYATHULA UNCINULATA (Schrad.) Schinz 
 
 
6.0. Abstract 
 
Cyathula uncinulata (Schrad.) Schinz is used in ethnomedine in various parts of 
the world. This study isolated and characterized bioactive compounds from C. 
uncinulata (Schrad.) Schinz based on its antibacterial activities from the previous 
plant screening. Separation of compounds from the bioactive ethyl acetate 
fractions of the plant was by solvent-solvent fractionation. The structure of the 
compounds was elucidated by nuclear magnetic resonance spectroscopy and 
mass spectroscopy methods. The NMR and EI-MS spectra of the isolated 
compound showed that the compound with formula C22H38O7 and molecular 
weight  414.5329, has a long aliphatic chain and is said to be made up of sugar 
and fatty acyl moiety. The MIC of fractions of extracts ranged from 0.39 mg/mL 
to 2.5 mg/mL, with the lowest MIC observed in ethyl-acetate fraction. The MIC 
of the selected sub-fraction of the ethyl acetate fractionation (SSC 1) was 0.63 
mg/mL. The MIC of the final purified compound was 0.34 mg/mL, indicating 
considerable bioactivity. This study isolated a glycosylated oleanolic acid from C. 
uncinulata (Schrad.) Schinz. The compound possessed considerable bioactivity in 
comparison with the crude extract and the control antibiotic. This is an indication 
that this plant may be a candidate template for new antimicrobial. 
Key words: Cyathula uncinulata, extract, fraction, MIC, bioactive, compound 
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6.1. Introduction  
Cyathula uncinulata (Schrad.) Schinz is a large genus of sub-shrubs of 
about 27 species distributed in Asia, Pacific Islands, Africa, and North and South 
America belonging to the family Amaranthaceae. The stems are erect or 
ascending and leaves are opposite, petiolate with entire 
margin. Flowers clustered in cymose partial inflorescences, 1-3 in each cluster, 
hermaphroditic and partly accompanied by sterile ones. The flowers are bracts 
ovate, membranous and often spiny. The seeds of C. uncinulata are oblong or 
ellipsoid. 
  In South Africa, C. uncinulata (CU) was recently described as one of the 
flora of 1195 species of the botanically least known regions, the Sneeuberg 
mountain complex (Eastern Cape). This region where the plant is referred to 
locally as Isinama (Dold and Cocks, 1999); comprises one of the most prominent 
sections of the Great Escarpment in Southern Africa (Clark et al., 2009). Previous 
studies on CU have reported its ethnobotanical study (Jeruto et al., 2008a), 
antidiarrheal activity and phytochemical screening (Tomani et al., 2008). In the 
Eastern part of former Zaire, CU is used by men as a philter or medicine for love 
(Yamada, 1999). Furthermore, an Ethiopian study reported a considerable 
consensus among traditional healers in the treatment of Rissaa (an ailment) by 
drinking a mixture of CU and leaves of Croton macrostachyus crushed fresh and 
mixed with water (Yineger et al., 2008). 
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Various reports on the ethnomedicine and ethnobiology of the genus 
Cyathula exist. A phylogenetic analysis found that Cyathula, some other 
members of the families Amaranthaceae and Chenopodiaceae constituted a 
monophyletic group and hence supported the call for Chenopodiaceae to be 
merged with Amaranthaceae (Ogundipe and Chase, 2009). Cyathula officinalis 
Kuan (COK) was shown to contain polysaccharides which could increase mouse 
red cell immunity function by strengthening red cell immune adherence and 
cleanup of circulating immune complex (Li et al., 1999). COK whose root is a 
commonly-used traditional Chinese herbal medicine with a wide range of 
pharmacological activities (Pharmacopoeia Commission of People’s Republic of 
China, 2000) has also demonstrated anti-tumor activity. Components of COK 
were able to suppress the growth of mouse S180 tumor, H22 liver cancer cells 
(Chen and Liu, 2001). In an antiviral experiment, sulfated derivative of RCP, a 
kind of polysaccharide extracted from COK was adjudged to express comparable 
antiviral activity with the commonly used antiviral drug ACV (0.5 mg/mL) at 
concentrations of 2.0 mg/mL and 4.0 mg/mL. 
In their bid to reinvestigate phytoecdysteroids of the Cyathula species, 
Okuzumi and co-investigators (2005) isolated two cyasterone stereoisomers and 
a known cyasterone reported to possesses antitumor-promoting activity 
(Takasaki et al., 1999). Several C29-phytoecdysteroids such as cyasterone 
(Takemoto et al., 1967; Slama et al., 1993), capitasterone (Takemoto et al., 
1968) and makisterone C (Imai et al., 1968) possess potent insect molting 
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hormone activity. In a clinical experiment, a traditional Chinese medicine: 
concentrated herbal extracts of cooked Cyathula and concoction of 9 other 
ingredients restored ovarian function effectively and promptly in a patient with 
premature ovarian failure (POF) and 8-year secondary amenorrhea, thus the 
combination may offer another option for treating infertility in patients with POF 
(Chao et al., 2003). Cyathula is a component of some Chinese formulations 
acclaimed to be therapeutic against endometriosis and have severe blood stasis 
effects (Dharmananda, 2002).  
The shoots of C. prostrata (L.) Bl. was reported to be used in India 
ethnotherapy of dysentery, skin diseases and as an appetizer (Kala 2005). In 
Kenya, the leaves and roots of C. schimperiana non Moq are used as decoction 
(internal) for malaria, as antidiarrhoea, against fungal infections while the root of 
C. cylindrica Moq roots is used as decoction (internal) for malaria, purgative and 
as emetic (Jeruto et al., 2008b). Among the native Ecuadorian, the Quichua 
people apply the flowers and shredded leaves of C. achyranthoides to dog bites 
(Lescure et al., 1987) while the Shuar eat the raw young leaves to relieve 
headaches (Russo, 1992). 
Previous studies have isolated bioactive compounds from some members 
of this Genus. Glycoside and oleanic acids were isolated and tested for their 
inhibitory activities by Zhou and his co-worker (2005). Fructans which exist as a 
wide range of oligo- and polysaccharides in many species of bacteria, fungi, and 
plants were isolated from COK by Chen and Tian (2003). Bioassays showed that 
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the graminans-type fructan that is comprised of a β-D-fructofuranosyl backbone 
could inhibit growth of Lewis pulmonary carcinoma implanted in mice (Chen and 
Tian, 2003). Recently, a new heterocyclic compound, named 5, 5′-diisobutoxy-2, 
2′-bifuran was isolated for the first time from COK (Liu et al. 2010). From our 
preliminary screening, C. uncinulata was among the plants which gave promising 
MIC values. However, based on the literature, studies on bioactive compounds 
from this plant species are very rare. This study explores the active components 
of C. uncinulata and their biological effects.  
 
6.2. Materials and methods 
 
6.2.1. Plant collection 
The leaves of C. uncinulata were collected in the Eastern Cape province of South 
Africa. C. uncinulata was identified by the Kei Herbarium curator, Dr. Immelman 
in the Department of Botany, Walter Sisulu University, South Africa where 
voucher specimen has been deposited. South Africa. The photographic images of 
CU are shown in Figure 6.1. The plant materials were air-dried at room 
temperature. Dried plant materials were ground to powder and stored in the 
dark at room temperature for further analysis. 
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Figure 6.1A. Leaves of C. uncunilata plant (Picture taken from source garden at 
Flagstaff, Eastern Cape, South Africa). Figure 6.1B. C. uncunilata showing the plant 
flowering. Source http://www.metafro.be/prelude/view_symptom?si=V(027) 
 
6.2.2  Extraction of plant material 
Powdered plant materials were exhaustively extracted with methanol 
(MeOH). The supernatant was filtered through cotton wool and Whatman No. 1 
filter paper using a Buchner funnel. The extract was concentrated at 45 °C using 
a Rotavapor (Eyela N-1100, Rikakikai, China). The reduced extract was 
transferred to a pre-weighed glass vial and sunction-dried at room temperature 
with a vacuum pump (ULVAC KIKO, Tokyo). The quantity extracted was then 
determined to be 2g. 
6.2.3. Solvent-solvent fractionation of dried plant extract 
The dried methanol extract of Cyathula leaves was subjected to solvent-
solvent fractionation as previously described by Oshima et al. (1986). The MeOH 
extract was partitioned sequentially in ethyl acetate (EtoAc), n-butanol and 
water.  The EtoAc fraction (1 g) was subjected to column chromatography over 
100 g silica gel 60 (70- 230 mesh) eluting with n-hexane–ethly acetate (10:1 → 
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4:1 → 1:1 → 1:4, v/v) and ethyl acetate–MeOH (10:0 → 9:1→ 4:1 → 1:1, v/v) 
to yield fractions designated as SSC1-1 to SSC1-8. Fraction SSC1-5 (20 mg) 
denoted SSC2 was further subjected to column chromatography over a lipophilic 
Sephadex (bead size 25-100 µL; Sigma-Aldrich) eluting sequentially with 
Chloroform and Chloroform-MeOH (20:1 → 9:1). The sub-fractions obtained 
were combined based on their TLC fingerprint pattern to yield 4 sub-fractions 
SSC2-1-2, SSC2-3 (3.6 mg); SSC2-4-6 (14.3 mg) and SSC2-7-10 (1.1 mg). A final 
column chromatography was performed with sub-fraction SSC2-4-6 now denoted 
as SSC3 using a finer silica gel 60 (40 – 50 µm Cica-Reagent, Kantochemical, 
Japan). The solvent flow of eluent was n-hexane- acetone (8:1 → 4:1 → 2:1) 
and acetone only. The flow through with similar Rf values from the TLC 
fingerprint were pooled together to yield four sub-fractions designated SSC3-1-8; 
SSC3-9-10; SSC3-11-14 and SSC3-15.  A schematic pictograph of the steps 
involved in the fractionation of extract and fractions is shown in figure 6.2. 
6.2.4. TLC fingerprinting of fractions 
The dried fractions were dissolved to a concentration of 10 mg/mL in 
methanol and TLC fingerprinting was done as described previously (Stahl, 1988). 
Several mobile systems were used. For the TLC of SSC1 fractions the mobile 
systems were H: E 4:1, H: E 1:1, C: M 20:1, C: M 8:1, C: M 2:1 and C: M: W: A 
1:1:0.1:0.05. For the TLC of SSC2, the mobile systems were H: A 2:1 and C: M 
20:1. Finally for the TLC of SSC3, the mobile system was C: M 20:1. The 
detecting agent for chromatograms was anisaldehyde.  
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Figure 6.2. Schematic diagram of Solvent-Solvent fractionation of C. uncinulata 
 
 
6.2.5. Antimicrobial assay of fractions 
The microplate dilution assay as previously described (Eloff, 1998) was 
used to determine the minimum inhibitory concentration (MIC) values of 
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fractions of C. uncinulata extracts against a kanamycin sensitive Escherichia coli 
HB101 strain (Lacks and Greenberg, 1977). 
 6.2.6. Isolation of pure compounds 
Based on TLC analysis and the bioassay-guided fractionation,  sub-fraction 
SSC3-9-10 (Figure 6.2) was selected for purification and further characterization.  
SSC3-9-10 was purified by a lipophilic Sephadex LH-20 (bead size 25-100 μℓ; 
Sigma-Aldrich) using MeOH (Oshima et al., 1995). The final pure compound was 
then subjected to NMR analysis and EI-MS. 
6.2.7. Preparation of pure compound for NMR and MS analysis 
NMR analysis was as previously described (Oshima et al., 1995). The 
vacuumed concentrated isolated pure compound was added to an NMR capillary 
tube and was dissolved by adding Chloroform-d for NMR (ACROS ORGANICS) 
and 99.8+% D, stab. with silver foil, 0.03 v/v % TMS (Merck) to a depth of 4 
cm. The NMR capillary tube was then fitted in place for the 13C and 1H NMR 
analysis in a JEOL-AL 400 FT NMR system 400 MHz (JEOL FT NMR System 
AL400). Electro impact mass spectra (EI-MS) were recorded on a JMS DX-303 
mass spectrometer (Guo et al., 2006). 
 
6.3. Results  
6.3.1. Solvent-solvent fractionation yield 
The solvent-solvent fractionation yielded four fractions. The result of 
fraction yield is tabulated below (Table 6.1). The highest quantity of plant 
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material remained in the water fraction; the quantity of plant material extracted 
in ethyl- acetate fraction was 300.7 mg while the lowest quantity was obtained in 
the methanol extract. 
 
 
 
 
In total, 1242.4 mg (approximately 1.2 g) was extracted from the 2 g starting 
methanol extract of C. uncinulata giving a 60 % yield.   
6.3.2. TLC fingerprints 
The TLC fingerprints of C. uncinulata after bulk extraction are shown 
below (Figure. 6.3). The solvent systems were Hexane and Ethyl acetate ratio 
one to one with 4 times capillary application of extract on TLC (H:E 1:1x 4); 
Hexane and Ethyl acetate ratio one to one with one capillary application of 
extract on TLC (H:E 1:1x1); Hexane and Ethyl acetate ratio four to one with 4 
times capillary application on TLC (H:E 4:1x 4); Hexane and Ethyl acetate ratio 
209 
 
four to one with one capillary application of extract on TLC (H:E 4:1x1); 
Chloroform and Methanol ratio two to one with 4 capillary application of extract 
on TLC (C : M 2:1x 4); Chloroform and Methanol ratio eight to one with one 
capillary application of extract on TLC (C:M 8:1x1); Chloroform and Methanol 
ratio twenty to one with one capillary application of extract on TLC = C:M 
20:1x1);  
  
 
 
Figure 6.3. TLC fingerprints of ethyl acetate fraction of C. uncinulata developed 
in A= H:E 1:1x4; B= H:E 1:1x1; C= H:E 4:1x4; D= H:E 4:1x1 E= C : M 2:1x4; 
F=.C:M 8:1x1; G= C:M 20:1; H= C:M:W:E 1:1:0.1:0.05. 
 
 
Figure. 6.3. TLC fingerprints of C. uncinulata after bulk extraction  
 
Chloroform, Methanol, water and Ethyl acetate with one capillary application of 
extract on TLC (C:M:W:A 1:1:0.1:0.05). A better separation of plant extract 
components was obtained with the hexane-ethyl acetate combinations compared 
to chloroform-methanol. The TLC plates of the further sequential fractions 
developed in anisaldehyde are shown in figures 6.4A to 6.4G. Lanes having 
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compounds with the same Rf values were pooled together. These pooling 
together of fractions in lanes 9 and 10 (Figure 6.4G) led finally to the isolation of 
a pure compound with Rf of 0.38. 
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1    2   3     4        5  6  7 8  9
ECU H:E 1:4 
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H:E 2:1
ECU H:E 1:4 
C:M 20:1
1   2    3   4    5     6  7 8 9
ECU H:E 1:4 
H:A 1:1
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Figure 6.4. TLC chromatogram showing fractions obtained from open column 
chromatography of ethyl acetate fraction of the methanol extract of C. uncinulata 
leaves. A- TLC for SSC1; the mobile systems were H: E 2:1 and C: M 20:1. B, C, 
D, E-TLC for SSC2; the mobile systems were C: M 8:1, C: M 20:1, H: A 1:1, H: A 
1: 4 respectively. F, G- TLC for SSC3; mobile system was C: M 2:1. All TLC plates 
were detected with anisaldehyde. (A= Acetone; H=Hexane; E=Ethyl acetate; 
C=Chloroform and M= Methanol). 
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6.3.3. Minimum inhibitory concentrations of the fractions 
The MICs of the fractions of C. uncinulata against E. coli are provided in 
Table 6.2. The MIC ranged from 0.39 mg/mL to 2.5 mg/mL whereas the MIC of 
Kanamycin, the positive control was 0.19 mg/mL. The lowest MIC was observed 
in ethyl-acetate fraction while the highest MIC values were recorded in n-butanol 
and water fractions. The MIC of the selected sub-fraction of the ethyl acetate 
(SSC 1) fractionation was 0.63 mg/mL while for the final purified compound; the 
MIC was 0.34 mg/mL 
6.3.4. Identification and elucidation of structure of the isolated compound 
 
The NMR and the EI MS spectra of the isolated compound are as shown in 
appendices 4A to 4C. The NMR spectra of the isolated compound showed that 
the compound has a long aliphatic chain. The proposed structure for the isolated 
compound as determined by 1H NMR spectrum is shown in appendix 4D. The 
formula of the compound is C22H38O7 while the molecular weight is 414.5329. 
 
 
6.4. Discussion 
Solvent-solvent fractionation and column chromatography were employed 
to isolate the pure compound. The structure of this compound was elucidated 
predominantly by nuclear magnetic resonance (NMR) spectroscopy and mass 
spectroscopy methods. NMR essentially provides a means of determining the 
structure of an organic compound by measuring the magnetic moments of its 
hydrogen atoms. In most compounds, hydrogen atoms are attached to different 
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groups (as –CH2, -, -CH3-, -CHO, -NH2-, -CHOH-, etc.) and the NMR spectrum 
provides a record of the number of hydrogen or carbon atoms in the different 
locations. The NMR proton and EI MS spectra of the fraction yielding the pure 
compound are shown in Appendix 4A-C. The isolated compound shown in 
appendix 4D is made up of sugar and fatty acyl moiety composed of hydrocarbon 
tails. A new glycoside, 3-O-[α-L-rhamnopyranosyl-(1→3)-(n-butyl-β-D-
glucopyranosiduronate)]-28-O-β-D-glucopyranosyloleanolic acid together with 
several other glycosides were isolated from the roots of C. officinalis by Zhou and 
co-workers (2005a). Glycosides of fatty acids or glycolipids are found in bacteria, 
yeasts and fungi but also in several plants. The functions and potential 
applications of this compound have been reviewed by Kitamoto and co-worker 
(2002). Sugar-based esters of fatty acids are nonionic surfactants of great 
potential applications. They are nontoxic, odourless, tasteless and biodegradable 
and because of their multi-functional properties and safety, this group of 
compounds has attracted attention from cosmetics, pharmaceutical, surfactant 
and nutrition scientists (Kitamoto et al., 2002). 
The aqueous fraction of the extract of C. uncinulata yielded the highest 
quantity of plant components while the ethyl acetate fraction extracted the least 
(Table 6.1). However, the least antibacterial activity was recorded in this fraction 
as opposed to the ethyl acetate fraction which had the least MIC values of 0.39 
mg/mℓ (Table 6.2) hence the choice of ethyl acetate fraction for further 
fractionation and isolation of bioactive compound.  The final compound had an 
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average MIC of 0.34 mg/mL which was very close to 0.19 mg/mL of kanamycin, 
the positive control, hence possessing a considerable antibacterial activity.  
Researchers have reported the isolation and biological activities of various 
compounds from members of the genus Cyathula. Four new compounds 4-[(1-
ethoxy-2-hydroxy) ethyl]phenol (1), 2,3-isopropylidene cyasterone (2), 24-
hydroxycyasterone (3) and 2,3-isopropylidene isocyasterone (4), together with 
fourteen known compounds  were  isolated from the C. Officinalis Kuan (Zhou et 
al., 2005b). C officinalis Kuan seems to be the most widely studied of the genus 
whereas reports on isolation of bioactive compounds from C.  uncinulata are 
scarce. Other studies on the genus Cyathula reported mainly on biological 
activities and cytotoxicity effect of extracts of C. achyranthoides and C. prostata 
(Sowemimo et al., 2009). This study is a report on a bioactive compound from C.  
uncinulata. Further work will be required to confirm the nomenclature of this 
compound but going by literature (Zhou et al., 2005a), this bioactive compound 
may be described as a glycosylated oleanolic acid.  
 
6.5. Conclusion 
This study isolated a glycosylated oleanolic acid from C. uncinulata 
(Schrad.) Schinz. The compound possessed considerable bioactivity in 
comparison with the crude extract and the control antibiotic. This is an indication 
that this plant may be a candidate or serve as template for new antimicrobial. 
The main focus of several studies are the isolation and identification of bioactive 
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compounds from plants, nonetheless, it is imperative to recognize the complexity 
of plants and that a single compound may not be responsible for the observed 
activity but rather a combination of compounds acting by synergism or as 
complements. This may further explain why bioactivity is lost in some cases in 
the course of isolation of active components. 
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CHAPTER 7 
 
CYTOTOXICITY OF SELECTED PLANTS USED IN ETHNOMEDICINE IN THE 
EASTERN CAPE PROVINCE OF SOUTH AFRICA 
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7.0. Abstract 
 
Several herbs are traditionally used in the treatment of various ailments 
particularly in the rural areas of South Africa where herbal medicine is often the 
only source of health care system. Many of these herbs have not been assessed 
for safety or toxicity to tissues or organs of the mammalian recipients. This study 
evaluated the safety of some medicinal plants used inter alia in the treatment of 
diarrhoea, and stomach disorders. The cytotoxicity of methanol extracts and 
fractions of six selected plants was determined by using a modified tetrazolium-
based colorimetric assay (3-(4, 5-dimethylthiazol)-2,5-diphenyl tetrazolium 
bromide (MTT) assay). The in vitro cytotoxicity assay on human 
hepatocarcinoma cell line (Huh-7) revealed that the methanol extract of Eucomis 
autumnalis had the strongest cytotoxicity with IC50 of 7.8 µg/mL. Ethyl acetate 
and butanol fractions of Cyathula uncinulata, Hypoxis latifolia, E. autumnalis and 
Lantana camara had lower cytotoxic effects on the cancer cell lines tested with 
IC50 values ranging from 24.8 µg/mL to 44.1 µg/mL while all the fractions of Aloe 
arborescens and A. striata had insignificant or no cytotoxic effects after 72 h of 
treatment. Our results indicate that the methanol fraction of E. autumnalis had a 
profound cytotoxic effect which puts a query on its safety and hence a call for 
caution in its usage. 
Key words: Herbs; extracts; fractions; safety; cytotoxicity; profile; treatment 
 
7.1. Introduction 
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Various plants are used in the ethnomedicine of enteric diseases. Several 
studies have documented reports on some herbs used in ethnotherapy of 
diarrhea, dysentery, vomiting, stomach cramps and other associated ailments 
(McGaw et al., 2000; Vieira et al., 2001; Samie et al., 2005).  Contrary to the 
belief of a large proportion of the populace that anything natural is safe, many 
commonly used herbs cause acute toxic effects and in the long term may be 
toxic. The toxic effects may range from diarrhoea, hypersensitivity reactions, 
nausea or vomiting, to organ-targeted toxicity; immunotoxicity, embryo/foetal 
and prenatal toxicity, mutagenicity/genotoxicity, hepatotoxicity, nephrotoxicity, 
presence of epileptogenic compounds, cardiac toxins, gastrointestinal toxins to 
carcinogenicity (Smolinske, 2005). Other adverse effects of herbal medicines 
may include cardiovascular, hepatic, renal, neurological and dermatologic toxic 
effects. In the review by Luyckx and Naicker (2008), it was stated that ‘drug-
induced nephrotoxicity reportedly contributes to up to 26% of cases of hospital-
acquired acute kidney injury (AKI) and 18% of cases of community-acquired AKI 
globally, and folk remedies account for up to 35% of cases of AKI in the 
developing world.’ 
Many of the plants widely acclaimed to be of therapeutic values have not 
enjoyed vigorous assessment of their safety profiles. A number of complications 
arising after the administration of medicinal herbs have been reported. Foyaca-
Sibat et al. (2001) described case reports of two patients with neuromyotonia 
not linked to malignancies. The patients were reported to have developed acute 
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renal failure while under treatment with herbal medications by their traditional 
healer in the former Transkei region of South Africa. 
Other researchers have also identified medicinal plants with potential 
toxicity such as the extracts of Athrixia phylicoides DC. (Bush tea) (McGaw et al., 
2006); extracts and a flavonol glycoside from Bauhinia galpinii (Aderogba et al., 
2007). Genotoxicity and mutagenic effects in the Salmonella microsome assay 
respectively have been reported in Crinum macowanii, Chaetacme aristata 
Planch. (Celastraceae), Plumbago auriculata Lam. (Plumbaginaceae), 
Catharanthus roseus (L.) G.Don. (Apocynaceae) and Ziziphus mucronata Willd. 
(Rhamnaceae) (Elgorashi et al., 2003). Additionally, Michellamine B-an alkaloid 
dimers isolated from Ancistrocladus korupensis was inhibitory to several 
laboratory and clinical strains of HIV-1, including the AZT resistant strain G910-6 
and the pyridinone-resistant strain A17; as well as strains of HIV-2. However, the 
high toxicity of this compound to several human cell lines prevented its further 
evaluation (Boyd et al., 1994). Data on the cytotoxic assessments of herbs are 
very few compared with the huge number of plants acclaimed to have 
therapeutic values (Oshima et al., 1986; Neuwinger, 2000).  This study 
investigated the cytotoxic effects of Aloe arborescens, A. striata, Cyathula 
uncinulata, Eucomis autumnalis, Hypoxis latifolia and Lantana camara commonly 
used in the treatment of gastrointestinal infections in the Oliver R. Tambo District 
Municipality (ORTDM), Eastern Cape Province, South Africa.   
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7.2. Materials and methods 
 
7.2.1. Plant material, extraction and fractionation 
 
Fresh plant parts were collected in ORTDM, Eastern Cape Province, South 
Africa between July 2008 and February 2010. The plants were identified in the 
Kei herbarium, Walter Sisulu University, South Africa where voucher specimens 
have been deposited. Information on the selected herbs is presented in Table 7.1 
(van Staden, 1981; Cunningham, 1993; Pooley, 1993; Inada et al. 1995; Dold 
and Cocks, 2000; Van Wyk and Gericke, 2000; Abdulla et al., 2009; Bisi-Johnson 
et al., 2010). The air-dried plant parts were extracted three times with methanol 
(Merck, Japan) and filtered using a Buchner funnel and Whatman No. 1 filter 
paper. The extracts were concentrated under reduced pressure at a temperature 
of 40oC using a rotating evaporator to yield methanol extract. The methanol 
extract was then suspended in deionised water and partitioned sequentially with 
Ethyl acetate and n-butanol. The fractions were concentrated under reduced 
pressure to yield the corresponding fractions and the remaining water fraction.  
7.2.2. Antibacterial assay 
 
The antibacterial assays involved the determination of the minimum inhibitory 
concentrations (MICs) of plant extracts against test organisms. The broth dilution 
method was carried out in 96-well microtitre plates using ampicillin-resistant and 
Table 7.1. Selected plants investigated and their usage 
 
Herb Local name Plant 
part 
Uses and Refences 
Aloe arborescens 
Mill 
Ikhala 
Inkalane 
Leaves Leaf decoction for diarrhoea (Bisi-
Johnson et al. 2009), effective 
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ASHODELACEAE encane (Z) burn treatment (Pooley, 1993) 
Aloe striata Ham 
ASHODELACEAE 
Inkalana (X) 
Intelezi (Ng) 
Leaves Leaf decoction for diarrhoea 
((Bisi-Johnson et al. 2009), 
purgative, expels worms 
Cyathula 
uncinulata 
AMARANTHACEAE 
Isinama (X) Leaves Leaf decoction for HIV treatment 
(Bisi-Johnson et al. 2009), 
stomach ailment 
Eucomis 
autumnalis 
HYACINTHACEAE 
Ubhulungu 
becanti (X) 
Umathunga 
(Z) 
Root Decoctions of bulb and roots for 
coli, flatulence (Cunningham, 
1993) 
Hypoxis latifolia 
HYPOXIDACEAE 
Ilabatheka 
(X,Z) 
Root Treat benign prostrate (van 
Staden , 1981); Headaches, 
dizziness, mental disorders, HIV 
inflammation (Singh, 1999; van 
Wyk, 2000); Boil ground dried 
tuber for diarrhoea. 
Lantana camara 
VERBENACEAE 
Ubuhobe 
besikhiwa 
(N) 
Mbarapati 
(S) 
Iqunube, 
utywala 
bentaka (X) 
Leaves 
Flower 
Leaf decoction for HIV treatment 
(this study); antivirus (Inada et al 
1995); rheumatism, sexually 
transmitted diseases (Dold and 
Cocks, 2000); treatment of wound 
(Abdulla et al 2009) 
 
Key: N – Ndebele; Ng – Nguni; S – Shona; X – Xhosa; Z – Zulu   
 
 
kanamycin-resistant strains of Escherichia coli as the test organisms. A 
McFarland No1 standard suspension of bacteria inoculum was prepared in sterile 
Mueller Hinton Broth (MHB). Triplicate tests were performed in a series of two-
fold dilutions of extract (10 mg/mL) as previously described (Eloff, 1998). 
Kanamycin was used as the positive control for ampicillin-resistant E. coli strain 
while ampicillin was used in the case of kanamycin-resistant E. coli strain. Plates 
were incubated at 37oC for 18 h and an hour before the end of incubation, 40 L 
of 0.2 mg/mL INT (p-iodonitrotetrazolium salt) solution was added to each well.  
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The lowest concentration indicating inhibition of growth was recorded as the 
MIC. This was indicated by the clear well after further incubation with INT as 
opposed to the pinkish colouration in growth wells. 
7.2.3. Cytotoxicity assays 
The in vitro cytotoxicities of the selected herbs and solvent-solvent 
fractions on a human hepatoma cell line, (Huh-7), which was established from a 
hepatocellular carcinoma were examined using a modified MTT assay (Plumb et 
al., 1989).  The Huh-7 was maintained at – 80oC in Dulbecco's Modified Eagle 
Medium (DMEM) and recovered from preservative by centrifugation. The pellet 
was re-suspended in fresh DMEM and cultured in a humidified atmosphere at 
37oC using RPMI 1640 supplemented with 10% foetal bovine serum, 100 U/mL 
penicillin G and 100ug/mL streptomycin and L-glutamine (Gibco BRL) in 5% CO2 
incubator (Thermo Fischer Scientific, Wakenyaku Co. Ltd, Japan). Cells were sub-
cultured every 2 days after confluent growth was observed.  
The MTT assay was carried out as follows. Briefly, the cells at a density of 
1×104 per cell were seeded in each well of a flat bottom 96-well plate containing 
100 µL of the growth medium. Cells were permitted to adhere for 24 h, and then 
treated with various fractions at concentrations 0, 1, 10 and 100 µg/mL for 72 h. 
After that, 20 µL of 5 mg/mL MTT in phosphate buffered saline (PBS) was added 
to each well and the plate was incubated for an additional 2 h. The medium was 
discarded and the formazan blue, which formed in the cells, were dissolved with 
100 µL MTT stop solution (Triton-X100-20 mL; Isopropyl alcohol-500 mL; HCl-2 
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mL). After incubation at 37oC for 10min, the absorbance of the dissolved 
solutions was detected at 490 nm on a microplate ELISA reader (Thermo 
Labsystems, Japan). Cytotoxicity was expressed as the concentration of extract 
or fraction inhibiting cell growth by 50% (IC50) and was analysed using MS Excel 
2007. All tests and analyses were run in triplicate.  
 
7.3. Results 
7.3.1. Antibacterial activities 
 
 The average MIC values of the plant extracts ranged from 0.27 mg/mL and 2.5 
mg/mL after 24 h of incubation (Figure 7.1). The Ethyl acetate fraction of each 
type of plant was the most active fraction against the test bacteria. E. autumnalis 
had the least MIC (0.27 mg/mL) followed by C. uncinulata (0.39 mg/mL) and 
thus demonstrated good antibacterial activities. The methanol extract of H. 
latifolia, water fraction of A. arborescens, C. uncinulata, E. autumnalis, and L. 
camara had the highest value of MIC (2.5 mg/mL).  
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Figure 7.1. Minimum inhibitory concentrations of plant extracts and fractions  
Figure legend: 
AA Me = Methanol fraction of A. arborescens (AA); AA Et = Ethyl acetate fraction 
of AA; AA Bu = n-Butanol fraction of AA; AA H2O = Water fraction of AA; AS Me 
= Methanol fraction of A. striata (AS); EUC Me = Methanol fraction of E. 
autumnalis (EA); EUC Et = Ethyl acetate fraction of EA; EUC Bu = n-Butanol 
fraction of EA; EUC H2O = Water fraction of EA; CI Me = Methanol fraction of C. 
uncinulata (CU); Et = Ethyl acetate fraction of CU; CI Bu = n-Butanol fraction of 
CU; CI H2O = Water fraction of CU; LCF Me = Methanol fraction of L. camara 
fruit/flower (LCF); LCF Et = Ethyl acetate fraction of LCF ; LCF Bu = n-Butanol 
fraction of LCF; LCF H2O = LCF Water fraction of LCF; LCL Me = Methanol 
fraction of L. camara leaves; HYP Me = Methanol fraction of Hypoxis latifolia. 
 
7.3.2. Cytotoxicities of methanol extracts and fractions. 
The results of cytotoxicities of the extracts and fractions of the 
investigated plants on human hepatic cell line (Huh-7) are shown in Table 7.2. 
The methanol extract of E. autumnalis (IC50 7.8 µg/mL) was more cytotoxic than 
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the control toxic substance, berberine (IC50 9.8 µg/mL), other plant extracts and 
solvent fractions.  
 
Table 7.2. Inhibitory concentration, IC50 (ug/ml) of selected herbs 
 
Code 
S/No 
Sample 
code 
Extract fractions IC50 (ug/ml) 
1 BUB Me AA Methanol fraction >1000  
2 BUB Et AA Ethyl Acetate 
fraction 
>1000  
3 BUB Bu AA n-Butanol fraction >1000  
4 BUB 
H2O 
AA Water fraction >1000  
5 BUS Me AS Methanol fraction 1000  
6 EUC Me EA Methanol fraction 7.8  
7 EUC Et EA Ethyl Acetate 
fraction 
28.5  
8 EUC Bu EA n-Butanol fraction 39.3 
9 EUC 
H2O 
EA Water fraction 379.0  
10 IS Me CU Methanol fraction 24.8  
11 IS Et CU Ethyl Acetate 
fraction 
36.3  
12 IS Bu CU n-Butanol fraction 30.0  
13 IS H2O CU Water fraction 714.0  
14 LCF Me LCF Methanol fraction 169.0  
15 LCF Et LCF Ethyl Acetate 
fraction 
44.1  
16 LCF Bu LCF n-Butanol fraction 150.0  
17 LCF H2O LCF Water fraction 1000  
18 LCL Me LCL Methanol fraction 161.0 
19 HYP Me HYP Methanol fraction 24.4  
PC Positive 
control 
Berberine  9.8  
 
Key: AA – Aloe arborescens; AS – Aloe striata; EA – Eucomis autumnalis; CI – 
Cyathula uncinulata; LCF – Lantana camara (flower/fruits); LCL – Lantana 
camara (leaves); HYP – Hypoxis latifolia. 
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Of the solvent fractions, the Ethyl acetate and butanol fractions of C. uncinulata, 
H. latifolia, E. autumnalis and L. camara had moderate cytotoxic effects on the 
cancer cell lines tested with IC50 values ranging from 24.8 µg/mL to 44.1 µg/mL 
while all the fractions of A. arborescens and A. striata had insignificant or no 
cytotoxic effects after 72 h of treatment (IC50 1000 to >1000 µg/mL).  
 
7.4. Discussion 
This study evaluated the cytotoxicity and antibacterial activities of 
methanol extracts and solvent fractions of A. arborescens, A. striata, C. 
uncinulata, E. autumnalis, H. latifolia and L. camara. Among all the samples, the 
methanol extract of E. autumnalis exhibited greatest cytotoxicity on the cell line 
tested with IC50 of 7.8 ug/mL). However, the water fraction of E. autumnalis and 
that of other plants showed markedly less cytotoxicity on the cell line, compared 
with the polar solvent fractions (Table 7.2). 
The Ethyl acetate fraction of E. autumnalis had the least MIC (0.27 
mg/mL) followed by C. uncinulata (0.39 mg/mL) against the test bacteria and 
thus demonstrated good antibacterial activities. Various biological activities of 
Eucomis were reported (Du Toit et al., 2005; Gaidamashvili and van Staden, 
2006). E. autumnalis is known for its anti-inflammatory and antispasmodic 
activities and these have been attributed to components such as 
homoisoflavones and flavonoids (Notten and Kirstenbosch, 2002). E. autumnalis 
also contains some steroidal triterpenoids which are known to be beneficial in 
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wound therapy (Notten and Kirstenbosch, 2002). However, the bulb was 
reported to be toxic (Notten and Kirstenbosch, 2002), in agreement with our 
findings.  
Eucosterol glycoside, a lanosterol oligosaccharides isolated from E. bicolor 
have demonstrated antitumor activity by causing 44% inhibition of TPA-
stimulated 32P incorporation into phospholipids of HeLa. This activity has been 
suggested to probably relate to the use of bulb decoctions of E. autumnalis to 
relieve abdominal distensions and abdominal pain by the Tswana and Pedi tribes 
of South Africa (Watt and Breyer-Brandwijk, 1962). According to Koorbanally et 
al. (2006), sheep drenched with fresh bulbs of E. autumnalis in an animal 
feeding trial presented with listlessness, anorexia, foaming at the mouth, 
tympanites, an inactive rumen and a strong pulse leading eventually to death 
within twenty-four hours. Despite these submissions Eucomis is one of the most 
traded genera of plants in South Africa (Dold and Cocks, 2002), hence the need 
for caution in their usage. 
The Hypoxis latifolia fraction also exhibited a considerable toxicity level 
(24.4 ug/mL). The antimycobacterial activity of hypoxoside has been attributed 
in part to the high cytotoxicity of this compound derived from Hypoxis species 
and this activity is presumed to be comparable to the cytotoxic effects 
demonstrated by Hypoxoside against melanoma cancer cells in vitro (Albrech et 
al., 1995). Lantana camara which is known to have several uses in 
ethnomedicine possessed moderate cytotoxic effects. The folk medicine uses includes 
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the treatment of cancers, chicken pox, measles, asthma, ulcers, swellings, eczema and tumors 
(Day et al., 2003). Some of the biological antagonistic or potential biocides usage 
includes the capability of its aqueous leachate at 1–3% to kill water hyacinth, a 
troublesome weed in many tropical countries even though its application as a weedicide depends 
on the size of the water bodies being treated and the cost of extraction of the leachate (Day et 
al., 2003). Some taxa of the widely variable L. camara complex are toxic to small 
ruminants and this effect has been associated with the types and relative 
amounts of some triterpene ester metabolites (Ghisalberti, 2000). Verbascoside, a 
bioactive compound from L. camara, was reported to possess antimicrobial, immunosuppressive 
and antitumor activities (Day et al. 2003). Other compounds isolated from L. camara: 
lantanoside, linaroside and camarinic acid have been investigated as potential nematocides 
(Begum et al. 2003).  
Cytotoxicity assay is a rapid inexpensive determination of significant 
quantities of biologically harmful contents of product measured as functions of 
fundamental biochemical pathways leading to cell death (Mosmann, 1983). 
Toxicity testing of ethnomedical preparations is essential because herbal 
products may contain undesirable or misidentified ingredients, sometimes toxic 
such as a toxic plant taken as a desired nontoxic plant or presence of heavy 
metals, radioactive particles, and microbes including pathogens, mycotoxins, 
endotoxins and pesticides (WHO, 2007).  In addition, safety assessment of 
herbal products is necessary for the safety of the recipients since herbs are 
generally heterogeneous, may produce multiple effects, and may affect multiple 
organs systems, including the nervous, cardiovascular, gastrointestinal, hepatic, 
renal, and hematologic systems (Barrueto and Hirshon, 2009). Furthermore, 
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cytotoxicity assay is a means of forestalling financial loss due to failure of a drug 
making it through the developmental processes. Some reasons for the failures 
are due to unacceptable toxicity levels (Ricerca, 1998). Testing hence prevent 
unacceptable compound going through unnecessary costly developmental 
stages. 
 Various methods are employed and these include using cell line assays 
and in vivo tests (use of animals). In addition, the brine shrimp (BS) mortality 
assay is widely accepted as a convenient probe for potential pharmacological 
activity in plants (Meyer et al., 1982), however some known toxic plants have 
exhibited non-toxic effect in brine shrimp (McGaw and Eloff, 2005) generating a 
misgiving on the capability of  BS detection of plant toxicity, hence the 
preference of cell-line cytotoxicity assay. Another approach to evaluate the safety 
of healthcare products is Bioequivalence studies in terms of toxicity effect. Two 
drugs are considered bioequivalent when there is no significant difference 
between them in terms of their absorption rates (Tu and Koh, 2010). Considering 
the body weight of each of two mice versus time for oral administration of two 
herbal products (TyrelTM and RumbionTM), Tu and Koh (2010) were able to 
conclude that there was no significant difference between the toxicity effect of 
TyrelTM and RumbionTM at 5000 mg kg-1 body weight. For the determination of 
mycotoxins in herbs, HPLC-based technique using a monoclonal antibody 
immunoaffinity column is recommended (Farmacopea Argentina, 2003). 
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7.5. Conclusion 
In conclusion, the results obtained indicated that the methanol extract of 
E. autumnalis exhibited much greater cytotoxicity than the methanol extract and 
solvent fractions of all other plants investigated even though it had strong 
antibacterial activities. E. autumnalis showed selective anticancer activity against 
the human hepatoma cell line, whereas the two Aloe spp. were non toxic on the 
cell line. In addition, the study showed that Aloe arborescens, A. striata and C. 
uncinulata may be candidate plants for eventual drug design. Medicinal plants 
are natural products and may have therapeutic potentials; however, being 
natural does not make them automatically safe. 
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CHAPTER 8 
 
GENERAL CONCLUSIONS AND RECOMMENDATIONS 
 
8.1. General conclusions 
Based on the results of this study, it is concluded that 
 The increasing rates of multi-drug resistant strains and emerging 
resistance of E. coli and Salmonella spp. to penem drugs and other 
antibiotics, regrettably may lead to fewer options of effective 
antimicrobials in the management of infections caused by the 
pathogens. 
 Molecular analysis showed that beta-lactamase enzymes (blaCMY-2, 
blaSHV-1, blaTEM-20 and blaTEM-1 genes) and class 1 integron (Int1) genes 
occurred significantly among the Salmonella spp.  
 Virulence of Salmonella spp. may be attributed to the virulence genes 
identified among the Salmonella strains; namely flic-flagellin H1, invA-
invasion, sefA- fimbrial antigen while aggR- transcriptional activator for 
EAEC aggregative adherence, fimbria I expression, eaeA-E. coli 
attaching and effacing and LT- heat-labile enterotoxin found among 
the E. coli isolates were the main indices of virulence. 
 Some of the diarrhoegenic E. coli isolated from apparently 
asymptomatic subjects expressed some virulence genes at frequency 
as high as seen in cases, which was an indication that asymptomatic 
individuals could serve as reservoirs of pathogenic strains of enteric 
238 
 
bacteria and may play a role in the spread and acquisition of virulence 
genes. 
 Ethnobotanical survey showed that traditional medicine was a popular 
and widely used system in the rural setting of ORTDM and was the 
only system available in many parts of the study areas.  
 Among the commonly used plants in traditional medicine, A. 
arborescens, A. striata, C. uncinulata, E. autumnalis and P. guajava 
exhibited antimicrobial properties and antibacterial activity was higher 
in the ethyl acetate fractions of the methanol extracts than other 
solvents employed. 
 Further fractionation and purification of bioactive components of the 
ethyl acetate fraction of C. uncinulata yielded an isolated compound, 
glycosylated oleanolic acid, a sugar with fatty acyl moiety, which had 
considerable antibacterial activities.  
 Cytotoxicity testing of the medicinal plants indicated that the methanol 
extracts of E. autumnalis were more cytotoxic than the methanol 
extracts and solvent fractions of other plants investigated, even though 
it had strong antibacterial activities. The use of E. autumnalis may 
therefore be fraught with risk of disagreeable side effects. The Aloe 
spp. studied were non toxic to cell lines, indicating strong potentials for 
drug development. 
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8.2. General recommendations 
The under-listed recommendations are made against the backdrop of the 
findings of the study. 
 Periodic studies on antimicrobial susceptibility or resistance patterns of 
E. coli and Salmonella spp. should be undertaken to provide updated 
information for empiric management of patients. 
 Public awareness campaigns or educational programs for traditional 
health care practitioners on the cytotoxic effects of some plants should 
be fore-grounded. 
 Extensive studies on the structural elucidation of the active compounds 
of the medicinal plants, including their effects on physiological, 
immunological and haematological parameters are necessary to further 
gauge their safety and potentials as candidate templates for drug 
design and discovery. 
 The administration of antibiotics, without results, on susceptibility 
testing may be fraught with risk due to increasing resistance profiles of 
E. coli and Salmonella spp. Therefore, antimicrobial therapy should be 
predicated on laboratory results of antibiograms.  
 Phylogenetic studies of E. coli and Salmonella spp. from different 
environmental and clinical sources, including correlation with virulence 
markers/ genes are recommended for a better understanding of their 
molecular epidemiology and pathogenicity. 
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APPENDICES 
 
 APPENDIX 1A 
 
 Faculty of Health Sciences 
      Department of Medical Microbiology, 
Nelson Mandela Drive, 
Private Bag X1, Mthatha 5117 
Tel/Fax: 047 502 2301 
VOLUNTEER INFORMATION SHEET 
TITLE OF PROJECT: “MOLECULAR CHARACTERIZATION, ANTIBIOGRAMS AND 
ANTIBACTERIAL ACTIVITIES OF SELECTED MEDICINAL PLANTS AGAINST SOME 
ENTERIC PATHOGENS” 
Hello! My name is Mary Bisi-Johnson and I would like to ask you for a little of 
your time to explain something to you, and ask you to please assist us in a 
research work that we are doing. As we discuss the information below please 
feel free to ask any questions.  
In South Africa, a substantial number of deaths due to diarrhoeal diseases have 
been reported. Some studies have implicated some of these enteric pathogens 
we are studying in cases of diarrhoea in people across ages. By doing this study, 
we will be able to know the germs that is making people sick of diarrhoea. We 
are at present doing a study that will be looking at the use of certain 
antibiotics/medicines and local herb in the community and how it affects the 
germs that infect people. We want to see if there is an increase in germs that 
will not be treated by antibiotics/medicines that we normally use and see if the 
local herb will be able to help. This will help in the control and prevention of 
these diseases.  
We would like to make sure that all the information we have about you is correct 
and then ask a few more questions about use of antibiotics. We will keep this 
information confidential, no one else will know that it is about you and all 
summaries or publications will only refer to group data.  
You can make the decision entirely on you own and none of us can force you to 
take part. If you decide to answer some of these questions, you may also change 
your mind at any time.  
You do not have to agree, and if you decide not to be involved it will not change 
the way you are treated in the hospital, and your doctor will not do anything 
differently.  
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Thank you for your time. Once you have asked any questions you may have, 
there is a form you need to sign if you agree to take part.  
Investigators details:  
Mrs. Mary Adejumoke Bisi-Johnson Contact No: 0766813494 
Prof. CL. Obi     Contact No: 047 502 2260/4 
Date:     
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APPENDIX 1B 
 
Faculty of Health Sciences 
       
Department of Medical Microbiology, 
Nelson Mandela Drive, 
Private Bag X1, Mthatha 5117 
Tel/Fax: 047 502 2301 
VOLUNTEER INFORMATION SHEET 
TITLE OF PROJECT: “MOLECULAR CHARACTERIZATION, ANTIBIOGRAMS AND 
ANTIBACTERIAL ACTIVITIES OF SELECTED MEDICINAL PLANTS AGAINST SOME 
ENTERIC PATHOGENS” 
Molo!, Igama lam ndingu Mary Bisi-Johnson, ndicela okokuba undiphe imizuzu 
embalwa kwixesha lakho onalo, ndinqwenela ukukucacisela nto ithile, 
ndikwakucela ukuba usincede kweli phulo siliqulunqayo. Xa sicacisa lo mba 
ongezantsi, uvumelekile ukuba ungabuza imibuzo. 
 
Emzantsi Afrika, Isibalo esiphezulu sabantu abasweleke ngenxa yesifo Sotyatyazo 
sithe sabikwa. Ezinye izifundo zithe zaveza ukuba ezintsholongwane esizifundayo 
zolutyatyazo zikho kubo bonke abantu, ukususela komncinci ukuyakutsho 
komdala. Ngokwenza ezizifundo, sizakuyazi intsholongwane ebangela ukuba 
abantu bagule sesisifo sotyatyazo. 
 
Okwangoku senza izifundo ezizakuthi zijonge ukuba leliphi ichiza/iyeza okanye 
nokuba sesiphi isityalo sasekuhlaleni nokuba liyichaphazela kanjani 
lentsholongwane esulela abantu. Sifuna ukubona ukuba iintsholongwane 
ezingenakunyangeka ngalamayeza ziyenyuka kusini na?, okanye Isityalo 
sasekuhlaleni singanceda na!!. Oku kunganceda Ekulawuleni nasekunqandeni ezi 
zifo. 
 
Singacela ukuqinisekisa ukuba zonke inkcukacha esinazo ngawe ziyinyaniso, 
siphinde sibuze eminye imibuzo ngokusetyenziswa kwamayeza/kwamachiza. 
Sizakuzigcina ezikcukacha ziyimfihlelo, Akukho namnye umntu ozakuyazi ukuba 
ezinkcukacha zingawe, kwaye wonke umpapasho uzakwenziwa ngesininzi. 
 
Isigqibo sesakho wedwa sokuba uyafuna ukuthabatha inxaxheba kwezi ngxoxo. 
Ukuba ufuna ukuphendula inxalenye yalemibuzo, naleyo ikuwe, isigqibo sesakho. 
 
Akunyanzelekanga ukuba uvume, kwaye ukuba awufuni ukubandakanyeka lonto 
ayizukutshintsha impatho oyifumana apha esibhedlele, noGqirha wakho 
akazukwenza tshintsho ngokwempatheko yokho. 
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Siyabulela ngexesha osiphe lona, Xa ubuzile imibuzo onganayo, kukho 
isivumelwano okufuneka usityikitye, ukuba uyavuma ukuthabatha inxaxheba. 
 
Iingcukacha zabaphandi: 
Mrs. Mary Adejumoke Bisi-Johnson   0766813494 
 Prof. CL. Obi      047 502 2260/4  
     
UMHLA: ………………………………. 
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APPENDIX 2A  
 
Faculty of Health Sciences 
      Department of Medical Microbiology, 
Nelson Mandela Drive, 
Private Bag X1, Mthatha 5117 
Tel/Fax: 047 502 2301 
INFORMED CONSENT 
TITLE OF PROJECT: “MOLECULAR CHARACTERIZATION, ANTIBIOGRAMS AND 
ANTIBACTERIAL ACTIVITIES OF SELECTED MEDICINAL PLANTS AGAINST SOME 
ENTERIC PATHOGENS” 
Investigators:  
Department of Medical Microbiology, WSU, Mthatha  
Mrs. Mary Adejumoke Bisi-Johnson      Contact No: 0766813494 
Directorate of Academic Affairs & Research, WSU, Mthatha  
Prof. CL. Obi     Contact No: 047 502 2260/4 
 
Hello! My name is Mary Bisi-Johnson and I would like to ask you some 
information. I will need to explain what it is we would like to do. You can help us 
a little if you listen and tell us what you think.  
We want to ask you or your mother/father/guardian some questions about you. 
We will ask questions about recent history of diarrhoea and about what 
medicines you took. We want to try and see if the germs we are studying 
(Salmonella and E. coli) are found in your stool and know the antimicrobial 
profile and the virulence factors. This is to enable us know whether the germs 
are causing more sickness in South Africa and if they are becoming more difficult 
to treat.  
Would it be alright for us to ask the above questions? When we work with this 
information we would not require your name.  
I have read and/or I understand the contents of the information sheet and 
understand that I have been invited to participate, that my agreeing is fully 
voluntary, and that I can withdraw at any time.  
 
A
Consent given:  Date: 
Witness:  Date: 
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APPENDIX 2B 
 
 Faculty of Health Sciences 
      Department of Medical Microbiology, 
Nelson Mandela Drive, 
Private Bag X1, Mthatha 5117 
Tel/Fax: 047 502 2301 
INFORMED CONSENT  
TITLE OF PROJECT: “MOLECULAR CHARACTERIZATION, ANTIBIOGRAMS AND 
ANTIBACTERIAL ACTIVITIES OF SELECTED MEDICINAL PLANTS AGAINST SOME 
ENTERIC PATHOGENS” 
Investigators:  
Department of Medical Microbiology, WSU, Mthatha  
Mrs. Mary Adejumoke Bisi-Johnson      Contact No: 0766813494 
Directorate of Academic Affairs & Research, WSU, Mthatha  
Prof. CL. Obi     Contact No: 047 502 2260/4 
 
Molo!, Igama lam ndingu Mary Bisi-Johnson, ndicela ukukubuza Imibuzo nje 
embalwa. Kuzakunyanzeleka ndikucacisele ukuba yintoni na le ndifuna siyenze. 
Ungasinceda ngokuba simamelane kwaye uyitsho into oyicingayo. 
 
Sicela ukubuza, wena No-Mama/No-Tata/Umniki Ncedo kwimpilo(Unomakhaya) 
wakho imibuzo ngempilo yakho nesigulo eso onaso. Sizakubuza imibuzo 
ngesigulo onaso nangamayeza obuwathabatha phambi kokuba uze Esibhedlele. 
Sifuna ukuzama, sibone ukuba intsholongwane le Siyifundayo/Siyihlolayo 
ayinguye na unobangela wezigulo esinazo apha emzantsi Afrika. 
 
Ingaba sivumelekile ukukubuza lemibuzo sele ndiyikhankanyile apha ngasentla, 
Xa sisebenza ngezinkcukaca asizukulibiza/ukulisebenzisa igama lakho. 
Ungaxhalabi xa uqonda ukuba kukho umbuzo ongacacelanga ukuwuphendula, 
akukho nento ezakujika ngempatho oyifumana kugqirha. 
 
Ndiyifundile/Ndiyawuqonda umxholo oqulethwe yile-ncwadilkwaye ndiyavuma 
ukuba  ndimenyiwe ndithabathe inxaxheba, kwaye ukuvuma kwam sisigqibo 
endizithabathele sona  ngokokwam kwaye ndingarhoxa nangaliphi ixesha 
ndithanda. 
 
IMVUME: UMHLA: 
INGQINA: UMHLA: 
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APPENDIX 3 
 
 
SURVEY INFORMATION FROM TRADITIONAL HEALERS ON HERBAL PLANTS IN 
TRADITIONAL TREATMENT OF DIARRHOEA 
 
DATE OF VISIT:                               PLACE OF VISIT: 
NAME OF TRADITIONAL HEALER: 
CONTACT ADDRESS & NO:  
 
Department of Medical Microbiology, WSU, Mthatha  
Mrs. Mary Adejumoke Bisi-Johnson      Contact No: 0766813494 
 
 
i) Do you treat Diarrhea? Yes  No   
ii) Do you treat some of other diseases linked to diarrhea? Yes    No 
iii) Do you treat both males and females? Yes  No 
iv) Which age group do you treat for diarrhoea?  
 
 
 
v) Do patients try self-treatment of diarrhea before consulting you? 
____________________________________________________________ 
  
vi) How effective is your treatment of diarrhea?________________________ 
____________________________________________________________ 
 ____________________________________________________________ 
vii) Do you experience cases where patients show adverse reactions to your 
treatment?  Yes  No   
viii) How do you feel about patients going to hospitals or clinics for further or 
(alternative) treatment?_________________________________________ 
____________________________________________________________ 
ix) Which plant/plants do you use for the treatment of diarrhea? 
____________________________________________________________ 
x) Do you use cultivated plants for the treatment of diarrhea? Yes   No  
Children Young adult Adult 
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xi) Which plant parts do you use?  
Leaves Stem Tree 
bark 
Whole plant Root Tuber Combination 
       
xii) How did you learn about the plant? From parent or during 
training______________________________________________________ 
xiii) What dosage/quantity do you give you patient?______________________ 
xiv) For how many days do they take the herb?_________________________ 
xv) How do you prepare your medication?  
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Appendix 4A. NMR spectrum for the isolated compound (SSC3-9-10). 
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Appendix 4B. Mass spectrum 1 for the isolated compound 
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Appendix 4C. Mass spectrum 2 for the isolated compound 
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Appendix 4D. Structure of the isolated compound 
 
 
 
 
 
 
 
 
 
 
 
